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Abstract 
 
Despite advances in medical research, the burden of disease in most countries remains high. 
Further, health inequalities continue to grow and emerging infectious diseases are still wreaking 
havoc across countries. To respond to contemporary public health challenges, a new systems 
thinking paradigm has emerged that highlighted a holistic approach towards health systems, 
resulting to an emerging field - health policy and systems research (HPSR). HPSR seeks to 
understand and enhance how societies organize themselves in achieving collective health goals, and 
how different actors interact in the policy and implementation processes. However, research gaps 
remain particularly in applying this paradigm to strengthen health systems performance across 
countries. This thesis contributes to HPSR by: a. examining the underlying concepts of health 
systems strengthening; b. determining how health systems contribute to better health outcomes, 
particularly on reducing infant mortality rates and improving life expectancies at birth, and c. 
understanding mechanisms to use findings from health systems strengthening assessments to inform 
global and national-level health policymaking processes.  
 
In 2015, 40% of the Global Fund investments go toward health systems strengthening (HSS). The 
global health threats posed by recent viral epidemics such as Ebola and Zika even further increased 
calls to invest in and develop better health systems. These health systems investments were also in 
most cases subjected to performance-based funding, but contrary to other monitoring and evaluation 
methods used for other health programs, health systems monitoring and evaluation demand a new 
analytical frame due to its complexity, along with the very different country capacities, uneven data 
sources and data availability and quality, including the varied contexts that drive priority areas for 
health systems. As such, monitoring these initiatives remain to be highly contentious despite its 
importance to inform health resource allocation. In particular, studies often highlighted different 
conceptual and methodological challenges associated with health systems assessments worldwide.  
 
To address these issues, I first introduced a new HSS framework based on existing monitoring and 
evaluation frameworks collected from my field experience, systematic reviews, and thematic 
analyses of existing HSS documents and database. Based on the developed HSS framework, 
existing HSS indicators were also examined to guide further analysis. Further, I quantitatively 
assessed health systems performance using a new composite indicator based on previous efforts for 
a global health systems performance index. To do this index, I used data collected from the 
Demographic Health Surveys, the World Bank Indicators, and the World Health Organisation 
  ii 
(WHO) Global Health Surveys. In particular, I used fixed-effects and random-effects regression 
analyses to determine how each health system characteristic affects health outcomes, particularly 
infant mortality rates and life expectancies. Specifically, I examined how global core health 
indicators can be used to assess each health systems building block (governance, financing, service 
delivery, health workforce, medical products and technologies, and health information systems. 
From global health systems assessments, I then examined the use of health systems monitoring and 
evaluation to assess one of the building blocks – governance – in Cambodia and the Philippines.   
 
In this thesis, I found about 3000 health systems indicators that countries can choose from to guide 
their current or future health systems performance assessments, while tailoring them into their 
specific country needs and contexts. In addition, I found a significant gap in country capacities to be 
able to monitor health systems performance, implying the need for better surveillance and reporting 
systems particularly in low- and middle-income countries. Further, I also quantified the 
contributions of each of the health systems building blocks to overall infant mortality rates and life 
expectancies and found that health systems can only effectively improve health outcomes if all of 
the building blocks are well-functioning. Using these information, I created an index for health 
systems performance assessments that can  be used for global monitoring and evaluation. Using this 
index, I found that many countries in Africa and Southeast Asia remain to have the least performing 
health systems, as well as health outcomes. The index was able to account for the different health 
systems building blocks, while controlling for socioeconomic factors and other health determinants. 
When applied in assessing health governance in Cambodia and the Philippines, I found that 
decentralization significantly contributed to improve Cambodia’s infant mortality rates, while 
finding a lesser effect for the Philippines. Given these findings, I concluded that health systems 
performance can be quantitatively assessed with these assessments providing comprehensive yet 
easily understandable overview of health systems performance in both national and global levels; 
hence, facilitating use in health systems decision-making processes.  
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“The very first requirement in a hospital is that it should do the sick no harm.” 
Florence Nightingale, a social reformer, statistician, and founder of modern nursing 
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Introduction 
 
Health systems strengthening (HSS) initiatives refer to improving the six health system building 
blocks (governance, financing, service delivery, health workforce, medical products and 
technologies, and health information systems) and their interactions to achieve more equitable and 
sustained improvements across health services and health outcomes (WHO, 2007). Millions of 
dollars were allocated under the umbrella of HSS (Warren, Wyss, Shakarishvili, Atun, & de 
Savigny, 2013). For example, the Global Fund, which is a partnership organisation designed to 
accelerate the end of AIDS, tuberculosis, and malaria as epidemics (Global Fund, 2015), allocated 
about 38% of its funding for HSS in 2015 (Warren et al., 2013). Around US$ 296 million was also 
allocated to specific health systems building blocks relevant to service delivery, human resources, 
and medicines and technology (Warren et al., 2013). Further, the global health threats posed by 
recent viral epidemics such as Ebola and Zika increased calls to invest in and enhance health 
systems performance (Moon et al., 2015).  
 
Figure 0.1 Percent distribution for round eight of the Global Fund grants: $184 million (14%) for 
system-wide HSS and $223 million (23%) for disease-specific HSS 
(Adapted from Warren et al., 2013) 
 
Allocation of these HSS resources is also subjected to performance-based funding (Low-Beer et al., 
2007). However, compared to other grants mechanisms, monitoring and evaluating health systems 
demanded a new analytical framework and approach since it is more complex with different 
country capacities to monitor and report on evaluation criteria. Specifically, countries have  uneven 
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data sources, limited data availability and quality, and varying factors that drive priority areas for 
health systems in different countries (Adam & de Savigny, 2012; Murray & Evans, 2003) . 
 
Research questions and objectives 
 
To guide health system resource allocation through evidence-based HSS monitoring and evaluation, 
I examined in detail HSS concepts, frameworks, and measures (Part A) and determined how health 
systems characteristics influence health outcomes, particularly child mortality rates and life 
expectancies (Part B). Specifically, I answered: 
1. How can HSS initiatives be assessed? This research question also involves answering the 
question “What are the key concepts and measures for assessing HSS”? 
Ø Objective 1: Determine how the concept of HSS relates to other priority areas for health; 
Ø Objective 2: Examine HSS concepts and develop an HSS framework based on existing 
health systems domains and measures; and, 
Ø Objective 3: Determine existing and potential HSS programme-level indicators tailored 
to assess specific country capacities and purposes. 
2. How significant are HSS initiatives to improve health outcomes? 
Ø Objective 4: Explore socioeconomic and institutional factors that may significantly 
influence child health outcomes and life expectancies; 
Ø Objective 5: Determine opportunities and barriers for developing a composite indicator 
for health systems performance and identify taxonomies of health systems performance 
in low- and middle-income countries; and, 
Ø Objective 6: Examine how HSS assessments can be conducted in specific country 
contexts. 
 
Contribution to knowledge 
 
One of the best measures of health progress is assessing health systems performance, which refers 
to the degree of achievement of the health system towards their health goals relative to their 
resources (Murray & Frenk, 2006). By monitoring and evaluating the health systems performance, 
aspects of health systems that significantly influenced health outcomes can be determined and 
resource allocation can be optimized to more efficiently respond to health needs (WHO, 2007). In 
contrast, inability to do such assessments may lead to failure to achieve health goals (WHO, 2000). 
Assessing health systems performance has been attempted in previous years, but remained highly 
contentious. In 2000, the WHO released findings on global assessments of health systems 
performance (WHO, 2000). However, the indicators and methods used may not necessarily reflect 
Introduction 
 4 
the country-specific needs and contexts, questioning their usefulness for policymaking (Brundtland, 
Frenk, & Murray, 2003; Musgrove, 2003). As such, comparative assessments of HSS remained a 
research gap (Basu, Andrews, Kishore, Panjabi, & Stuckler, 2012). Since HSS concepts and 
measures have not been agreed upon, it is also difficult to examine how effective HSS initiatives 
were in meeting their objectives, particularly for low- and middle-income countries1 (Decoster, 
Appelmans, & Hill, 2012).  
 
Although LMICs accounted for 84% of the world’s population with at least 90% of total disease 
burden, LMICs most likely do not have enough capacity to continuously monitor health systems 
progress (Macinko, Starfield, & Erinosho, 2009; Shukla & Johnson Lassner, 2012). This lack of 
enhance surveillance systems in LMICs may be explained partly by substantially lower per capita 
total health expenditure in LMICs compared with high income countries (Figure 0.2a). Specifically, 
average total health expenditure is only at $301 per capita in LMICs, more than ten times lower 
than that of LMICs at $3,370 per capita. This less government allocation for health in LMICs also 
implies lesser people who can access healthcare services. In 2000, over one billion people from 
LMICs living on less than $1 per day were unable to access healthcare services (Frenk, Bobadilla, 
Sepuulveda, & Cervantes, 1989). The limited health spending was also coupled by increasing 
disease burden from both non-communicable and communicable diseases (Figure 0.2b) (Knaul, 
Frenk, & Shulman, 2011; WHO, 2002, 2009b). These circumstances have further pushed people 
into poverty and increased both social and health inequalities in LMICs (Wilkinson & Marmot, 
2003).  
 
Various health systems reforms have been undertaken to address these pressing needs, but there is 
still limited evidence about the effectiveness of these reforms (Task Force, 2005). Previous studies 
argued that HSS assessments would have helped best inform policy decisions on health systems 
reforms (Adam et al., 2012). However, these types of research were even lesser in LMICs, where it 
is needed the most (Figure 0.2c) (Adam, Ahmad, Bigdeli, Ghaffar, & Røttingen, 2011). Official 
development assistance (ODA)2 may have helped increase health resources. Despite increasing 
ODA from 2000 to 2010 (Figure 0.2d), this increase does not necessarily put HSS assessments high 
on the agenda even if the development assistance is allocated for health systems (Bonita et al., 
2012; Costa Font & Sato, 2012). Hence, research that laid the foundations on HSS assessments 
                                                
1   LMICs refer to the World Bank’s member economies and all other economies with populations of more than 30,000 
that have a gross national income (GNI) per capita of $12,615 or less (as of 2012) (World Bank, 2015e). 
2   ODA are flows to countries and territories provided by the official or executive agencies to promote economic 
development and welfare of developing countries. ODA is concessional in character and conveys a grant element of 
at least 25% calculated at a rate of discount of 10% (OECD, 2016). 
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using data from high quality evidence is needed. However, previous research on assessing HSS has 
focused on select aspects of health systems rather than on more holistic system-wide approaches for 
monitoring and evaluation (Murray & Evans, 2003). Countries are also faced with the challenges of 
translating findings from HSS assessments to their specific country needs and practices (Jamison, 
2006), which could have helped achieve more efficient use of health system resources (Hoffman, 
Rottingen, et al., 2012).  
 
Figure 0.2 LMIC’s health systems profile by World Bank Income Groups: a) per capita total health 
expenditure (in PPPint$); b) burden of non-communicable diseases (NCDs), communicable 
diseases (CD), and injuries (inj), including total disease burden; c) number of health policy and 
systems research (hpsr) publications; and, d) amount of ODA commitments (in millions, 2009 US$) 
World Bank income groups: LIC – low-income countries, LMI - lower middle-income countries, 
UMIC - upper middle-income countries, HIC – high-income countries (World Bank, 2015e) 
Source: Author’s computations using data from 1990-2013 Demographic Health Surveys for 
figures a, b, and d (Rutstein & Rojas, 2006); and data from Adam et al (2011) for figure c. 
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Thesis outline 
 
This thesis follows the steps on HSS assessments outlined by (Murray & Frenk, 2000): 
a) conceptualize health systems by exploring their contexts, applying existing frameworks and 
indicators, and examining each health systems building block; and,  
b) determine health system performance by focusing on how a health system has reached its 
fundamental goal of improving health. 
Using both quantitative and qualitative data, this thesis examines HSS concepts and measures and 
applied findings in global and national contexts by determining how each health systems building 
block relates to select health outcome indicators such as infant mortality rates, life expectancy at 
birth, and immunisation coverage. The thesis is divided into two parts:  
 
The first three chapters (Part A) discusses the key concepts and metrics for HSS:  
1. Priority areas for health systems strengthening; 
2. Key performance frameworks and actors for monitoring and evaluating HSS initiatives; and,  
3. Data sources and tailored indicators for programmatic-level monitoring and evaluation of 
intermediate HSS results. 
The last three chapters (Part B) examines the relations between health systems building blocks and 
health outcomes:  
4. Health systems building blocks and health outcomes; 
5. Taxonomy of health systems performance in low- and middle-income countries; and,  
6. Health systems strengthening in the context of decentralization.  
Table 1 provides a summary of the thesis research questions and the corresponding objectives that 
each chapter seeks to address.  
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Table 0-1 Thesis outline 
Research 
questions 
Objectives Thesis chapters 
Part A. How 
can HSS 
initiatives be 
assessed? 
What are the 
key concepts 
and measures 
for assessing 
HSS?  
Objective 1: Determine how the 
concept of HSS relates to other priority 
areas for health; 
Chapter 1: Priority areas for health 
systems strengthening 
Objective 2: Examine HSS concepts 
and develop an HSS framework based 
on existing health systems domains and 
measures; and, 
Chapter 2: Key performance 
frameworks and actors for monitoring 
and evaluating HSS initiatives 
Objective 3: Determine existing and 
potential HSS programme-level 
indicators tailored to assess specific 
country capacities and purposes. 
Chapter 3: Data sources and tailored 
indicators for programmatic-level 
monitoring and evaluation of 
intermediate HSS results 
Part B. How 
significant are 
HSS initiatives 
to improve 
health 
outcomes? 
Objective 4: Explore socioeconomic 
and institutional factors that may 
significantly influence child health 
outcomes and life expectancies; 
Chapter 4: Health systems building 
blocks and health outcomes 
Objective 5: Determine opportunities 
and barriers for developing a composite 
indicator for health systems 
performance and identify taxonomies of 
health systems performance in low- and 
middle-income countries; and, 
Chapter 5: Taxonomy of health 
systems performance in low- and 
middle-income countries 
Objective 6: Examine how HSS 
assessments can be conducted in more 
specific contexts. 
Chapter 6: Health systems 
strengthening in the context of 
decentralization 
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Part A: Basic concepts and metrics for health systems strengthening 
 
Part A responds to the following research questions:  
1. How can HSS initiatives be assessed?  
2. What are their key concepts and measures?  
Part A determines how the concept of HSS relates to other priority areas for health, examines HSS 
concepts and develops an HSS framework based on identified key health systems domains and 
measures, and determines existing and potential HSS programme-level indicators tailored to 
specific country capacities and purposes. 
 
Prior to conducting global and national HSS assessments, transparency with the HSS framework 
and measures used as a basis for comparing attainment of health systems goals is needed 
(Braveman, 2003; van Olmen, Marchal, Van Damme, Kegels, & Hill, 2012). However, existing 
HSS frameworks, including HSS indicators, may not be applicable across many countries (Macinko 
et al., 2009; Shukla & Johnson Lassner, 2012). This thesis used two approaches suggested in 
previous studies (Murray & Frenk, 2000): a. examine public health priorities and strategies, and b) 
identify HSS frameworks and indicators. In particular, Part A highlights a new conceptual 
framework and compiles a list of HSS indicators that builds upon existing country-driven health 
systems monitoring and evaluation frameworks and other internal documents gathered from select 
countries, field observations, and two international organisations. This bottom-up approach ensures 
that findings are more reflective of the national health systems priority areas and strategies, which 
were deemed necessary to more responsively inform the formulation of health policies, programs, 
and priorities. Developing and examining these frameworks and measures were essential to create 
more informed strategies for assessing health systems and determining priorities for improvement 
(Papanicolas & Smith, 2013), as well as to improve efficiency, equity, and quality of healthcare 
deliveries (Arah, Westert, Hurst, & Klazinga, 2006).  
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Chapter 1 Priority areas for health systems strengthening 
 
This chapter provides an overview of the state of HSS in the field of public health and how inter-
sectoral actions, as well as both small-scale and large-scale actors, may influence the HSS agenda. 
As the number of stakeholders involved in HSS increases, there is a need to frame the HSS agenda 
in relation to health promotion and public health endeavours. This framing will help clarify further 
HSS concepts and goals and provide an evidence base for informing HSS initiatives. In this chapter, 
I did a thematic analysis of sixteen key statements about health promotion and health systems 
strengthening from 1978 to 2016 to extract key HSS themes and foci. As a way of understanding 
the historical context for HSS, these themes clarify the health system priority areas and how these 
areas have evolved over the past years. I found nine themes which were common across all the 16 
statements: a. improving equity, access, and social justice; b. increasing funding and better priority 
setting to achieve universal health coverage (UHC); c. improving governance for health; d. building 
capacities for research, health workforce, and health systems; e. creating better collaboration and 
cooperation, as well as integrating and embedding health across sectors; f. reorienting towards 
improved community action and people-centeredness; g. determining appropriate metrics, and 
developing better monitoring and evaluation processes for health systems; h. creating a supportive 
environment for health and addressing key health determinants; and, i. calls for action from 
different health system actors.  
 
1.1 Consensus statements and global health 
 
Over the years, there has been a growing shift of the global health agenda from disease-specific to 
systems-thinking approaches. Specifically, ambitious health-related Sustainable Development Goals 
can only be achieved if countries invest on health systems (Tangcharoensathien, Mills, & Palu, 
2015). However, there are essential considerations needed to guide decisions on health priorities: 
 
First, investing more on health systems calls for stronger evidence about health systems priorities 
and the different bottlenecks that existing HSS interventions aim to address (Shakarishvili et al., 
2011; Tangcharoensathien et al., 2015). As such, HSS also demands better technical capacities for 
data analysis and evidence-based participatory decision-making and action (Brownson, Baker, Leet, 
Gillespie, & True, 2010; Nutbeam, 1998). Such evidence should inform countries on how to align 
their country-specific HSS targets to the global HSS targets, provide updates about the development 
of country-specific HSS frameworks, and define potential measures for monitoring and evaluating 
HSS progress (Hoffman, Røttingen, et al., 2012; Tangcharoensathien et al., 2015).  
Chapter One 
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Second, HSS research also needs more multi-sectoral interventions from different actors working 
towards better health outcomes such as international organisations, community health workers, 
physicians and other allied health workers, as well as ministries of different sectors from health, 
financing, and education (Shakarishvili et al., 2011). In particular, national leadership and 
governance play a critical role in HSS (Shakarishvili et al., 2011).  National leaders can be held 
accountable for their health systems performance and in monitoring progress and impact towards 
global health systems targets (Papanicolas & Smith, 2013). In return, national leaders who track 
progress possess an essential tool to ensure country coordination and improve implementation 
(Gostin & Friedman, 2013; ter Veen & Commins, 2011). Otherwise, weak leadership and 
governance can result to poorer health systems performance; hence, lower achievement of health 
outcomes (Mehrotra & Jarrett, 2002). 
 
To illustrate these two key considerations, conference or “consensus statements” from global health 
events can be examined since these statements  serve as useful references for a better understanding 
of what was known about a topic at a particular point in time, including whether gaps in research 
identified at the time of each conference have since been filled (NIH, 2013). In addition, the 
conference participants endorse these statements with the goal of providing a call to action and a 
more concrete guidance (WHO, 2013c), placing pressure on global and regional stakeholders and 
governments (NIH, 2013). Hence, these statements promoted or advocated a position or specific 
information and offered guidance to the stakeholder’s community regarding an organisation’s 
stance on health care policies and programs (NIH, 2013). Some types of statements were also 
targeted towards ensuring visibility of the issue being discussed such as HIV/AIDS, and infectious 
diseases, among others (NIH, 2013). Over the years, different organisations have also been 
publishing their statements. In PubMed alone, the average number of statements published 
increased from an average of 20 statements in 2000 to about 80 statements in 2014. Hence, 
conference statements can be used to identify research gaps and health systems agenda. In 
particular, statements can provide an evidence base, which can be analysed to give an overview of 
global priority areas and calls for evidence. As such, I did a thematic analysis of conference 
statements to see what international organisations tell about their foci, targets and calls for action 
towards HSS and other health promotion strategies. 
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Figure 1.1 The number of records that resulted from PubMed, an online database search engine, 
using the search word “conference statements” and “consensus statements” published from 1978 
to 2016. 
 
When mapped with the key conference statements identified by Ghaffar et al (2016), two records in 
1980 increased to about four times within ten years with peaks after the 2008 Global Ministerial 
Forum on Research for Health (n = 179 in 2009 (Figure 1.2). 
 
1.2 Methods 
 
I selected the 1978 Alma-Ata Declaration as a starting point because it was the first international 
declaration underlining the significance of primary health care, which has since then been accepted 
by the WHO Member States as key to achieving the “Health for All” goal (WHO, 1978). To gather 
more statements published since the 1978 Alma-Ata Declaration, I used internal documents from 
the WHO headquarters in Geneva, Switzerland and searched other online databases:  
 
First, I used statements available from the websites of organisations involved in global health with 
past or on-going HSS initiatives such as through provision of HSS grants and/or publications of 
HSS resources or guidelines (e.g. World Health Organisation, the GAVI Vaccine Alliance, 
President’s Emergency Plan for AIDS relief (PEPFAR), the Global Fund to Fight AIDS, 
Tuberculosis, and Malaria, and the European Commission).  
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Figure 1.2 Number of HSS-related conference statements released per year and plotted against 
health policy and systems research milestones. These milestones were adapted from the previous 
study of Ghaffar et al (2016) (Ghaffar, Gilson, Tomson, Viergever, & Røttingen, 2016). 
 
Second, I used HSS-related statements published by PubMed, Embase, and other online databases. I 
also retrieved articles from the reference lists of available HSS statements, if any. By and large, I 
conducted the search from August 2015 to March 2016. To search online databases, I used the 
search terms “health systems” and “statements” or “health systems strengthening” and “statements” 
in combination with the WHO health systems building blocks (health financing, service delivery, 
human resources, health information systems, medicines and technologies and governance) (Figure 
1.2). This framework was preferred because it was the most commonly used compared with other 
HSS frameworks (Marchal, Cavalli, & Kegels, 2009).  
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Figure 1.3 The WHO Health Systems Building Block Framework 
Adapted from: WHO, 2010b 
 
Inclusion criteria include: a) statements focusing on health systems; b) statements that have a global 
or regional geographic focus; and c) statements published in English. I excluded journal articles, 
review articles, books and book chapters.  
 
Overall, I collected 1187 documents, of which  277 duplicates were removed. The 910 retained 
documents include: 39 documents collected from the HSS organisations; 175 documents from 
websites of key HSS events; and 696 documents from online databases. I then removed 709 records 
without concrete HSS targets and proposed actions and statements focusing on disease-specific 
rather than systems-thinking approaches, retaining 201 statements. Another 185 documents were 
then excluded due to their geographical focus on national priorities instead of its application to 
global or regional HSS decision-making. In the end, I had sixteen statements retained for further 
analysis. 
 
To extract key themes from the statements, I first transcribed and inputted the textual information 
into RQDA, which is a qualitative analysis software application from R package used to assist in 
the analysis of textual data (RQDA, 2016). Specifically, I extracted the following information: 1) 
publication citation including authors, title, journal name, year of publication, and place of 
publication; 2) corresponding information on the venue and date of the conference where the 
statement was released; 3) whether the statement focuses on health systems; and 4) any HSS goals, 
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targets and calls to actions. I then extracted the descriptive characteristics of the retrieved articles in 
a table to produce a textual summary of the results. This enabled the exploration of themes both 
within and between the studies reviewed.  
 
After extracting the textual data, I then grouped them into sub-themes and themes, which was done 
in consultation with three other health systems researchers. I chose thematic analysis, a method that 
is often used to analyse data in primary qualitative research, because it does not require any pre-
existing theoretical framework and can be used within different theoretical frameworks (Braun & 
Clarke, 2006). I categorized the textual data based on health system goals, targets, and any calls for 
action. First, I identified health systems goals which may include average level of health or average 
health adjusted life expectancy, the distribution of health or the differences in health-adjusted life 
expectancy across social groups, the average level of process outcome or the patient experiences, 
distribution of process outcome or the differences in experiences between patients across social 
groups, and financial fairness or the persons in poverty because of health system payments (Franken 
& Koolman, 2013) Second, I identified health systems targets, which should align new 
interventions with developing country health systems and provide a clear rationale for each of the 
desired health systems characteristics (Brooks et al., 2012). Third, I examined any calls to action or 
statements providing instructions to a target audience with the goal of provoking an immediate 
response (Vallacher & Wegner, 1985). Then, I selected key themes out of the categories identified 
for each health system goals, targets, and calls for action. The themes were then discussed with the 
other authors and refined until an agreement is reached about the thematic areas. Overall, I found 
nine overarching themes and 44 sub-themes.  
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Figure 1.4 Selection flow diagram 
 
The sixteen statements used in the analysis include: 
Table 1-1 Conference statements selected for thematic analysis 
Year Title Conference Name Venue 
(Country) 
Venue 
(Country) 
1978 Alma-Ata Declaration 
(WHO, 1978) 
International Conference on 
Primary Health Care 
Alma-Ata Kazakhstan 
1986 Ottawa Charter for Health 
Promotion (WHO, 1986) 
First International 
Conference on Health 
Promotion 
Ontario Canada 
1988 Adelaide Recommendations 
on Health Public Policy 
(WHO, 1988) 
Second International 
Conference on Health 
Promotion 
Adelaide Australia 
1991 Sundsvall Statement on 
Supportive Environments 
for Health (WHO, 1991) 
The Third International 
Conference on Health 
Promotion: the Sundsvall 
Conference  
Sundsvall Sweden 
1997 Jakarta Declaration on 
Leading Health Promotion 
into the 21st Century 
(WHO, 1997) 
The Fourth International 
Conference on Health 
Promotion: New Players for 
a New Era - Leading Health 
Promotion into the 21st 
Century 
Jakarta Indonesia 
2000 Mexico Ministerial 
Statement for the Promotion 
Fifth Global Conference on 
Health Promotion 
Mexico 
City 
Mexico 
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of Health: From Ideas to 
Action (Catford, 2000) 
2004 The Mexico statement on 
health research (WHO, 
2004) 
Ministerial Summit on 
Health Research 
Mexico Mexico 
2005 The Bangkok Charter for 
Health Promotion in a 
Globalized World (WHO, 
2005) 
Sixth Global Conference on 
Health Promotion 
Bangkok Thailand 
2008 Shaping the future of health 
promotion: priorities for 
action (IUHPE, 2008) 
International Union for 
Health Promotion and 
Education (IUHPE)  
Vancouver Canada 
2008 Tallinn Charter: Health 
Systems for Health and 
Wealth (WHO, 2008b) 
WHO European Ministerial 
Conference on Health 
Systems 
Tallinn Estonia 
2009 Venice concluding 
statement on maximizing 
positive synergies between 
health systems and global 
health initiatives (WHO, 
2009d) 
High-level Dialogue on 
Maximizing Positive 
Synergies Between Health 
Systems and Global Health 
Initiatives 
Venice Italy 
2010 Montreux Statement (HSG, 
2010) 
First Global Symposium on 
Health Systems Research 
Montreux Switzerland 
2012 Beijing Statement (HSG, 
2012) 
Second Global Symposium 
on Health Systems Research  
Beijing China 
2013 The Helsinki Statement on 
Health in All Policies 
(WHO, 2013e) 
8th Global Conference on 
Health Promotion  
Helsinki Finland 
2014 Cape Town Statement 
(HSG, 2014) 
Third Global Symposium on 
Health Systems Research  
Cape town South Africa 
2016 Bangkok Statement 
(Mahidol, 2016) 
Prince Mahidol Award 
Conference 
Bangkok Thailand 
 
1.3 Results 
 
1.3.1 Common themes on priority areas, targets and calls for action 
 
I found nine thematic areas: a) enhancing equity, access, and social justice; b) increasing funding 
and better priority setting to achieve UHC; c) improving governance for health; d) building 
capacities for research, health workforce, and health systems; e) creating better collaboration and 
cooperation, as well as integrating and embedding health across sectors; f) reorienting towards 
improved community action and people-centeredness; g) determining appropriate metrics and 
developing better monitoring and evaluation processes for health systems; h) creating a supportive 
environment for health and addressing key health determinants; and i) calling for action from 
different health system actors (Figure 1.6).  
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a. Enhancing equity, access, and social justice 
 
Fifteen of the 16 statements highlighted the need to address equity, access and social justice. Equity 
refers to gender equity (WHO, 1986) (WHO, 1988) (WHO, 1991) (WHO, 1997) (WHO, 2009d) 
(HSG, 2012), access to medicines (WHO, 2009d) (HSG, 2014), inequities in health information, 
and emerging technologies. Specifically, the statements call for the use of reliable, unbiased and 
timely health information (WHO, 2004) (IUHPE, 2008) and high-quality health care services 
(WHO, 2008b), while relying on the best available evidence. The digital divide was apparent since 
2008. Specifically, emerging technologies was said to lead to rapid structural changes to 
inequalities (WHO, 1988) despite its importance to improve health and support more informed 
decision-making (IUHPE, 2008; WHO, 2008b). Using technology allows primary health care to be 
based on practical, scientifically sound and socially acceptable methods and technology made 
universally acceptable to individuals (WHO, 1978). It is a valuable tool for priority setting for 
health (HSG, 2014; Mahidol, 2016). As such, re-channelling of health resources should also include 
the transfer of safe and reliable technology (WHO, 1991). Meanwhile, access to medicines was 
called for since the 1978 Alma Ata Declaration (WHO, 1978), along with the equitable delivery of 
vaccines and diagnostics (WHO, 2004), and the ethical and effective use to support evidence-
informed decision-making (WHO, 2008b) (WHO, 2009d). Similarly, social justice was called for 
since the 1978 Alma-Ata Declaration. Social justice was identified as a pre-requisite for health with 
the basic principle of ensuring access to health (WHO, 1988). Hence, primary health care is a key 
part of development in the spirit of social justice (WHO, 1978) (WHO, 1991) (WHO, 1997) (WHO, 
2013e).  
 
b.  Increasing funding and better priority-setting to achieve Universal Health Coverage  
 
All statements called for the need to increase funding and better priority-setting towards Universal 
Health Coverage (UHC). These calls affirmed the need to bring more effective HSS to accelerate 
UHC (HSG, 2010) (HSG, 2012), specifying UHC not only as a health systems task but a societal 
goal (HSG, 2014). Further, it calls for UHC to be led by citizens, local and national governments 
rather than external actors (Mahidol, 2016), recognizing that UHC will require difficult trade-offs 
between the number of people covered and the scope of services provided. To achieve UHC, HSS 
needs to develop and embed evidence-informed and transparent priority-setting processes into UHC 
decisions (Mahidol, 2016).  
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Figure 1.5 The different themes and sub-themes identified using thematic analysis as illustrated by RQDA.
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c. Improving governance for health 
 
All statements highlighted the importance of better governance systems for health, including the 
need to ensure accountability, strengthened advocacy, better evidence translation and transparency:  
First, governance requires accountability of both the national and global sectors. Specifically, 
accountability demands a clear political commitment to health and equity  (WHO, 1986) (WHO, 
1988) (WHO, 1991) (IUHPE, 2008) (WHO, 2008b) (WHO, 2013e). At the global level, the United 
Nations was also called to be accountable for the health impact of the development agenda 
(Catford, 2000). In addition, governance entails heightened advocacy, which also necessitates 
improved communication mechanisms. Specifically, decisions should be communicated with the 
groups mostly affected by the policy concerned (WHO, 1988), as well as the communities and 
governments involved (WHO, 1991) (IUHPE, 2008) (HSG, 2012) (HSG, 2014). To support this 
approach, media support for community capacity and empowerment should be sought (WHO, 
1997) (WHO, 2004) (HSG, 2010) (WHO, 2013e). Third, calls for evidence translation was traced 
back as early as the 1978 Alma-Ata Declaration when it called for primary health care to be based 
on practical, scientifically sound, and socially acceptable methods and technology (WHO, 1978). 
Using high quality research, experts can then be mobilized to translate the evidence and ensure its 
usefulness for policy-making (Mahidol, 2016) (WHO, 2004) (IUHPE, 2008) (WHO, 2008b) (HSG, 
2010) (WHO, 2009d) (HSG, 2012). Evidence translation is also a pre-requisite towards  transparent 
governance mechanisms (WHO, 1997) (WHO, 2004) (WHO, 2008b) (WHO, 2013e) (Mahidol, 
2016). Last, statements also highlighted the need to mediate, which demands consultation and 
negotiation (WHO, 1988). In particular, coordination among all concerned (WHO, 1986), 
particularly among those with conflicting interests in society, is needed (WHO, 1991). For example, 
mediation among politicians and the private sectors is said to be essential for advocacies (IUHPE, 
2008) to strengthen the capacity of the Ministries of Health (WHO, 2013e).   
 
d.  Building capacities for research, health workforce, and health systems 
 
Another theme was on building better research and institutional capacities. It was particularly 
emphasised during the 2004 Mexico Statement on Health Research (WHO, 2004). To build 
capacities, current health information systems and its human capacities should be developed 
through quality education and training. For health information systems, highly integrated, 
functional, and mutually supportive referral systems are needed (WHO, 1978) (WHO, 2009d) 
(HSG, 2012) to evaluate the impact of policy and practice (WHO, 1988) (IUHPE, 2008), to ensure 
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a single point of access (WHO, 2004), and to assist those at the frontlines of healthcare (HSG, 
2014). For the health workforce, education and training were said to be the keys in building 
institutional capacities (IUHPE, 2008; WHO, 2008b;  HSG, 2014; WHO, 1978; WHO, 1986; 
WHO, 1988; WHO, 1991; WHO, 1997; IUHPE, 2008; WHO, 2008b; WHO, 2009d; HSG, 2010;  
HSG, 2014).  
 
e. Creating better collaboration and cooperation, integrating and embedding health 
across sectors 
 
Calls for better collaboration and cooperation, as well as integrated and embedded health 
promotion, were noted in all statements. Since the 1978 Alma-Ata Declaration, all countries have 
been requested to cooperate in the spirit of partnership and service to ensure primary health care for 
all (WHO, 1978; WHO, 1986; WHO, 1988; WHO, 1991; WHO, 1997). Strengthened mechanisms 
of collaboration are urgent to address the social, economic, and environmental determinants of 
health (Catford, 2000). This collaboration includes global and public-private partnerships (WHO, 
2004; WHO, 2005; WHO, 2013e), particularly building alliances with the civil society (WHO, 
2005) and health professionals (IUHPE, 2008). In addition, collaboration includes coordinated 
interventions and approaches, such as linking health efforts to economic and social policies, as well 
as education, transport, housing and urban development. Of particular importance is the need for 
South-South exchange of innovations specifically to achieve UHC (HSG, 2012). In return, 
collaboration will facilitate exchange of information on which strategies have proved to be effective 
and in which settings (WHO, 2008b; WHO, 2009d;  HSG, 2010), as well as support mutual 
assistance within and among countries (WHO, 1997; IUHPE, 2008; WHO, 2008b; WHO, 2009d; 
HSG, 2012; Mahidol, 2016).  
 
f.  Reorientation towards improved community action and people-centeredness 
 
Reorientation of health systems towards improved community action and people-centeredness has 
also been called for since the 1978 Alma-Ata Declaration. Individuals are the main health resource 
and their voices are of utmost importance to healthcare (WHO, 1986). Specifically, people have the 
right and duty to participate individually and collectively in healthcare planning and 
implementation (WHO, 1978). Collective efforts are then central to foster healthy public policy as 
these efforts ensure community involvement and control (WHO, 1988; WHO, 1991). To achieve 
people-centeredness, there is also a need for community capacity and empowerment (WHO, 1997; 
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WHO, 2004; WHO, 2005; IUHPE, 2008; WHO, 2009d; HSG, 2012; WHO, 2013e; HSG, 2014;  
Mahidol, 2016).  
 
g. Determining appropriate metrics and developing better monitoring and evaluation 
processes for health systems 
 
Monitoring and evaluation of health system processes and determining more appropriate metrics are 
also needed to assess the impact of policy (WHO, 1988) and to make health services more 
responsive to people’s needs (WHO, 1997; HSG, 2014). Evidence from monitoring and evaluation 
also guides the design and implementation health system reforms (WHO, 2008b) as it considers the  
complexity of health systems, policies, and implementation processes; thereby, capturing the 
historical origins, current status and future long-term health impacts (HSG, 2012; WHO, 2004;  
IUHPE, 2008; Mahidol, 2016). Essential to these monitoring mechanisms is the development of 
adequate health and social measures, which are responsibilities of the governments (WHO, 1978). 
Measures include developing and using indicators, their methods, and instruments to assess health 
progress and reduce mortality and morbidity (IUHPE, 2008; WHO, 2008b; HSG, 2010; HSG, 
2012). In addition, developing conflict of interest measures (WHO, 2013e) and agreeing on clear 
targets and indicators for health systems strengthening (Mahidol, 2016) are also needed.  
 
h. Creating supportive environments for health and addressing key health determinants 
 
Supportive environments may mean proper loving and working environments (WHO, 2013e),  
effective environments (HSG, 2014), or enabling environments for priority setting processes 
(Mahidol, 2016). These environments are essential for health promotion (WHO, 1986; WHO, 1997; 
IUHPE, 2008) and serve as the main aim of healthy public policy (WHO, 1988). Further, these 
environments also call for the inevitable need to prevent and control diseases from locally endemic 
diseases (WHO, 1978), new and re-emerging infectious diseases (WHO, 1997; Catford, 2000;  
IUHPE, 2008), mental health problems (WHO, 1997), other communicable and non-communicable 
diseases (WHO, 2004; WHO, 2008b; HSG, 2010), sexual and reproductive health, injuries, 
violence (WHO, 2004), and maternal and child health (WHO, 1978; WHO, 2009d; HSG, 2010). 
Lastly, these environments also include promotion of food supply and proper nutrition (WHO, 
1978;  WHO, 1986; WHO, 1988; WHO, 2009d).  
 
i. Calls to action from different health system actors 
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All health system actors such as governments, the international community, funders, and research 
community are also called for to increase accountability for health (WHO, 1978; WHO, 1988;  
WHO, 1991; WHO, 1997; Catford, 2000;  WHO, 2004; WHO, 2008b; WHO, 2013e). Actors were 
also called to build capacities that will help advance the promotion of health and proliferate funding 
for health, health systems, and health research (WHO, 1978; WHO, 1988; Mahidol, 2016; WHO, 
2008b; HSG, 2014;  WHO, 2013e; WHO, 2004; WHO, 2012c; WHO, 2009d). In addition, health 
actors were called to improve guidelines and policies based on the principles of sustainable 
development (WHO, 1988;  WHO, 2005; WHO, 1991; WHO, 2009d), assist the development of 
enabling environments for health and health systems, and increase their commitment to health. 
Further, health actors should coordinate and strengthen current health and health system networks 
(WHO, 1978; WHO, 1988; Jakarta Declaration; WHO, 1997; WHO, 2008b; WHO, 2013e; WHO, 
2004; Mahidol, 2016; WHO, 2009d). Health actors were also invited to share the key health 
messages, and establish activities to communicate, improve access to, and promote the utilization of 
health information (WHO, 1997; WHO, 2004;  WHO, 2013e).   
 
1.4 Reframing health service delivery to address system-wide priority areas 
 
Findings showed nine themes, which were common among all 16 statements delivered from 1978 to 
2016 (Figure 1.7). These themes echoed across all health actors and were not driven by individual 
or organisational health priorities. Instead, the themes reflected global consensus among the 
different health systems actors that may also have conflicting interests. As such, these themes can 
be a good starting point to resolve any conflicting interests for health investments. Hence, these 
themes demonstrate priority areas for health that resonate across various health actors, serving as a 
tool to achieve the health goals across sectoral boundaries. 
 
The years 1998 to 2008 were considered as the grand decade of global health (Lidén, 2013), when 
global health approaches shifted from a problem-focused to a more system-focused approach. 
Specifically, the main approaches include establishment of partnerships, improved coordination, 
and attempts to introduce objective evidence-based decision-making for the allocation of 
multilateral resources (Lidén, 2013). However, I found that these themes have been called for even 
before the grand decade of global health. What seems to change in 2008 was not the approach, but 
the emphasis given to these key themes (Figure 1.8). In 2008, two key statements with global 
impacts, Shaping the future of health promotion and the Tallinn Charter, have specifically been 
identified. As such, although the nine themes consistently resonated throughout the years, the 
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intensity of the messaging around the themes change with some years stressing one area over the 
others (Figure 1.8).  Nevertheless, systems-wide dimensions of equity, universal health coverage, 
and governance have remained common areas of interest, implying that global health approaches 
have ever since taken a comprehensive view of health. Hence, moving the discussions forward 
would always require going beyond the organisational vision and avoiding the risks of overlooking 
significant global health dimensions.  
 
The repetitiveness in the themes may seem to be interpreted in two ways. First, these themes meant 
consistency in the global health approaches that transcends beyond the political will and conflicting 
interests of the Member States. On the other hand, this repetitiveness may also be viewed as a 
cyclical global health process or a never-ending global health burden without much progress, 
implying that more innovation is needed to move the discussions forward.  To innovate, reporting 
on progress against these identified key themes should be considered. This reporting will guide 
further tracking and monitoring of progress made against key issues identified and ensure that 
statements were not just cyclical and rhetorical. To facilitate reporting on progress, recent 
developments in health information systems create timely opportunities (Ledikwe et al., 2013). 
Using advances in information systems, global health targets should be backed up by relevant data 
for each recognized theme to also unify sporadic global health efforts. To improve health 
information systems especially data availability and quality, international stakeholders have 
conducted consultative workshops, particularly with LMICs (COHRED, 2005). These data can be 
starting points for further academic work on each of the themes and to facilitate their translation for 
evidence-informed decision-making (Rice, 2013).  
 
Other than tracking progress against these themes, another challenge is on propose concrete actions 
to address HSS issues. In particular, impact assessment and results framework are seldom 
developed to monitor global health statements. An interim assessment mechanism for these themes 
may include setting concrete parameters for each of the priority themes agreed upon. Hence, 
tracking progress and proposing concrete actions should be part of a shared accountability among 
the various health actors. Specifically, accountability implies the existence of well-established 
transparent processes for monitoring progress and performance of the different stakeholders in 
achieving their own targets. Accountability is also needed to inform current processes for health 
planning and decision-making. Other than accountability, the themes and other priority areas by 
each organisation should always be made transparent to the broader community. To achieve 
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transparency, statements should be made to include a more inclusive policy dialogue and better 
evidence-informed healthcare decisions.  
 
Overall, examining these statements was vital to determine priority areas in global health. Not only 
will monitoring health statements enhance accountability and inclusiveness of the different health 
stakeholders, it will also provide an overview of the state of governance in global health and how 
inter-sectoral actions, as well as both small-scale and large-scale actors affect progress and 
performance in healthcare. This chapter was intended to provide a global overview of the health 
systems situation with statements that have global implications. Given this objective, any 
statements with implications specific were excluded. For example, many statements were found 
from the US National Institutes of Health, but the implications of these statements were also limited 
within the jurisdiction of the US. Future studies may examine these statements at a national level. 
Ideally, global health statement and commitments should be accompanied by clear objectives, 
goals, and monitoring and evaluation processes, which reflect sound logic and sufficient robustness. 
It may also include proposed budgets, as well as more specific, measurable, and attainable targets 
and strategies for health systems strengthening. Future studies may consider expanding these 
statements to include other consensus documents of different health actors. More importantly, 
future studies should examine related data sources and other relevant indicators to track progress 
against these global health themes.  
 
To examine these data sources and indicators, this thesis further examines the different aspects of 
health systems, and the potential measures that can be used to frame a more comprehensive 
monitoring and evaluation system for health care services. Future chapters use the themes identified 
from this chapter to guide further work on developing an HSS framework (Chapter 2), and 
examining potential and existing HSS indicators (Chapter 3) before applying these HSS measures in 
global (Chapters 4 and 5) and national contexts (Chapter 6).  
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Figure 1.6 Nine common themes identified from the thematic analysis. These themes were found common across all the sixteen global consensus 
statements delivered from 1978 to 2016
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Figure 1.7 Diversity of thematic areas and the number of codes identified per year of publication. 
The number of words (codes) related to the nine thematic areas that were found from the sixteen 
global consensus statements. These codes were plotted against the years when the associated 
consensus statement was delivered from 1978 to 2016.  
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Chapter 2 HSS performance theoretical frameworks and key actors  
 
Chapter One identifies nine common themes emerging from global health statements that highlight 
how global health discussions moved towards system-wide priority areas for health. It also 
discusses the need to provide clearer and more specific health targets, as well as provide concrete 
measures to monitor such targets. By examining existing concepts, frameworks, and domains used, 
as well as key health actors, for HSS monitoring and evaluation across the WHO European Member 
States, I developed an expanded theoretical framework for conceptualising HSS based on an 
analysis of country-driven frameworks from the 53 Member States of the WHO Regional Office for 
Europe and using the WHO health systems building blocks framework. Overall, this chapter 
provides baseline information on how HSS monitoring and evaluation is being done across the 
European Region. Where data permit, I developed a template for HSS monitoring and evaluation 
framework and processes that other countries can use as a guide for their own. This chapter is based 
on research I did during an internship with the WHO Regional Office for Europe Division of 
Information, Evidence, Research, and Innovation. Using internal documents, transcripts of 
interviews made among select WHO Member State representatives, administrative data and other 
health systems-related reports published online and provided by the WHO Europe’s Country 
Offices, I examined existing HSS frameworks and domains used by select WHO Europe Member 
States to monitor and evaluate HSS initiatives. Findings were used to inform ongoing research on 
Europe’s regional HSS monitoring and evaluation guidelines using the HSS definitions, domains, 
indicators, and processes examined in this chapter.  
 
2.1 Defining health systems strengthening 
 
In examining HSS initiatives, it is first necessary to define health systems and other related 
concepts. (Hammer & Burill, 2012). Generally, health systems are defined using the WHO’s 
definition, which refers to all activities whose primary purpose is to promote, restore or maintain 
health (WHO, 2009c). Specifically, HSS is described as improving the six health system building 
blocks (governance, financing, service delivery, medical products and technologies, health 
workforce and health information systems) and managing their interactions to achieve more 
equitable and sustained improvements across health services and health outcomes (WHO, 2000). 
Due to complexity and the multifaceted relationships among health systems functions, it is difficult 
to operationalize the definition of HSS that will be useful for more dynamic and holistic monitoring 
and assessment processes (De Savigny & Adam, 2009). As such, although the thesis is initially 
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guided by the WHO health systems definition and the WHO Health Systems Building Block 
framework, findings revealed other relevant health system areas, which are also existing measures 
used by the Member States. 
 
2.2 Research gaps in HSS assessments 
 
Health policymakers have emphasized the importance of using health systems evidence to improve 
performance (El-Jardali et al., 2012). To provide evidence, HSS monitoring and evaluation can help 
determine aspects of health systems that significantly influence health outcomes and enable 
resource allocation to make service delivery more efficient (Palen et al., 2012). Determining these 
aspects will aid governments that are pressured to provide better health services, while also 
restraining taxation levels (Lopez Acevedo, Krause, Mackay, & World, 2012). These scenarios 
motivated governments to create formal systems for monitoring and evaluation on a regular, 
planned and systematic basis to provide evidence and inform health decision-making processes 
(Lopez Acevedo et al., 2012).  
 
However, conceptualising health systems and assessing their performance are driven by two 
competing needs. On the one hand, there is a need to have a common framework and agreed-upon 
measures. On the other hand, different countries have different capacities to comply with a common 
framework. Country-specific contexts also matter, implying that a common framework and set of 
measures may not be as responsive to local needs considering the country’s priorities, levels of 
resources, data availability, and local capacity to monitor and evaluate. Therefore, there is a need 
for a framework that is general enough to be applicable in different contexts but is also able to 
accommodate within country differences (Berman & Bitran, 2011; Murray & Frenk, 2000). Hence, 
multilateral organisations recommended that countries should have their own HSS framework and 
measurement systems that are more likely in line with their national priorities and health needs 
(Papanicolas & Smith, 2013).  
 
However, not all countries have the capacity to do their own HSS frameworks and measures. In a 
report released in 2015 by the WHO European Region, only 32 of the 53 Member States claimed to 
have an existing HSS monitoring and evaluation system, of which mostly are poorer countries 
(Tello & Baez-Camargo, 2015). Despite the need for evidence to guide allocation of their limited 
resources, poorer countries have less capacity to conduct data collection and monitoring systems. 
These countries also tend to have national monitoring and evaluation systems that were also 
chronically challenged by persistently incomplete reporting and inaccurate data, which undermined 
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the translation of evidence into policies and practices (Ekouevi, Karcher, & Coffie, 2011). To 
address this gap, comparative HSS assessments may be able to respond to the limited availability of 
comparable data, while providing a vast potential for both within and cross-country learning 
(Murray & Frenk, 2006; Nakaima, Sridharan, & Gardner, 2013; Papanicolas & Smith, 2013; 
Rasmussen, Collins, Doty, & Garber, 2013). However, challenges remain on how evidence from 
HSS assessments of other countries can be used to improve current HSS efforts (De Savigny & 
Adam, 2009). To ensure responsiveness to current health needs and health systems priorities, 
community participation for HSS monitoring and evaluation is significant (Donnelly et al., 2011; 
Valdez-Vivas et al., 2015). Communities play a vital role in setting the scene, priorities and also 
future directions of HSS and should, therefore, be mapped and analysed (Hoffman, Røttingen, et al., 
2012). Therefore, aligning HSS with national priorities and health needs requires better 
understanding of how health systems interact with the wider economic, political and social 
structures (Papanicolas & Smith, 2013).  
 
2.3 HSS monitoring and evaluation in the European context 
 
HSS monitoring and evaluation in Europe and beyond has largely been catalysed by various 
organisations, signature events and policy or program statements and frameworks (Avila, Menser, 
& McGreevey, 2009). For example, the Organisation for Economic Co-operation and Development 
(OECD) convened policymakers to discuss progress in pursuing a performance measurement and 
improvement cycle (OECD, 2002). This event included studies on international comparisons 
highlighting important aspects of performance, and outlined the range of levers that policymakers 
and healthcare managers can use to improve their health systems (OECD, 2002). Meanwhile, the 
Member States of the WHO Regional Office for Europe committed to improve people’s health by 
strengthening health systems, acknowledging that high-performing health systems contribute to 
economic development and wealth in 2008 (WHO, 2010a). These commitments formed part of the 
Tallinn Charter that also calls for more health systems investments, as well as promoting 
transparency and accountability for HSS to achieve measurable results and health system reforms 
(WHO, 2010a). To implement the Tallinn Charter, the WHO supported its Member States in the 
development of health systems and in providing cross-country coordination, as well as the 
measurement of performance and the exchange of experiences in implementing their commitments 
(WHO, 2010a).  
 
In addition, the European Observatory on Health Systems and Policies also reported about the 
various opportunities and challenges for performance measurement, examined the levels at which 
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HSS assessments were to be undertaken, and outlined the technical instruments and tools available, 
as well as their implications for policymaking (P. Smith, Mossialos, & Papanicolas, 2008). Since 
then, many other notable health systems publications were released (P. Smith et al., 2008;  WHO, 
2012a;  WHO, 2012b). In 2014, the European Commission along with its Member States also 
formed an Expert Group3 on HSS monitoring and evaluation, specifying the need to better 
understand how health systems were progressing and to use this information to carry out HSS 
interventions. The Commission also noted that a sound HSS was essential to identify good and bad 
practices, strengthen the effectiveness of care, increase accessibility, and improve patient-safety 
(EuropeanCommission, 2015b). HSS assessments have also been widely emphasized in many of the 
Commission’s high-level meetings (EuropeanCommission, 2015d). The Expert Group also 
emphasised the importance of developing practical, accessible and resilient health systems and of 
creating modern, responsive and sustainable health systems (EuropeanCommission, 2015c). In 
2015, German Chancellor Angela Merkel and the WHO  Director-General Dr Margaret Chan also 
highlighted the need for all countries to have stronger and more resilient health systems (WHO, 
2015i).  However, resilience cannot be achieved without a better understanding of how current 
health systems are performing (Avila et al., 2009; Dalziell & McManus, 2004). To support these 
health systems monitoring, baseline information on the existing HSS domains and indicators are 
needed.   
 
To summarise the various activities done by the Member States to strengthen health systems 
accountability, the WHO European Region conducted a study, which found that some Member 
States were developing overarching national health strategies for a whole-of-government 
responsibility, rather than health sector plans (Tello & Baez-Camargo, 2015). This scenario created 
new challenges when it came to monitoring HSS, as it expanded the scope beyond the five health 
systems building blocks defined by the WHO. The Report also showed that at least 32 of the 53 
Member States claimed to have HSS assessments already in place, of which some also had existing 
HSS indicator packages (Tello & Baez-Camargo, 2015).  By 2020, the WHO European Region 
envisions improve health for all, reduce the health divides, and improve leadership and participatory 
governance for health (WHO, 2013b). To do these visions, the Region plans to invest in health 
through a life-course approach and people empowerment; tackle Europe’s major health challenges: 
NCDs and communicable diseases; strengthen people-centred health systems, public health 
                                                
3  This Expert Group included members from Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, 
Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, 
Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden. 
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capacities and emergency preparedness, surveillance and response; and, create resilient 
communities and supportive environments (Table 2-1) (WHO, 2013b).  
 
Table 2-1 The Health 2020 European Policy Framework 
Two strategic objectives: 
Working to improve health for all and 
reducing the health divide 
Improving leadership, and participatory 
governance for health 
Four common policy priorities for health: 
Investing in health 
through a life-
course approach 
and empowering 
people 
Tackling Europe’s 
major health challenges: 
NCDs and 
communicable diseases 
Strengthening people-
centred health systems, 
public health and 
capacities and emergency 
preparedness, 
surveillance and response 
Creating resilient 
communities and 
supportive 
environments 
Source: WHO 2015 
 
Countries also adopted a European policy framework and strategy for the 21st century titled Health 
2020, wherein one of the priority areas focused on strengthening people-centred health systems 
(WHO, 2012d). This monitoring framework is intended to identify the core areas of health and 
highlights the need for establishing accountability mechanisms for every country (WHO, 2013b).  
 
Table 2-2 Health 2020 Policy Monitoring Framework 
Reduce 
premature 
mortality 
Increase 
life 
expectancy 
Reduce 
inequalities 
Enhance 
well-being 
UHC and 
right to 
health 
National 
targets 
Premature CVD, 
cancer, diabetes, 
and chronic 
respiratory 
mortality 
Tobacco use 
Alcohol 
consumption 
Overweight and 
obesity 
Vaccination 
coverage 
External causes 
of mortality 
Life 
expectancy 
at birth 
Infant mortality 
Life expectancy 
at birth 
Primary school 
enrolment* 
Unemployment 
rate* 
National 
inequality 
policies 
GINI coefficient 
Life 
satisfaction 
 
 
 
Objective 
indicators 
Out-of-
pocket 
expenditure 
as percent of 
total health 
expenditure 
Vaccination 
coverage 
Total health 
expenditure 
as percent of 
gross 
domestic 
product 
National 
policies aligned 
with Health 
2020 
Implementation 
plan 
Accountability 
mechanism 
 
 
Source: WHO 2015 
 
Examining HSS was particularly relevant in the context of the European Region, where there was 
wide variability in HSS monitoring and evaluation practices (Tello & Baez-Camargo, 2015). Since 
countries within the European Region are members of many international organisations that are 
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doing HSS, there is a need to better understand these existing concepts and measures before 
attempting to develop standardised HSS frameworks and measures. Furthermore, different 
international organisations may have different HSS frameworks that were provided to countries as a 
guide thereby potentially creating confusion and in some cases, reporting nightmare. Hence, this 
makes examining the overall picture of what HSS is for these countries extremely important. WHO 
had the widest reach across Europe with 53 Member States as of April 2016. Of these 53 Member 
States, 20 of them were exclusive only to the WHO Europe and were not part of the OECD and the 
European Commission. 28 of the WHO Member States were also members of the European 
Commission and 26 of the WHO Member States are also members of the OECD. 21 Member States 
were also members of both the European Commission and the OECD.  
 
Table 2-3 International organisation memberships of the countries in the European Region 
Membership: Number of countries: 
Exclusive to the 
WHO 
20 Albania, Andorra, Armenia, Azerbaijan, Belarus, Bosnia and 
Herzegovina, Georgia, Kazakhstan, Kyrgyzstan, Macedonia, 
Moldova, Monaco, Montenegro, Russia, San Marino, Serbia, 
Tajikistan, Turkmenistan, Ukraine, and Uzbekistan 
Both the WHO and 
the OECD 
5 Iceland, Israel, Poland, Switzerland, and Turkey 
Both the WHO and 
the European 
Commission 
7 Bulgaria, Croatia, Cyprus, Latvia, Lithuania, Malta, and Romania 
All: WHO, 
European 
Commission, and 
OECD 
21 Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, 
France, Germany, Greece, Hungary, Ireland, Italy, Luxembourg, 
Netherlands, Norway, Portugal, Slovakia, Slovenia, Spain, Sweden, 
and United Kingdom of Great Britain and Northern Island 
Source: Author’s computations using internal data from WHO Europe (last updated August 2015) 
 
Given that there are various frameworks, concepts and approaches that were being utilised by each 
of these international organisations such as the OECD and the European Commission, determining 
existing HSS measures is not only vital to ensure coherence and achieve a minimum degree of 
comparability across all countries. Moreover, a better understanding more country-driven HSS 
processes will prevent any potential confusion in the recommended approaches or in setting 
guidelines for HSS monitoring and evaluation across countries, while limiting or eliminating any 
reporting burden to countries. Such an approach is expected to lead to better country-specific 
population health goals (Gottret, Schieber, & Waters, 2008). As specified by Tello and Baez-
Camargo (2015): 
“The process of reviewing and assessing HSS against stated outcomes enables decision 
makers to develop and implement the necessary measures to assure continued improvement 
of health outcomes in an evidence-based manner” (Tello & Baez-Camargo, 2015). 
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Given the variety and complexity of existing HSS frameworks and monitoring and evaluation 
initiatives, this chapter examines HSS as used in the European context by identifying the different 
definitions, critical domains, and indicators used by the Member States. It also explores why 
Member States undertake HSS and describes the principal actors involved in conducting HSS.  This 
approach allows me to develop a consistent conceptual framework and provide a set of 
recommendations for appropriate measurement, monitoring and evaluation.  Based on field 
observations and to the best of knowledge, no previous research has examined and described the 
different packages of system level indicators for HSS through a bottom-up approach. This has 
highlighted these concepts and measures in such depth and breadth across the different HSS 
domains and indicators used by each Member State. Findings were expected to assist other 
countries in developing and designing HSS monitoring and evaluation systems and towards 
achieving the health systems targets set in the Health 2020 Policy Framework and the Tallinn 
Charter that Member States committed into. 
 
2.4 Conceptual framework 
 
As discussed above, the European Region was characterised by a broadly common approach to HSS 
monitoring and evaluation, with general dimensions and similarities, but also country-specific 
variations.  To deal with this variability, I used a conceptual framework that identified core 
dimensions involved in HSS to capture the relevant information pertaining to HSS, while still 
taking into account the different approaches currently in place across the European Region. 
Strengthening health systems was one of the six items on the Agenda of the WHO and it envisioned 
to establish core and additional health system metrics to track health system performance for use by 
countries and external agencies (WHO, 2010a). Through this, governments may be able to monitor 
their progress and be more informed on whether their investments in health systems have actually 
translated to better health outcomes (WHO, 2010a). 
 
Other international organisations and government agencies such as the World Bank, United States, 
Australia and other OECD countries follow their own HSS monitoring and evaluation framework. 
In this study, I used the WHO health systems building block framework to further operationalise the 
definitions of health systems and its core HSS requirements. I chose the WHO health systems 
framework because all the 53 countries included in this research were WHO Member States. This 
framework included six essential health system building blocks: service delivery, health workforce, 
information, medical products, vaccines and technologies, financing, and leadership/governance 
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(WHO, 2015d). Intermediate results of effective and efficient health systems building blocks were 
expected to include improved access, coverage, quality and safety of health services (WHO, 
2015d). These were all vital to achieve the expected overall goals and outcomes of a health system 
(WHO, 2015d). 
 
2.5 Methods 
 
2.5.1 Data sources  
 
Data sources include health systems-related documents (e.g. national strategic plans for health or 
health systems, HSPA reports, national health target reports) for each Member State. Initially, I 
purposively sought for the HSPA reports cited in the Accountability Study. Then, I searched for 
other health system-related documents from the websites of ministries of health, national boards of 
health, national health institutes or agencies, other government resources, and publications of 
international organisations (i.e., WHO, European Commission, the OECD). I gathered health 
systems-related documents published from 1993 to 2016. These documents include national health 
accounts, joint annual reviews, national health targets and other health development strategy 
reports, health systems in transition reports, and health system reviews from international 
organisations.  
 
2.5.2 Selection criteria and screening process 
 
Initial data collection resulted in 640 records, which included 326 publications from PubMed and 
Embase (n = 326); national health accounts, joint annual reviews, and other health development 
strategies or health target reports taken from official websites of national institutions (n = 134), 
health system reviews conducted by international organisations such as OECD and the European 
Commission (n = 11), health systems in transition report of the European Observatory on Health 
Systems and Policies (n = 84), and records identified through database searching (n = 85). Of the 
640 records, 312 duplicates and documents without publicly available records were removed and 
328 records were retained. Fifty-seven documents, of which 51 documents focused on regional 
comparison of health systems performance and not on country-level measurement, were further 
removed. The other six documents removed from the final selection focused on discussing general 
concepts of health systems performance instead of existing health systems measures used by the 
Member States.  These studies were excluded in the analysis because the focus of the research was 
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on country-driven HSS monitoring and evaluation that should also reflect concrete measures on 
national level HSS initiatives. After this initial screening, I was left with 271 documents.  
 
Each Member State may have several reports related to HSS such that one Member State may have 
an OECD health system review, health systems in transition reports (HiTs), and an HSS report 
released in different years. Since the goal of this research was to describe the most recent HSS 
monitoring and evaluation practice in each WHO Member State, I selected only the latest report per 
Member State for further analysis. The selection follows this order of preference: complete HSS 
reports, partial HSS reports, national health systems reviews, national strategic reports, national 
health targets, joint annual reviews, OECD health systems reviews, HSS articles or journals and 
HiTs. Per consultations with WHO experts, I gave priority to documents that explicitly stated that it 
was an HSS report e.g. title used or the description of the report stated that it was an “HSS 
monitoring and evaluation” report or a “health systems (performance) monitoring and evaluation” 
report. These reports may either be complete (n = 9) or partial (n = 6) for every Member State. A 
complete HSS report had HSS domains and indicators explicitly stated. A partial HSS report meant 
that it provided information about the conduct of HSS in the Member State but did not necessarily 
provide a comprehensive list of HSS indicators. The second type of report included interview 
transcripts from the WHO Regional Office for Europe. To get these transcripts, key representatives 
from the Member States’ Ministry of Health were interviewed to provide their insights on how they 
do HSS monitoring and evaluation. I included partial HSS reports in the study because they still 
reported HSS domains that can provide insights into the HSS priority areas of each country. For 
those Member States without any full or partial HSS report, a national strategic report or review (n 
= 34) was then selected next since these reports were country-driven and still reflected HSS priority 
areas. To be included in the study, these reports should also have a section on “assessing health 
systems” or “monitoring and evaluating HSS.”  
 
OECD health systems studies (n = 3) then followed, after which HiTs (n = 20) were used. The order 
of preference for the documents was consulted with the WHO Europe. All HiTs were considered as 
national strategic reports. OECD reviews of health systems were in-depth studies of the health 
system of Member States with a particular focus on economic issues (Arah et al., 2006; Hurst & 
Jee-Hughes, 2001; Reinhardt, Hussey, & Anderson, 2002). OECD reports assessed the performance 
of health systems in a comparative context, identified the main challenges faced by the country’s 
health system and put forward policy options to better meet health systems challenges (Arah et al., 
2006; Hurst & Jee-Hughes, 2001; Reinhardt et al., 2002). According to the OECD, these reviews 
were initiated at the request of the country to be examined, placing emphasis on specific issues of 
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key policy interest (Arah et al., 2006; Hurst & Jee-Hughes, 2001; Reinhardt et al., 2002). Each 
report described the country's health system, assesses its strengths and weaknesses regarding access 
and insurance coverage, responsiveness to patient needs and quality of care, efficiency in health 
service provision, and financial sustainability (Arah et al., 2006; Hurst & Jee-Hughes, 2001; 
Reinhardt et al., 2002). It also included an analysis of the major recent reforms or programs of 
particular relevance to the country and recommended how to address policy and performance 
challenges (Arah et al., 2006; Hurst & Jee-Hughes, 2001; Reinhardt et al., 2002). OECD reviews of 
health systems were informed by comparative data analysis, specific indicators and benchmarking 
of policies from other OECD countries (Arah et al., 2006; Hurst & Jee-Hughes, 2001; Reinhardt et 
al., 2002). The OECD Secretariat analysed the country-specific documentation and data for the 
country under review (OECD, 2015a). Meanwhile, health systems in transition series (HiTs) were 
used to provide an overview of the health system (Albreht et al., 2009). HiTs were reports from the 
European Observatory on Health Systems and Policies, which “systematically described the 
functioning of health systems in countries as well as reform and policy initiatives in progress or 
under development” (EuropeanObservatory, 2015a). HiTs were available for most WHO Member 
States, as well as some additional OECD countries, were updated on a regular basis, and were 
mostly available in English (Albreht et al., 2009; Glenngård, Hjalte, Svensson, Anell, & 
Bankauskaite, 2005).  
 
I consulted WHO’s HSS experts throughout the study selection. Overall, 52 documents were 
selected for final analysis and to represent the most recent HSS practice for each of the 52 (out of 
53) Member States of the WHO Europe. I did not find any relevant document to reflect HSS 
measures used in Serbia, and the documents used in Israel did not list any indicators. All the 
documents selected for analysis were in English. I excluded reports in local languages due to 
limited capacity for translating the contents of the report. Each WHO country office or the 
Ministries of Health contacted for the study was also not required to provide translated materials in 
English. As of date, they were not contacted again to validate or verify the selected HSS reports 
used for the analysis. 
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Figure 2.1 Selection flow diagram 
 
2.5.3 Analysis 
 
To extract the data, I copied any health systems domains and indicators identified from the 
document into an excel spreadsheet. In the excel sheet, I created two categories: themes and 
indicators. Specifically, I copied the headings of the report in verbatim and categorized them as 
“themes”. Similarly, any subheading and figure or table titles were copied as is and categorized as 
“indicators”. Every indicator corresponds to its theme that was specified in the document. The list 
resulted to about 3000 indicators. I, in collaboration with two other health systems researchers, 
screened the list and retained the information if the indicator: a) assesses health system performance 
or progress, b) is measurable and specific, and c) has data that is readily available or can be 
reasonably collected. I also removed any duplicates in the indicators. After repeatedly screening the 
list, I retained 2,282 indicators. Further, I also extracted HSPA frameworks illustrated in any of the 
documents we have initially collected regardless of whether the report satisfied our initial inclusion 
criteria or not. Overall, I found 13 HSPA frameworks. 
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During the initial phase of the study, I coded each heading in the report and classified them as ‘HSS 
domains’ and any specific indicators for each heading in the HSS report were also coded and 
classified as ‘HSS indicators.’ Each HSS domain was then clustered under each of the WHO health 
systems building blocks as discussed in the section above. I did a semantic similarity analysis 
(SSA) to identify domains and indicators used for HSS monitoring and evaluation by calculating 
the normalized Google distance for each identified domains. Keywords with the same or similar 
meanings in a natural language sense tend to be close in units of normalised Google distance, while 
words with dissimilar meanings tend to be farther apart. Specifically, the normalized google 
distance between two keywords x and y is: !"# $, & = 	)*+ ,-. / 0 ,,-. /(2) - ,-. /(0,2),-. 5-)67 ,-. / 0 ,,-. /(2)       (2.1) 
where !  is the total number of web pages searched by Google multiplied by the average number of 
singleton search terms occurring on pages; f(x) and f(y) are the number of hits for search terms x 
and y, respectively; and f(x,y) is the number of web pages n which both x and y occur (Cilibrasi & 
Vitanyi, 2007). If NGD(x,y) = 0 then x and y are viewed as likely possible, but if NGD(x,y) >1, then 
x and y are very different (Cilibrasi & Vitanyi, 2006, 2007).  
 
After retaining similar words, I then used the Cortical.io keyword extraction software 
(http://www.cortical.io/keyword-extraction.html) to generate the keywords from the pool of 
domains identified (De Sousa & Eduardo, 2016). The Cortical.io is a natural language processor 
and an automatic keyword generator, search engine optimizer, and content classifier (De Sousa & 
Eduardo, 2016). It works by parsing the input text and creating a semantic fingerprint for the entire 
input test as well as for each of its individual terms (De Sousa & Eduardo, 2016). These fingerprints 
were compared with the text fingerprints to determine their semantic overlap, which is then 
weighed together with the proportion of occurrences of each term in the input text in comparison 
with its frequency within the entire coding Retina to determine its overall important to the text (De 
Sousa & Eduardo, 2016). I also created new HSS clusters for every domain identified from the 
records that did not directly fall under the WHO health systems building block. For the indicators, I 
removed any indicator disaggregates or stratifiers (e.g. gender, age, or equity) to identify unique 
indicators. 
 
2.6 Results 
 
2.6.1 Correlation between types of report and country memberships 
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I first examined whether countries with most memberships also produced more types of health 
systems reports (e.g. complete HSS, partial HSS, national health target reports). At least nine 
different types of reports have been identified as relevant to health systems assessments for 
countries with memberships for all three international organisations that also have different HSS 
frameworks: the WHO, the European Commission and the OECD. I collected the most number of 
documents from the United Kingdom with nine strategic reports, one HiT, one complete HSS 
report, one partial HSS report, and two health systems reviews. In contrast, I found the least number 
of reports from Belarus (one HiT), Montenegro (one strategic report). These two countries are also 
exclusive members of the WHO. 
 
Table 2-4 Types of documents collected per Member State 
Number of types of documents Frequency Percent 
1 4 7.55 
2 24 45.28 
3 16 30.19 
4 5 9.43 
5 2 3.77 
6 1 1.89 
9 1 1.89 
Total 53 100 
Source: Author’s computations using internal data from the WHO Europe 2015 
Note: The frequencies referred above include countries with documents written in either English or 
in local languages. The table only represents the number of documents collected for each country. 
 
A simple linear regression revealed that the number of a country’s memberships to international 
organisations is significantly associated with the number of types of health systems assessment 
documents produced by that country (ß=0.358; p <0.01).  
 
Table 2-5 OLS estimates for the number of memberships and the number of types of 
documents published by each Member State 
 
Types of documents 
Number of memberships 0.358** 
0.008 
N 53 
adj. R-sq 0.111 
Standardised beta coefficients; p-values in parentheses 
* p<0.05, **p<0.01, *** p<0.001 
Source: Author’s computations using internal data from the WHO Europe 2015 
 
2.6.2 HSS goals, purposes, and definitions as defined by the Member States  
 
I found that the terms used to refer to HSS vary across the Member States. Alternative terms used in 
the HSS reports to refer to health systems strengthening include the following:  
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Table 2-6 Alternative terms used in the reports that were found to be similar to the definitions 
used for HSS monitoring and evaluation 
Terms used Frequency 
health care performance assessment 12 
health system monitoring 5 
health systems reviews 23 
health systems strategy 4 
health target indicators 2 
healthcare quality and efficiency 1 
Source: Author’s computations using internal data from the WHO Europe 2015 
 
Some reports have explicitly specified their motivation for conducting an HSS monitoring and 
evaluation report as listed in Table 2-7 below. These purposes may include the use of HSS as a 
governance tool or as a means to ensure accountability, while others specified how it can be used as 
a benchmark for their individual performance over the years compared with other countries.  
 
Table 2-7 Country commitments that motivated the development of an HSS report identified 
from the records collected 
Purpose of conducting HSS Countries 
As part of the commitments to the Tallinn 
Charter 
Armenia, Belgium, Estonia, Georgia, Hungary, 
Moldova, Netherlands, Turkey 
As part of the commitments for Health 2020 Croatia, Czech Republic, Israel 
As part of Israel’s Healthy People 2010 
strategy 
Israel 
To achieve Health for All Israel, Georgia 
As a follow up to the WHO report on Health 
Systems in 2000 
Israel, Georgia 
As a submission to OECD Sweden, Malta 
As a report to funding organisations Kyrgyzstan 
Source: Author’s computations using internal data from the WHO Europe 2015 
 
Other uses are identified as follows:  
• as a dissemination tool showing health system progress over the years,  
• as a monitoring tool for their health systems or as a priority-setting, and strategic or 
planning tool to assist Member States in making evidence-informed policy decisions, 
• as a capacity building tool,  
• as a coordinating tool,  
• as a health information system tool, and  
• as a sustainability tool.  
Other than these explicit descriptions the reports contained no further descriptions or explanations 
of how HSS monitoring and evaluation or what outcomes were achieved after HSS assessments.   
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transparency tool
sustainability tool
priority setting, strategic or planning tool
monitoring tool
health information system tool
governance tool
dissemination tool
coordinating tool
communication tool
capacity building tool
benchmarking tool with self and other countries
accountability tool
 
Figure 2.2 Themes for the purposes of HSS monitoring and evaluation as explicitly stated in the 
reports collected for analysis. Frequency refers to the number of times the specific purpose was 
mentioned in the report. 
 
Member States also defined HSS assessment in their reports as: 
Table 2-8 Sample HSS definitions as reported in the records collected and analysed 
Country Definitions used 
Belgium • A country-owned process that allows the health system to be assessed 
holistically 
• A health check of the entire health system 
• Based on statistical indicators which provide signals aiming to contribute to 
the strategic planning of the health system 
• Developed along the lines of a strategic framework specific to the country 
Austria • Assesses both efficiency as well as effectiveness of health care delivery 
• Includes public health aspect via the integration of a broad range of health-
related outcomes (in particular life styles)  
• Does not include health determinants outside the scope of the health care 
system, which are usually addressed by Health in All Policies (HiAP) and 
public health frameworks. 
 
The definitions used in Table 2-8, similar to that of the WHO’s, described HSS monitoring as a 
“country-driven” process used to achieve health systems goals. Further, performance assessments 
should include specific measures or statistical indicators, as well as other health determinants such 
as socioeconomic indicators. To further contextualize these definitions, I found 14 Member States 
to have developed their own national HSS frameworks: Armenia, Austria, Belgium, Bosnia and 
Herzegovina, Estonia, Georgia, Hungary, Kyrgyzstan, Moldova, Netherlands, Portugal, Tajikistan, 
Turkey, and the United Kingdom. Sample HSS frameworks are listed in Figure 2.3. 
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a) Assessment framework for Armenia, 2009 b) Assessment framework for Belgium 
  
     c) Assessment framework for Kyrgyzstan, 2002      d) Assessment framework for Georgia, 2009 
 
Figure 2.3 Sample HSS Frameworks collected from the records used in this study
Chapter Two 
 43 
 
2.6.3 Domains identified and categorized following the WHO health systems framework  
 
Results of the semantic similarity analysis showed wide variability across the different domains 
used by each Member State. Overall, I found 485 domains used by countries in their HSS 
monitoring and evaluation. These domains spanned into different health systems contexts, health 
systems functioning, health outcomes and outputs. I computed for the semantic similarity scores 
and used the cortical.io to generate keywords. After that, I validated each keyword identified with 
select experts from the WHO health systems department to determine whether or not they agreed 
with the semantic analysis results. Figure 2.4 below shows the resulting cortical fingerprint from the 
semantic analysis of the all collected records generated from cortical.io. This fingerprint is similar 
to a human fingerprint, which shows the biological identity of a single person. Likewise, a semantic 
fingerprint is the identity card of a single concept, which defines a unique, descriptive way that the 
meanings are associated with that concept. This semantic analysis is more comprehensive than 
other textual analyses because the semantic analysis enables the creation of a unique fingerprint 
automatically by structuring huge amounts of texts into clusters. As shown in Figure 2.4, each data 
point, which corresponds to each word, is shown to be related to the specific set of words forming 
clusters of data points. Each of these clusters was identified and coded as a specific domain of HSS. 
This computer-generated method is vital for this analysis, which used large textual databases of 
HSS reports gathered from the 53 WHO Europe Member States. 
 
Figure 2.4 Resulting cortical fingerprint from the semantic analysis of all records collected. A 
cortical fingerprint is used in the semantic analysis to identify clusters of relevant keywords used in 
the records collected for analysis. Each fingerprint shows the clusters of data points (keywords) 
identified as the main theme from the records collected. 
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The identified clusters from the analysis showed 27 keywords (themes) from the 485 sub-domains:  
1) access,  
2) efficiency,  
3) financing,  
4) governance,  
5) health information systems,  
6) health status,  
7) medicines and technology,  
8) quality of health services,  
9) responsiveness,  
10) safety,  
11) health service delivery,  
12) social and financial risk protection,  
13) health workforce,  
14) appropriateness of service delivery,  
15) availability of healthcare services,  
16) competence,  
17) continuity and sustainability,  
18) cultural and environmental contexts,  
19) effectiveness,  
20) equality,  
21) equity,  
22) impact,  
23) inter-sectoral,  
24) assessment of their own monitoring and 
evaluation system,  
25) other health determinants,  
26) people-centeredness and empowerment, 
27) socioeconomic contexts.  
 
Table 2-9 lists the number of domains found per Member State. Looking at the said list, I found out 
that the most number of domains was available in Albania (n = 29), Andorra (n = 21), Macedonia (n 
= 19), Latvia (n = 17), and Sweden (n = 16). However, the least number was found in Austria, 
Germany, Kyrgyzstan, Monaco, and Russian Federation (n = 3). After doing another semantic 
analysis for the remaining domains, I uncovered four overarching themes from the initially 
identified 27 key domains:  
 
a) determinants or domains that described the contexts surrounding the HSS,  
b) health systems functions, which referred to each of the WHO health system building blocks 
identified by the WHO Health Systems Framework (WHO, 2010a),  
c) intermediate results, which referred to direct outcomes from health systems functions related to 
access, appropriateness, availability, competence, continuity and sustainability, effectiveness, 
efficiency, equality, equity, quality, responsiveness, safety, and social and financial risk protection; 
d) health outcomes, which referred to the overall health status and health impact.  
 
Two other crosscutting themes were identified:  
a) inter-sectoral linkages and  
b) monitoring and evaluation of existing HSS practices. 
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Table 2-9 Number of HSS domains identified per Member State based on the keyword 
determined from the semantic analysis 
Country Number of domains Country Number of domains 
Albania 29 Lithuania 11 
Andorra 21 Luxembourg 6 
Armenia 10 Macedonia 19 
Austria 3 Malta 9 
Azerbaijan 12 Moldova, Republic of 6 
Belarus 13 Monaco 3 
Belgium 13 Montenegro 4 
Bosnia and Herzegovina 12 Netherlands 8 
Bulgaria 10 Norway 10 
Croatia 12 Poland 8 
Cyprus 9 Portugal 4 
Czech Republic 7 Romania 9 
Denmark 4 Russian Federation 3 
Estonia 5 San Marino 7 
Finland 6 Slovakia 10 
France 8 Slovenia 11 
Georgia 8 Spain 11 
Germany 3 Sweden 16 
Greece 13 Switzerland 5 
Hungary 8 Tajikistan 11 
Iceland 11 Turkey 9 
Ireland 10 Turkmenistan 8 
Italy 10 Ukraine 11 
Kazakhstan 10 United Kingdom 9 
Kyrgyzstan 3 Uzbekistan 10 
Latvia 17 
  Source: Author’s computations using data gathered from the WHO Europe 2015
 
The identified themes were used to develop a new theoretical framework for the recognised HSS 
domains. This framework was proposed to the WHO Regional Office for Europe and further 
research is ongoing to refine and validate it across all Member States. Figure 2.5 presents the 
expanded HSS theoretical framework. 
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Figure 2.5 Summary of all identified HSS domains further categorized into four different clusters 
Source: Author’s illustration based on themes identified from the analysis 
 
2.6.4 Sample indicators for select HSS domains  
  
An initial listing of the HSS domains and indicators used in the reports resulted in 4,720 indicators. 
I found out that the highest number of indicators used was in Tajikistan with 648 indicators, 
followed by Spain (n = 238), Germany (n = 177), Norway (n = 173), Bulgaria (n = 163), and 
Sweden (n = 161). On the other hand, the least number of indicators used was found in Monaco (n 
= 7), Kyrgyzstan (n = 13), Montenegro (n = 18), Macedonia (n = 19), Finland (n = 20), Estonia (n = 
22), and Poland (n = 22). As discussed above, I found no records available for Israel.  
 
Some indicators collected for this analysis included stratifiers or disaggregates. For example, the 
‘bed occupancy rate’ can be disaggregated into bed occupancy rate for males and females. To select 
only the core meaning of each indicator, these disaggregates attached to every indicator was 
removed. After removing them, I identified 628 unique indicators. Chapter 3 uses this pool to 
further identify indicators that were most relevant for a program-level (that is intermediate 
outcome-level) HSS monitoring and evaluation. 
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Table 2-10 Number of HSS indicators identified per Member State 
Country 
Number of 
indicators Country 
Number of 
indicators 
Israel 0 Cyprus 79 
Monaco 7 Romania 80 
Kyrgyzstan 13 Armenia 82 
Montenegro 18 Switzerland 82 
Macedonia 19 Kazakhstan 88 
Finland 20 Ukraine 88 
Estonia 22 Andorra 91 
Poland 22 Lithuania 93 
Austria 29 Azerbaijan 96 
Ireland 32 Iceland 99 
Latvia 33 Italy 100 
Denmark 36 Greece 113 
Hungary 36 United Kingdom 114 
Czech Republic 43 Malta 115 
Luxembourg 43 Uzbekistan 117 
Albania 45 Slovenia 122 
Portugal 56 Croatia 125 
France 58 Belarus 131 
Bosnia and Herzegovina 60 Slovakia 135 
Georgia 61 Netherlands 154 
Turkey 64 Sweden 161 
Turkmenistan 64 Bulgaria 163 
Moldova 65 Norway 173 
San Marino 65 Germany 177 
Belgium 68 Spain 238 
Russian Federation 77 Tajikistan 648 
  
Total 4,720 
Source: Author’s computations using data gathered from the WHO Europe 2015 
 
 
The number of domains and indicators illustrates the variability and heterogeneity of measures used 
for HSS monitoring and evaluation in Europe. Table 2-11 provides examples of the variability of 
the indicators used in different countries. For example, the domain ‘accessibility' was measured 
differently by Armenia and Moldova. Armenia used ‘hospitalization rate per 100 population’ while 
Moldova used ‘number of hospital admissions.’ For the domain ‘health service delivery,’ although 
most Member States used the ‘average length of hospital stay,’ some like Bosnia and Herzegovina 
and Moldova used ‘average length of stay for hospital patients,’. On the other hand, Belgium used 
‘average length of stay for normal delivery,’ while Malta used ‘average length of stay only for 
select diagnoses.’  
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Table 2-11 Sample HSS indicators identified from the records collected 
Domain Country Sample Indicators 
Accessibility Armenia Hospitalization rate per 100 population 
Moldova Number of hospital admissions 
Effectiveness Kyrgyzstan Quantity of areas covered by health promotion 
programs 
Netherlands Number of hospital admissions per 100000 
population 
Efficiency Spain Health care expenditure per capita 
Netherlands Health expenditure in relation to life expectancy 
Financing Netherlands Total health expenditure at macro level and by sector 
Moldova Expenditure for health per person US$ purchasing 
power parity  
Switzerland Expenditure on promotion as share of current health 
expenditure 
Croatia Expenditures for health care per capita 
Malta Expenditures for health care as percentage of GDP 
Service 
Delivery 
Bosnia and 
Herzegovina, Moldova 
Average length of stay for hospital patients 
Belgium Average length of stay for normal delivery 
Malta Average length of stay for limited diagnoses 
 
2.6.5 Key HSS actors: Typologies and coordination mechanisms 
 
In each of the HSS report, I have identified the different actors involved when conducting HSS 
assessments. It was relevant to note which institutions have been involved in creating HSS 
monitoring and evaluation systems to serve as a guide for other countries when forming their own 
HSS monitoring and evaluation or reforming their current HSS assessment systems.  
 
From the collected records, I listed down some data on the various individuals, institutions, and/or 
countries responsible for or involved in conducting HSS monitoring and evaluation. Following 
another semantic similarity analysis, I found out that the following key HSS actors involve: 
universities (n = 166), other countries such as the United Kingdom and the United States (n = 64), 
ministries of health (n = 47), national registration agencies (n = 43), the World Bank (n = 28), the 
European Observatory (n = 24), the WHO Europe (n = 23), health insurance fund agencies (n = 20), 
local associations for health (n = 17), other professional associations of health care workers (n = 
13),  the WHO country offices (n = 11), country experts (n = 8), local government units (n = 7), the 
WHO headquarters (n = 7), the European Commission (n = 5), and the Ministry of Finance (n = 5), 
among others (where n refers to the number of times it was stated to be involved in HSS 
assessments).  
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The findings show that HSS assessment included multiple players outside the commonly known 
health institutions such as the Ministries of Health and health insurance organisations. This result 
supported previous discoveries that successful HSS conduct may require different actors to be 
involved and that there is a need for a strong coordinating body to bring them together to help 
ensure the development of a comprehensive and integrated plan for HSS (WHO, 2010).  
 
 
Figure 2.6 Actors involved in conducting HSS monitoring and implementation as identified from the 
records collected 
Source: Author’s computations using internal data from the WHO Europe 2015 
 
 
Some records also showed how each organisation contributed to the HSS assessment. I carried out 
another semantic analysis for each identified role and found six keywords on how the different 
actors contribute to HSS assessments: 
 
1. As an advisory group: Universities and academic institutions were frequently involved as 
advisory groups for HSS surveillance. Unless the national ministry of health (MoH) has a 
separate health policy monitoring unit or an ad hoc group for HSS surveillance, Health 
Ministries commissioned advisory responsibilities to academic institutions. International 
organisations such as the Commonwealth Fund, the Global Fund, the Rand Corporation, the 
World Bank, and the WHO Regional Office for Europe were also part of advisory panels. 
Public health institutes also joined the advisory group of some countries, along with other 
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professional associations, hospital federations and local foundations. In some cases, the HSS 
advisory group also included government ministries of other sectors outside health (e.g. 
council of ministers, the ministry of food and environment, and the ministry of social affairs 
or social security). 
 
2. As an author or editor of the HSS report: Members of the universities and academic 
institutions were primary authors of the HSS monitoring and evaluation reports with some 
being co-authored by MoH and international organisation representatives mostly from the 
WHO Regional Office for Europe, the WHO country offices, or the European Observatory.  
One HSS monitoring and evaluation report has also been co-authored by a representative 
from the Ministry of Finance. 
 
3. As members for capacity building on HSS surveillance: Institutions involved in capacity 
building for HSS monitoring and evaluation primarily included the MoH along with other 
sectoral government committees. In some countries, an MoH sub-unit was formed to take 
part in HSS capacity-building initiatives such as a health information centre within the 
MoH. Some policymakers played a role in initiating, developing, and monitoring HSS 
practice.  Some countries have also involved country experts and formed a health 
transformation program unit. Other statistical units such as the Department of Household 
Surveys also took part in HSS capacity-building initiatives.  
 
4. As a provider of HSS data or clearinghouses: Actors involved in collecting, maintaining 
and disseminating HSS data included public health institutes, state health agencies, the 
European Observatory, health information centres, and national statistical offices. This 
include OECD, the WHO, and the World Bank. These institutions were responsible for data 
collection and validation needed for HSS. 
 
5. As external validators and reviewers: Some reports mentioned that some institutions such 
as the World Bank, the European Observatory, the OECD, and university representatives 
served as external validators and reviewers for the HSS assessments. 
 
6. As funders: Funding for HSS usually came from the MoH as part of budgets allotted for 
improving the country's health information systems. Others found financial support from the 
European Commission and/or the European Union. 
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Bosnia and Herzegovina and Croatia also identified their lead institutions as the Ministry of Health 
headed the HSS assessments. In Belgium for instance, their National Institute of Health was 
identified as their lead for HSS monitoring and evaluation. Conversely, Armenia specified that the 
HSS was led by the country but for the purpose of reporting to donors and other development 
partners. On the other hand, Kyrgyzstan’s HSS was led by the national government driven by the 
need to monitor and evaluate effects of implementing their national health programs. Apart from 
that, there were also the three countries that claimed to have an established and structured HSS 
monitoring and evaluation group that were mostly formed on an ad hoc basis with the first two 
establishing an HSS assessment task force in 2005 and the latter in 2002. 
 
2.7 Discussion 
 
Various international health partnerships and initiatives led to global calls for a coherent HSS 
monitoring and evaluation approach (McCoy et al., 2012; Storeng, 2014). However, such a standard 
monitoring and evaluation framework remains a challenge due to very different country capacities, 
disparate data sources and data availability across the various countries, and also varied contexts 
that drive priority areas for health systems (Ramalingam, Mitchell, Borton, & Smart, 2009; Veillard 
& Maurice, 2012). As an essential component of developing a comparable but contextually 
sensitive HSS monitoring and evaluation framework, this Chapter reports research providing a 
comprehensive suite of domains and indicators that overview the regional level of capacity of each 
WHO European Member State to monitor achievement towards the Health 2020 European policy 
framework and other overarching goals such as the Sustainable Development Goals. The HSS 
inventory developed from this research and identified from country-driven data sources can be used 
to identify relevant regional or global health system priority areas and provide insights on data 
availability and comparability. 
 
In summary, I found 27 HSS domains and identified 628 unique indicators that spanned four 
broader themes: determinants, health system functions, intermediate results, and health outcomes. 
As specified above, 14 Member States were also found to have developed their own national HSS 
frameworks. Moreover, I also found that there are different actors involved in conducting HSS 
assessment. Apart from the Ministries of Health, the WHO and local communities or professional 
associations, universities and other international organisations were also included. These results 
illustrate the complexity of HSS and of developing global and regional guidelines for HSS 
assessments, which should not only focus on the different health system building blocks or 
functions, (e.g. governance, financing, service delivery, health workforce) but also take into 
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consideration how these building blocks may be influenced by other factors such as the social 
determinants of health and other intermediate results of HSS. The findings also showed that 
outcomes of HSS assessments can be based on the other output and outcome measures such as 
parameters related to improved health (level and equity), responsiveness, social and financial risk 
protection, improved efficiency, and other more intermediate HSS results (e.g. access, 
appropriateness, availability, competence, continuity and sustainability, effectiveness, efficiency, 
quality, and safety).   
 
Hence, domains and indicators for HSS assessment were not only focused on the WHO Health 
Systems Building Blocks, but also involved other factors that may either be directly or indirectly 
related to HSS. The domains and indicators identified above also fit the priority areas in the Health 
2020 European Policy Framework (WHO, 2013b). In this framework, the domains and indicators 
used in conducting HSS have spanned the different strategic objectives and the four common policy 
priorities for health (WHO, 2013b). Furthermore, the goals listed in the Health 2020 monitoring 
framework (reduce premature mortality, increase life expectancy, reduce inequalities, enhance well-
being, UHC and right to health, and national targets) were also captured in the resulting expanded 
theoretical framework. HSS assessments, therefore, can be a way to monitor and evaluate how 
strategic objectives for the Health 2020 monitoring framework, as well as the Tallinn Charter, will 
be met to provide evidence on health systems progress (WHO, 2010a). The framework described in 
this Chapter added context to the domains used in the Health 2020 monitoring framework by 
matching these to the HSS indicators that were already being used by the Member States. This 
approach avoids further duplication in monitoring and evaluation tools and further burdening of 
countries arising from the various reporting processes for HSS grants and resource allocation. The 
framework also showed the different determinants and pathways that may influence the 
achievement of the Health 2020 objectives.  
 
Moreover, the results also validated how the Health 2020 framework reflected the priority areas for 
health and health systems of the European Region.  Since accountability mechanisms were part of 
the national targets of the Region, HSS assessments may also be a transparent mechanism for 
illustrating the government’s accountability for health systems. The four common policy priorities 
for health were also similarly linked to the HSS domains: investing in health through a life-course 
approach and empowering people; tackling Europe’s major health challenges such as NCDs and 
communicable diseases; strengthening people-centred health systems, public health and capacities 
and emergency preparedness, surveillance and response; and creating resilient communities and 
supportive environments. Likewise, NCDs and communicable diseases were also part of the HSS 
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identified HSS domains as a key output to assess HSS outcomes. The key principles of people-
centeredness, capacities and resources were also captured in the HSS domains identified in this 
Chapter and were noted to be vital to the functioning of the health systems.  Resiliency, as well as 
sustainability, can also be both assessed by looking at the inter-sectoral HSS practice as well as in 
seeking progress in the way HSS were being monitored and evaluated over the years. 
 
However, the marked differences in HSS monitoring and evaluation across the Member States 
made comparability and quantification of HSS domains and indicators challenging. Nevertheless, 
this Chapter also identified that there is a greater need for better structure and clearer guidance from 
the WHO and other international organisations in relation to its assessment. The various HSS 
frameworks and domains used by each Member State suggested that WHO technical guidelines on 
HSS framework, domains, and indicators should direct HSS assessments in the Region, and that 
such guidelines should also consider each Member State’s particular contexts. Measurement and 
reporting differences and cycles, and varying contextual factors also made regional comparison 
arduous since effective regional comparison required either measurement and reporting cycles to be 
standardised or comparisons to be appropriately sensitive to differences; likewise, for uncontrolled 
contextual factors. Therefore, key planning considerations for regional comparisons include 
variability across HSS definitions, domains and indicators used; different reporting cycles per 
country; and any uncontrollable contextual factors affecting health and HSS progress, among 
others. HSS monitoring and evaluation was also found to serve as an accountability tool to monitor 
and evaluate performance; hence, it should also be made transparent. Therefore, WHO and other 
international organisations may need to increase capacity to document and update existing HSS 
practices in the Region, while addressing potential factors that may limit access and analysis of 
available data on HSS assessments such as language barriers.  
 
The variability in the domains and indicators found in this research also reiterated the need for a 
‘systems thinking lens’ (De Savigny & Adam, 2009), which offered a practical approach to 
strengthening health systems (De Savigny & Adam, 2009). This approach highlights that as 
investments in health are increasingly directed to HSS, there is also a demand to understand not 
only what works, but also for whom and under what circumstances (De Savigny & Adam, 2009). A 
systems thinking lens was asserted to be highly relevant when monitoring how health systems were 
progressing and in identifying key strengths and weaknesses of existing systems (De Savigny & 
Adam, 2009). There were two key principles identified for a systems thinking lens: a) that systems 
adjust and readjust at many interactive timescales (De Savigny & Adam, 2009); and, b) that the 
high degree of connectivity means that change in one subsystem affects the others (De Savigny & 
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Adam, 2009). I also found these as characteristics of HSS assessments. HSS monitoring and 
evaluation was found to not only be complex and comprehensive but also a dynamic process that 
countries were undergoing. HSS assessments, therefore, need to be carefully designed with existing 
HSS domains that a country has found to be most appropriate and responsive to their existing 
capacities, health needs, and priorities. Such conduct was also not only limited to quantitative or 
statistical indicators, but may also include qualitative parameters (e.g. quality of healthcare services, 
access, and distribution) that provide further meaning and contexts to the country’s health systems. 
 
Findings also provide evidence that different sectors including the private sectors, financial 
agencies, and universities participated in the process of conducting HSS assessments. The variety of 
actors involved in HSS assessments further highlights the need to enhance communications and 
collaborations across Ministries of Health and these different stakeholders to achieve more 
comprehensive HSS assessments. Engaging these different actors may help develop a shared vision 
towards a more coherent, integrated, efficient and useful HSS assessment (Dodds, 2015). These 
actors may include producers and users of information, those involved in the actual health service 
delivery as frontline health workers, and funding agencies, as well as other international level 
organisations (WHO, 2007). When different groups are involved in HSS assessments, findings from 
these assessments may become more responsive and efficient to health systems needs and 
challenges (Guest, Ricciardi, Kawachi, & Lang, 2013; Mutale, 2014). Specifically, a multi-sectoral 
approach for HSS assessment provides more responsive outcome-based indicators, as well as inputs 
and process indicators that tailor more in addressing the different countries (Kusek & Rist, 2004; 
Shield et al., 2003). Such process not only engaged more sectors in the process but also provided 
vital inputs to the current HSS implementation mechanisms to ensure development of a well-
integrated and more comprehensive HSS practice (Busse, Aboneh, & Tefera, 2014; Israel, Schulz, 
Parker, & Becker, 1998). Such community involvement was also relevant in managing different 
expectations among the various health systems actors and foster HSS monitoring and evaluation 
ownership (Barker, 2015; Naimoli, 2009). Hence, the findings highlighted how HSS assessments 
cut across various sectors, including non-state actors, universities, and academicians, among others. 
 
2.8 Conclusion 
 
This chapter provides a comprehensive description of the different concepts, domains, and 
indicators used for HSS assessments across the European Region, which can serve as vital baseline 
information for future work in developing regional and global HSS assessments. More importantly, 
the said findings can also be used for the initial design phases of HSS for other countries who are 
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yet to design and conduct HSS monitoring and evaluation. Hence, the findings provided countries 
with resources to choose from to map, measure, and assess their own HSS and/or improve their 
current HSS assessment practices. Such inventory of domains and indicators may also be tracked 
over time to examine at a country level how HSS frameworks and priority areas change in line with 
current health systems policies and reforms. Compared to previous studies, this research gathered 
information from country-driven resources and applied a bottom-up rather than a top-down 
approach for developing a monitoring and evaluation framework. There are many ways in which 
the findings of this research can be used to motivate future work in this area. Similar to the 
‘Strengthening health systems accountability’ report of Tello & Baez-Camargo Camargo (2015), 
this research was not intended to provide an exhaustive account of all HSS measures. Reviewing 
the literature was primarily done by the author and was not compared with views of others. I 
examined the material in its entirety and only included records that fit the selection criteria of the 
study and were available online. Omitting HSS materials that were excluded due to language or 
failing to fit the search criteria may also significantly influence my findings. The findings were also 
limited to studies, which focused on the European region and used specific HSS measures. 
Moreover, I also only communicated with close contacts of the WHO Europe. As such, none of the 
country offices were required to send HSS reports. Despite such limitations, the findings reported in 
this Chapter can serve as benchmark indicators not only for the Member States of the WHO 
European Region but also across other countries. Though regional comparisons remain a challenge 
primarily due to the wide variability and heterogeneity across domains and indicators used by each 
Member State, my findings also showed that there were common areas or themes that most of them 
monitor for HSS. The findings from this study can also be used to tailor future work on 
understanding target audiences when developing a technical guidance document for HSS 
assessment since they provided an overview of what was currently measured across the Member 
States reflecting their existing capacities and priority areas for health systems. Understanding these 
existing concepts and measures of health systems using a bottom-up approach should be taken into 
consideration before making any attempt to do a regional framework for HSS assessments that 
countries should adhere to or report against to avoid reporting burden and to ensure responsiveness.  
Furthermore, an individual country’s capacity for evidence-informed decisions for HSS should not 
depend on that country’s level of resources allocated to monitoring and evaluation processes. 
Hence, HSS assessment should reach at least a minimum degree of quality and comparability across 
countries.  
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Chapter 3 Data sources and tailored indicators for program-level monitoring and 
evaluation of intermediate HSS results 
 
In the previous chapters, I discussed HSS goals and calls to action (Chapter 1) and proposed 
an expanded theoretical framework (Chapter 2) based on an empirical analysis of existing 
HSS frameworks and domains that can be used for HSS monitoring and evaluation. This 
chapter extends the framework to program-level HSS monitoring and evaluation using data 
sources gathered and field observations while at the Gavi Vaccine Alliance4 in Geneva, 
Switzerland. In particular, this chapter develops a new set of tailored indicators for 
monitoring the intermediate results of HSS initiatives that countries can choose from for new 
and future HSS grant applications to funding organisations.  This chapter: 
 
1. Identifies indicators from the Global Reference List of 100 Core Health Indicators 
(WHO, 2015d) which are relevant to Gavi HSS grants; 
2. Identifies additional tailored HSS indicators from existing HSS grants, based on 
available HSS monitoring and evaluation frameworks and HSS frameworks from 
each Gavi recipient country. These are internal documents available within Gavi Each 
HSS framework has been consulted with the ministries of health and have been 
validated and supported by a decision letter to use the indicator for HSS monitoring 
and evaluation signed by the Gavi-eligible country and Gavi;  
3. Creates a database of tailored HSS indicators based on systematic analysis of existing 
indicators from these different sources, identifying any existing strengths and 
limitations of the tailored HSS indicators; and 
4. Creates a guidance document for countries explaining how they can use the list to 
select their tailored HSS indicators, and under what circumstances/conditions they 
may differ from the list.  
 
Using data gathered from field observations at the Gavi Vaccine Alliance, a resulting 
reference guide for sample tailored indicators for assessing HSS intermediate results was the 
key output of this study. This chapter has been considered alongside the 2016 Gavi Reporting 
                                                
4  The Gavi Vaccine Alliance, referred here as “Gavi”, was created in 2000 as an international organisation 
dedicated to bring together public and private sectors with the shared goal of creating equal access to new 
and underused vaccines for children living in the world’s poorest countries (Gavi, 2016). 
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and Renewal Guidelines (Gavi, 2015b, 2016). In summary, indicators were selected based on 
examining monitoring and evaluation reports, other publications, grey literature and internal 
documents within Gavi and its partners. This includes WHO which provided the indicators 
and measures that can be used to monitor program-level health system strengthening projects 
to support vaccine service delivery. The selection of indicators was based on specific criteria. 
The indicators were also initially selected from the Global Reference List of 100 Core Health 
Indicators (WHO, 2015d) and was then supplemented by additional HSS indicators from 
other data sources available within Gavi which they have identified as tailored to the 
country’s needs and contexts, as well as its specific grant objectives. 
 
3.1 The Gavi Vaccine Alliance and health systems strengthening for vaccine service 
delivery 
 
Gavi Vaccine Alliance, referred as ‘Gavi,’ was created as an international organisation 
dedicated to bring together public and private sectors with the shared goal of creating equal 
access to new and underused vaccines for children living in the poorest countries (Gavi, 
2016).  Although the primary mandate is to increase access to immunisation, Gavi recognised 
that immunisation coverage was constrained by health system barriers (Marchal et al., 2009). 
As such, Gavi considerably invested in health systems strengthening particularly attending to 
health systems functions that were essential for the implementation of immunisation 
programmes: i.e. cold chain storages for vaccines, refrigerated vehicles for transporting 
vaccines, training of health workers on the expanded program on immunisation, among 
others (Marchal et al., 2009; Naimoli, 2009). Strengthening health systems remains as one of 
the Gavi’s strategic goals for 2016 to 2020 as presented in Figure 3.1 (Gavi, 2016). 
Specifically, Gavi aims to “increase effectiveness and efficiency of immunisation delivery as 
an integrated part of strengthened health systems” (Gavi, 2016) by providing financial 
support called “HSS grants” to assist countries in addressing health system bottlenecks and 
improve immunisation (Gavi, 2016). With these grants, countries are allocated a dollar 
amount based on their Gross National Income and population (Galichet et al., 2010). 
Ministries of Health were invited to use available health sectoral reviews to identify health 
systems constraints and plan health systems to improve immunisation and wider primary 
health care services (Galichet et al., 2010). The funding is to be considered as additional and 
complementary to existing  government and other local health sources (Galichet et al., 2010).  
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Figure 3.1 Strategic framework for the Gavi Vaccine Alliance 2016-2020 with disease dashboard and goal-level indicators 
Source: Gavi 2016 (Gavi, 2016) 
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The application process required the countries to submit core and tailored indicators to form 
part of their Grant Performance Framework, which is a new monitoring and reporting tool 
introduced by Gavi in early 2015 The Grant Performance Framework is an upfront agreement 
between a country and Gavi on the key metrics that Gavi can use to monitor and report on 
grant performance during HSS implementation. A list of 20 mandatory core indicators at 
every level of the results chain for both vaccine and cash support has already been developed 
and were based on standard definitions which were already, in almost every case, being 
monitored by countries. The indicators include agreed baselines, target, data sources, and 
reporting schedule. However, core indicators were found to be insufficient to measure 
performance for the HSS grants because of specific activities and objectives that vary across 
countries (Gavi, 2015b).  
 
As such, Gavi’s Grant Performance Framework was adjusted to include a combination of 
core and tailored indicators (Gavi, 2015b). Core indicators were unlikely to be sufficient to 
measure performance along each grant’s result chain because of the variability of specific 
objectives across grants. Core indicators, therefore, needed to be complemented by a small 
number of additional indicators tailored to the particular objectives of each grant and aligned 
with the specific country contexts. Similar to the findings highlighted in Chapter Two, HSS 
frameworks needed to be dynamic and linked to specific country contexts. This combination 
of core and tailored indicators ensures that the Grant Performance Framework provides a 
complete overview of how Gavi’s HSS funding support is being used by the recipient 
countries. The Grant Performance Framework should show how intermediate results between 
the implementation of an activity and the intended outcomes could be measured; not just the 
number or quality of a product but if and how these products were used (Gavi, 2015b). Gavi 
has selected the core indicators for each step of the HSS grant result chain as identified in the 
2016 Gavi Grant Performance Indicator Reference Sheet (Figure 3.2). The Framework also 
specified that tailored indicators may include the following (Gavi, 2015b): 
 
1. A small number of tailored outcome indicators may be included to reflect country-
specific circumstances or grant objectives. These indicators were especially important 
for HSS as progress against them is used by Gavi to inform decisions on grant 
renewal (Gavi, 2015b).  
2. A small number of tailored intermediate results indicators should be included to 
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ensure monitoring of each grant objective.  These indicators were especially important 
for HSS as progress against them is used by Gavi to inform decisions on disbursement 
(Gavi, 2015b). For most countries, tailored indicators comprise the set of indicators 
that measure progress achieved in the HSS process and intermediate results level 
(Gavi, 2015b). 
3. A small number of tailored process indicators should be included to monitor the 
implementation of the most significant activities of Gavi cash grants. Progress against 
these indicators is also used by Gavi to inform decisions on disbursement. These 
indicators should align with the content of countries’ interim financial reporting to 
Gavi (Gavi, 2015b). 
 
To date, there is a limited number of tailored indicators for Gavi’s HSS grants. For the past 
years, the Gavi Secretariat has observed that countries’ capacities to select and develop their 
own tailored HSS indicators were varied. Most countries applying for HSS grants stated that 
a reference list of tailored indicators would have guided them in creating their own HSS 
framework. Tailored indicators may be used at three levels of the performance framework 
(Gavi, 2015b): 
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Figure 3.2 Gavi Grant Performance Indicators Reference Sheet with core and tailored identified for each type of indicator (process, 
intermediate results, and outcomes) Source: Gavi 2016 
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The previous chapter proposed a new conceptual framework for HSS monitoring and 
evaluation that identified core dimensions involved in the intermediate results of HSS 
projects to capture the relevant information about HSS while still taking into account the 
variation in approaches currently in place across the different countries. These domains were 
then used to further guide data collection for Gavi’s tailored HSS intermediate result 
indicators. This chapter focuses on tailored indicators at the intermediate results level for 
HSS grants, while the succeeding chapters will focus on using the different tailored process 
HSS indicators identified in this Chapter and applied in different contexts. Tailored process 
and outcome indicators are available within Gavi. 
 
 Intermediate results indicators for monitoring HSS grant objectives need to be proposed by 
countries (Gavi, 2015b). The number of intermediate results indicators varies depending on 
the complexity and duration of the grant. Between five to ten indicators is ideal at a 
minimum: with one to two specific, measurable, available, scientifically robust and time-
bound (SMART) intermediate results indicators per objective (Gavi, 2015b; Lopez Acevedo 
et al., 2012). Performance against these intermediate results shall inform joint appraisal 
assessments of the sufficiency of the progress a country has achieved and associated 
modifications to Gavi’s support (Gavi, 2015b). The findings in this chapter are intended to 
provide a menu of tailored intermediate results indicators from which countries can select – 
or define their own – especially if relevant indicators were already tracked by countries 
through their existing monitoring and evaluation systems, such as periodic Health Facility 
Assessments or Immunisation Dashboards (Gavi, 2015b). 
 
Figure 3.3 provides an overview of how the Gavi Grant Performance Framework is used for 
Gavi’s HSS grant mechanisms based on my observations. As specified in this flowchart, 
annually before January 15, countries can setup their own grant performance framework 
through Gavi’s online portal system  by contacting the Gavi representative in their country.  
Through a series of consultations, countries agree to the metrics that will be used in their 
performance framework which may include both core and tailored indicators. Gavi then 
reviews and approves the grant application and each country is expected to report against 
their own grant performance framework. Reporting is also done online through the Gavi 
country portal. Although countries can always apply for HSS grants, renewal of HSS grants 
is based on a country’s reported performance against the HSS intermediate results indicators 
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for both core and tailored indicators. Hence, funding for HSS used a performance-based 
approach and as such, selection of appropriate intermediate results indicators is vital in 
determining continuing investments for health systems strengthening.   
 
 
Figure 3.3 Gavi HSS grant cycle based on observations while on field work 
Source: Author’s illustration from observations while on field work. 
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There are many potential sources for HSS intermediate results indicators. In 2014, the WHO 
conducted a rapid assessment of the burden of indicators and reporting requirements for 
health monitoring (WHO, 2015d). This evaluation revealed how global investments in 
disease- and programme-specific monitoring and evaluation programmes by different 
agencies have contributed to a vast number of indicators, varying indicator definitions and 
reporting frequencies, fragmented data collection, and uncoordinated efforts to strengthen 
national institutional capacity (WHO, 2015d). This existing system of reporting also led to an 
unnecessary burden on countries and inefficiencies in strengthening country health 
information systems as scarce resources are devoted to compliance and reporting (WHO, 
2015d). As a result, WHO developed the “Global Reference List of 100 Core Health 
Indicators” to guide the monitoring of health results nationally and globally, reduce excessive 
and duplicative reporting requirements, and enhance the efficiency of data collection 
investments in countries (WHO, 2015d). This list was confined to indicators for global and 
regional assessment levels and excluded indicators for national health systems (WHO, 
2008b). It also ruled out indicators requiring more detailed programme management at the 
national and sub-national levels or for financial tracking of specific grants and projects that 
were highly relevant to Gavi’s monitoring and evaluation and grant management needs 
(Gavi, 2016; WHO, 2008b). Hence, this limited the number of indicators directly or 
indirectly linked to HSS grants was (Gavi, 2016; WHO, 2008b). The vast variation in each 
Gavi-supported countries’ monitoring and evaluation systems challenged how the Gavi 
Secretariat and the Alliance partners individually help each country in developing robust 
indicators for the tailored intermediate result HSS indicators. Although countries were 
entirely free to develop these indicators to monitor progress on HSS grants, a common 
reference list has to be provided to guide them in choosing intermediate result HSS 
indicators. This list can serve as a tool to facilitate Gavi’s support for countries and also to 
develop robust indicators responsive to each country’s needs and contexts, while ensuring 
standard quality guidance across countries. It is expected to provide an enhanced means of 
monitoring and learning from the impact of Gavi’s HSS programmes and to improve future 
grant mechanisms. Therefore, a reference list intended to act as a helpful resource for 
countries will also to ensure efficiency and quality country-driven monitoring of HSS grants. 
Countries can then continue to propose their tailored indicators based on the specific 
objectives of their grant, available data sources and systems. 
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3.2 Methods 
 
The primary objective of this chapter is to develop a list of tailored indicators for monitoring 
and evaluating HSS intermediate results that can be used for further research and from which 
countries can choose from for new and future HSS grant applications. To achieve this, 
relevant literature was examined to identify HSS indicators to allow monitoring of the 
intermediate results of Gavi’s HSS grants and to assist in conceptualising future research in 
this area. Consultations with the Gavi Secretariat and the Strategic Goal 2 Management Team 
(SG2MT) were conducted to assist with conceptualising the study approach and 
consolidating the tailored intermediate results indicators for HSS grants. The SG2MT is part 
of the technical consultation group of Gavi that recommends and informs the development of 
the indicators and targets for the Gavi strategic goals and the indicators for the disease 
dashboard (Gavi, 2016). Specifically, the SG2MT was responsible for identifying indicators 
specific to Gavi’s Strategic Goal 2 to “increase the effectiveness and efficiency of 
immunisation delivery as an integral part of strengthened health systems” (Gavi, 2016). In 
collecting the relevant documents, a desk study was also conducted based on a search for the 
period of 2012 to 2015 for all Gavi-supported countries. Indicators were also grouped based 
on Gavi’s cost categories and also classified following the proposed HSS framework 
discussed in Chapter 2. 
 
3.2.1 Data sources 
 
Overall, 350 HSS materials were collected from internal and external search, of which 75 
records were retained after excluding any duplicates and policy documents that did not 
include HSS indicators. The following data sources were retained: the Global Reference List 
of 100 Core Health Indicators (WHO, 2015d), the immunisation-specific guidelines from the 
Global Vaccine Action Plan (WHO, 2015a), the most recent Grant Performance Framework 
from 48 countries and additional eleven Gavi’s HSS monitoring and evaluation frameworks 
for countries with approved HSS grants from 2012-2015. The latter HSS monitoring and 
evaluation frameworks were used by countries for HSS monitoring prior to the development 
of a grant performance framework. These frameworks may not necessarily include the core 
indicators for HSS intermediate results, but were expected to have tailored intermediate 
results HSS indicators. Five more national monitoring and evaluation results framework from 
pooled funds and national country planning cycles and eight additional immunisation-related 
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HSS reports from other international organisations were also collected. These country 
planning cycles provide a country-by-country overview of national planning, health program 
and project cycles together with information on donor involvement and technical support 
(WHO, 2015g). The planning cycles aim to improve coordination and synchronization of 
country health system planning efforts (WHO, 2015g). The reports from international 
organisations include three from the WHO, one from the Global Fund, two from the 
European Commission, one from the World Bank, and one from the USAID. Another 
USAID HSS survey dataset was also used. Data was last collected on 31 December 2015. 
 
 
Figure 3.4 Selection flow diagram for Chapter Two 
Source: Author’s illustration. 
 
3.2.2 Translations 
 
I collected raw intermediate results HSS indicators in English and French with 542 and 176 
indicators, respectively. Indicators in French were translated into English using translation 
support from Gavi. Figure 3.5 shows the breakdown of countries had data sources submitted 
in English and in French. 
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Figure 3.5 Language used by the records collected for Chapter Three 
Source: Author’s computations using primary data collected from the field work. 
 
English indicators were found for: Afghanistan, Cote d’Ivoire, Cuba, Djibouti, Ghana, Haiti, 
Honduras, India, Kenya, Kyrgyzstan, Lesotho, Liberia, Moldova, Mozambique, Myanmar, 
Nepal, Nicaragua, Pakistan, Somalia, South Sudan, Sudan, Uganda, and Uzbekistan. French 
indicators were found from Burkina Faso, Comoros, Democratic Republic of Congo, Guinea, 
Madagascar, Mali, Niger, Sao Tome and Principe, Senegal, and Togo.  
 
3.2.3 The tailored HSS indicators database 
 
After identifying an exhaustive indicator set, an HSS indicators metadata database was 
developed from the different data sources identified in the previous section. To guide the 
database development, the same outline and metadata used in the Global Reference List of 
100 Core Health Indicators was followed. These include the following (WHO, 2015d): 
a. Indicator definition, including numerator and denominator. Definitions of the 
indicators were fine-tuned based on the most common definition that was used across 
countries; 
b. Disaggregations, which include equity stratifiers as deemed appropriate (e.g. age and 
sex, geography, socioeconomic status, place of residence, equity and sustainability); 
c. Additional dimensions such as frequency of reporting, pros and cons of using the 
indicator, and additional information on countries that have used the indicators, 
including accompanying contexts if available. 
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Indicators for significant HSS areas for which the Gavi health systems team lacked standard 
measures such as leadership management coordination and civil society areas were purposely 
sought. Additional indicators, which may not have been previously identified, were added if 
they were considered to be crucial for tracking Gavi’s HSS grant implementation. SG2MT 
members’ expertise was crucial in determining the indicators. Overall, 718 programme-level 
indicators were collected from the data sources, of which 197 indicators were from the 
country monitoring and evaluation framework. 27 indicators were from the Gavi Vaccine 
Action Plan, 19 indicators were from the Global Core Health Indicators, and 475 indicators 
were from the Gavi performance frameworks. Countries which had Grant Performance 
Frameworks available within Gavi and the corresponding number of intermediate HSS 
indicators found from each country Grant Performance Framework are presented in Figure 
3.6. Any duplicates for the indicators were removed in the analysis. Data were securely 
stored in a password-protected computer within Gavi. 
 
Figure 3.6 Intermediate HSS indicators found from each country’s Grant Performance 
Framework Source: Author’s computations using primary data collected. 
Chapter Three 
 69 
 
3.2.4 Indicator classifications, selection and prioritization 
 
Each indicator was coded and assigned keywords. Similar keywords were matched using the 
same semantic analysis methods discussed in Chapter Two. Each keyword generated was 
grouped under each HSS domain illustrated in the WHO HSS Building Block framework. 
The domains were then linked with each Gavi HSS cost category to ensure their relevance 
and alignment with Gavi’s HSS internal grant processes. Indicators that did not directly link 
to any of these categories were allocated their own categories.  
 
The Gavi HSS cost categories were already pre-determined by Gavi (Gavi, 2015a). The cost 
categories were intended to provide ideas for HSS activities to grant applicants and to allow 
Gavi to analyse its HSS support by type of grants (Gavi, 2015a). The cost categories are not a 
prescriptive list of activities and countries can identify their own activities to be included in 
their proposal. The cost categories were structured around the WHO Health Systems 
Framework which additional activities were included to also cover communities and program 
management activities (Gavi, 2015a). 
 
Table 3-1 Gavi HSS cost categories and sub-categories 
Grant category Grant sub-category 
1. Scale-up and improve 
accessibility and quality of 
service delivery, including 
community level services 
and implementation 
support: outreach, access, 
mobilisation 
1.1 Capital investment in infrastructure including upgrading and 
renovations 
1.2 Improve service organisation and facility management, 
including integrating immunisation services within maternal 
and child health services (maternal, neonatal and child 
health and integrated management of childhood illness) 
1.3 Improve quality of care, including testing innovative service 
delivery models 
1.4 Improve the transportation system for vaccines and service 
providers for outreach activities, including vehicle 
procurement 
1.5 Improve the waste management system 
1.6 Support maintenance and operating costs - recurring costs - 
of the delivery of immunisation services 
2. Produce, distribute and 
retain skilled health and 
community workforce and 
human resources 
2.1 Provide pre-service training of health professionals and/or 
improve pre-service training systems 
2.2 Provide in-service training of health professionals and/or 
improve pre-service training system 
2.3 Conduct supervision of health professionals and/or 
improve in-service training system 
2.4 Scaling-up trained workforce (health professionals) 
2.5 Address workforce retention of health professionals 
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2.6 Scaling-up volunteer/community health workers 
2.7 Address volunteer/community health worker retention 
2.8 Train and supervise volunteer/community health worker 
2.9 Establish, support and strengthen performance-based 
incentive systems 
2.10 Establish and/or strengthen the human resources 
management information system 
3. Strengthen procurement 
and supply chain 
management system, 
including access to 
essential medicines and 
commodities management 
3.1 Scaling-up or upgrading procurement and supply 
management infrastructure 
3.2 Build and/or rehabilitate cold chain facilities 
3.3 Procure cold chain equipment 
3.4 Procure other immunisation-related equipment and 
consumables 
3.5 Improve the supply chain management system for 
immunisation services, including resources (computers, 
etc.) and processes (forecasting, storage, distribution, etc.) 
3.6 Procure commodities, other than drugs and vaccines (Gavi 
HSS funds cannot be used to procure drugs or vaccines) 
4. Strengthen facility 
reporting and health 
information systems 
4.1 Strengthen routine health data reporting system and 
harmonisation of parallel reporting systems and electronic 
data capture, includes monitoring and evaluation indicators 
of Gavi HSS grant 
4.2 Strengthen supportive supervision and training on data 
recording and data reporting practices 
4.3 Improve analytical and research capacity, including the 
strategic use of data and information for programme 
management 
4.4 Strengthen vaccine preventable disease surveillance 
4.5 Strengthen logistics management information systems 
4.6 Strengthen data quality through both self and independent 
assessments followed by costed improvement plans 
4.7 Conduct health facility surveys to assess readiness to 
provide immunisation and other health services, including 
availability of staff, tracer items and valid vaccines 
4.8 Strengthen adverse events following immunisation 
monitoring systems 
4.9 Conduct household surveys to assess immunisation 
coverage and factors associated with non-immunisation 
5. Empower community and 
other local actors 
5.1 Support demand generation activities including: 
communication for immunisation, social mobilization, mass 
media management, material development and capacity 
building 
5.2 Enhancing enabling environment and advocacy 
5.3 Establish public private partnerships with civil society 
organisations 
5.4 Strengthen the capacity of community groups and networks 
6. Create enabling legal, 
policy and regulatory 
environments, including 
national strategic planning 
6.1 Strengthen the governance system of immunisation 
programs, including regulatory and oversight mechanisms  
6.2 Develop, ratify, and execute non-discriminatory, evidence-
based laws, policies, national plans, regulations, 
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and management coordination and quality assurance mechanisms 
6.3 Build capacity to implement laws, policies, and regulations, 
including strengthening capacity of any national regulatory 
authorities 
6.4 Develop and support independent mechanisms to supervise, 
monitor and report on implementation of laws and policies 
7. Ensure adequate financing 
of the health and 
community system 
7.1 Improve revenue collection, pooling and purchasing for 
ensuring financial sustainability of service delivery 
7.2 Improve equity of healthcare and community level financing 
7.3 Improve public financial management of health system, 
including accurate tracking of government and donor 
investments (national health account, mid-term expenditure 
framework, etc.) 
8. Other 8.1 Any activity not captured in other categories e.g. seeking 
effective synergies with other immunisation resources like the 
polio eradication systems and their workforce, and 
campaigns/supplementary immunisation activities 
9. Programme management, 
planning and 
administration 
9.1 Cover management costs, including financial audits 
9.2 Provision of technical support for grant implementation 
9.3 Provision of technical assistance to build local capacity of 
individuals (service providers, managers, etc.) institutions 
(expanded program on immunisation unit, etc.) and 
organisations (civil society, non-government) etc. 
9.4 Conduct operations research and any special studies such as 
knowledge attitude, and perceptions survey, related to health 
system strengthening and immunisation services, relevant to 
the Gavi HSS grant 
Source: Gavi 2015 (Gavi, 2015a) 
 
In consultation with the HSS and monitoring and evaluation experts within Gavi, I removed 
the disaggregates for every indicator to select only the core intermediate results HSS 
indicators; hence, retaining only the unique indicators. These disaggregates were similarly 
described in the previous chapter. For example, a bed occupancy rate may have been 
disaggregated into two: bed occupancy rate for males and bed occupancy rate for females. 
For these types of indicators, these disaggregates were removed. Using the example given, 
these two indicators were clustered under “bed occupancy rates”. Separating disaggregates 
reduced the number of raw indicators from 718 to 127 unique indicators. Three external 
reviewers and coders who were experts from the Gavi Vaccine Alliance Health Systems and 
Information Strengthening and the Monitoring and Evaluation Departments assessed each of 
the 127 unique indicators identified. These reviewers separately scored the indicators based 
on the following criteria:  
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1. The indicator should be specific, measurable, available, scientifically robust and time-
bound (SMART) (Lopez Acevedo et al., 2012). This criterion was subjective and was 
based on the reviewer’s perception. 
2. There should be a strong suitability of the indicator for HSS monitoring and/or a 
strong track record of measurement experience with the indicator. The indicator 
should be frequently measured across countries. More frequently collected indicators 
are prioritised to allow a more in-depth analysis of the progress since analysis based 
only on one or two data points will not make it possible to visualize the progress of 
HSS grants in the future. However, in many Gavi recipient countries, indicators may 
not necessarily have accompanying regularly collected data. In such cases, indicators 
may still be selected to be part of the Gavi’s HSS tailored indicators as long as they 
satisfy at least one of any other indicator criteria. To inform decisions on this 
criterion, information on the frequency of reporting for each indicator was collected 
and provided to external reviewers for their reference. 
3. The indicator should satisfy a minimum level of comparability, coherence, and 
consistency between the way the indicator is measured by Gavi-supported countries 
and the way the measure can be applied to monitor Gavi’s HSS grants. Information on 
whether an indicator is reported by at least two countries was also provided to 
external reviewers to inform their decisions for this criterion. 
4. The indicator should align with Gavi’s strategic goals, which include: 
• To contribute to strengthening the capacity of the health system to deliver 
immunisation and other health services in a sustainable manner; 
• To accelerate the uptake and use of underused and new vaccines and associated 
technologies and improve vaccine supply stability; and 
• To increase the predictability and sustainability of long-term financing for 
national immunisation programs. 
 
Each reviewer was asked to give a score of ‘0’ if they thought the indicator did not meet the 
specific criterion or ‘1’ if they agreed that the indicator met a specific criterion. Hence, the 
maximum score an indicator can receive is four if they meet all four criteria specified above. 
Average scores per indicator were then computed. Indicators that received an average score 
of ’0’ were dropped from the list. The indicators were then sorted and their inclusion in the 
Chapter Three 
 73 
reference list of tailored HSS indicators was prioritised based on their average scores 
received from all three external reviewers: 
 
Table 3-2 Average scores received by each unique indicator identified 
Average score Number of indicators 
3.01 - 4.00 40 
2.01 - 3.00 42 
1.01 - 2.00 30 
0.01 - 1.00 13 
0.00 2 
Total 127 
Source: Author’s computations based on scores given by the reviewers 
 
Further consultations on the selected indicators that were undertaken with other Gavi 
stakeholders such as those represented at the SG2MT, across the Alliance partners such as the 
WHO and the UNICEF, and other key HSS actors that were identified as crucial for HSS 
assessments as discussed in Chapter Two, including Gavi’s regional heads and senior country 
managers.  
 
3.3 Results and discussion 
 
3.3.1 Sample tailored intermediate results HSS indicators 
 
As specified above, the initial 718 indicators were reduced to 127 indicators. Further 
information was gathered for each of the 127 indicators, including the indicator’s definition, 
numerator, denominator, disaggregation/additional measure, method of measurement or 
estimation, data sources, and countries which have used the indicator in their past Grant 
Performance Frameworks.  
 
I found additional information for 105 of the 127 indicators. The other 22 indicators were 
removed from the reference list due to lack of information on how they can be measured. 
Table 3.3 presents the number of indicators retained per Gavi HSS cost category and health 
system function.  
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Table 3-3 Number of indicators per Gavi HSS cost category and health system building 
block 
Health system 
building block 
Gavi HSS Cost Category Indicators 
Governance 1 Policy and governance 5 
 
2 Programme management planning and administration 7 
Health workforce 3 Health and community workforce 3 
 
4 Empower community and other local actors 8 
Medical products 
and technologies 
5 Strengthen procurement and supply chain management 
system 2 
Health financing 
6 Ensure adequate financing of the health and community 
system 6 
 
7 Programme support costs 4 
Health service 
delivery 
8 Scale-up and improve accessibility and quality of 
service delivery 28 
Health 
information 
systems 
9 Improve availability, quality and use of immunisation 
and health systems data 10 
Others 10 Others 32 
Source: Author’s computations based on internal data collected 
 
Sample indicators for each Gavi HSS cost category are presented below. The full list of the 
indicators is undergoing further review and can be accessed from the Gavi Vaccine Alliance 
country portal website.  
  
Table 3-4 Sample indicators per health system building block and Gavi HSS cost-
category 
Health 
system 
function 
Gavi HSS cost 
categories 
Sample indicators 
Governance 1. Policy and 
governance 
Proportion of localities or health facilities with 
Effective Vaccine Management (EVM) scores of at 
or above 80% 
Vaccine wastage rates or proportion of localities 
with vaccine wastage rates that are aligned with the 
national policy aiming to reduce wastage (or 
proportion of reduction in vaccine wastage rates 
compared to existing rates) 
2. Programme 
management 
planning and 
administration 
Number of technical committees at the national level 
Presence of an independent technical advisory group 
that meets defined criteria 
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Financing 3. Ensure 
adequate 
financing of 
the health and 
community 
system 
Total government funds allocated to EPI budget or 
proportion of traditional vaccines with funds 
allocated from the national budgets or Proportion of 
funds for routine immunisation provided by the 
government direct contribution 
4. Programme 
support costs 
Proportion of utilisation of Gavi HSS annual budget 
(or Rate of financial execution of Gavi RSS) 
Proportion of multi-year aid commitments disbursed 
by development partners 
Medical 
products 
and 
technologies 
5. Strengthen 
procurement 
and supply 
chain 
management 
system 
Proportion of pharmaceutical companies with good 
laboratory practices (GLP) and good manufacturing 
practices (GMP) 
Average procurement time process for 
immunisation-related goods and services at specific 
levels (e.g. at the level of the ministry of 
health/public health) 
Extent to which procurement departments meet 
certification requirements 
Workforce 6. Health and 
community 
workforce 
Proportion of volunteers and community health 
workers who received immunisation training 
according to standards; OR Percent or total number 
of targeted communities with volunteers or CHWs 
trained to undertake EPI activities 
Proportion of active and practicing CHWs 
7. Empower 
community 
and other local 
actors 
Level of community knowledge on immunisation  
Proportion of target districts that benefitted from 
communication and advocacy 
Service 
delivery 
8. Scale-up and 
improve 
accessibility 
and quality of 
service 
delivery 
Proportion of districts with at least one 
Comprehensive Emergency and Obstetric Neonatal 
Care site  
 
9. Improve 
availability, 
quality and use 
of 
immunisation 
and health 
systems data 
Proportion of health facilities regularly submitting 
surveillance data on reportable diseases including 
VPD and AEFI integrated disease surveillance 
Others 10. Others Proportion of households with a specific place for 
hand washing where water and cleansing agents are 
present  
Evidence of improved infection prevention and 
health care waste management   
Proportion of mothers who have initiated breast 
feeding within first hour following birth 
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3.3.2 Considerations for conducting program-level HSS monitoring and evaluation 
 
Interest in a common monitoring and evaluation framework for Gavi’s health systems 
strengthening grants was stimulated as a result of various international health partnerships 
and initiatives undertaken in the past (WHO, 2009a). However, such a common health 
system monitoring and evaluation framework still remains a challenge due to the very 
different country capacities, uneven data sources and data availability and quality across 
countries, including the varied contexts that drive priority areas for health systems (De 
Savigny & Adam, 2009; Hong & Huibin, 2002; WHO, 2003). As part of a strengthened focus 
on results, Gavi has introduced performance-based funding for HSS grants, drawing on the 
International Health Partnerships Plus (IHP+) Monitoring and Evaluation framework and has 
been working with partners on the intermediate results for HSS (Shorten, Taylor, Spicer, 
Mounier-Jack, & McCoy, 2012). Performance-based or outcomes-based funding for 
programs is increasingly common not only for health, but also for other service delivery areas 
(Fretheim, Witter, Lindahl, & Olsen, 2012; Odden & Busch, 1998; Soeters & Vroeg, 2011; 
Toonen, Canavan, Vergeer, & Elovainio, 2009). The intermediate results provided the link 
between HSS grant activities and improved immunisation outcomes, such as coverage and 
equity (Glassman & Savedoff, 2011). For reporting on immunisation results, Gavi 
recommends that countries identify and use tools for data collection that are appropriate for 
their country’s context. Gavi collaborates with the WHO and other partners in using 
standardised tools that measure data quality, service readiness, and service availability (Gavi, 
2010). As a key component of such M&E framework, this research provided a 
comprehensive suite of indicators that may also give an overview of the national and regional 
level of capacity of each Gavi-supported country and assist in monitoring their achievements 
towards the overall Gavi strategic goals. Findings ensure that the monitoring and evaluation 
framework for HSS grants is responsive and flexible while also enabling the use of standard 
measures and methods. 
 
Indicators were classified across the WHO health systems building blocks and the different 
strategic objectives and HSS cost categories of Gavi. The results of this research showed that 
under each of the WHO health systems building block, Gavi HSS cost-categories can also be 
utilised for more program-focused HSS grant monitoring. Each of the indicators identified 
from the Grant Performance Frameworks and other core data sources fit into each of the 
priority areas were also aligned with global health development goals. The HSS grant 
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indicators specified above can then be used for monitoring and evaluating progress towards 
each of the WHO health systems building blocks, and towards achieving more resilient and 
sustainable health systems. Since the indicators have been identified from the Gavi 
performance frameworks and submissions from each Gavi-supported country, they can also 
reflect the relevant policy areas and provide insights on data availability and comparability. 
This can provide a more transparent mechanism for illustrating the government’s 
accountability for their country’s health progress. The findings also showed multi-stakeholder 
support and inter-sectoral indicators that were vital for HSS, supporting the results discussed 
in the previous chapters. 
 
3.3.3 Limitations 
 
While this chapter led to the development of a new indicator set that can be used by grant-
receiving countries for performance-based accountability reporting back to Gavi, it does also 
suffer from some limitations. In particular, only intermediate results indicators for Gavi’s 
HSS grants were included. Outcome and process tailored indicators were not identified and 
the database was not expanded to include broader HSS indicators. The indicator list is also 
not exclusive but indicative. This chapter was also restricted to a desk review of data sources 
available within Gavi - those that were submitted as part of HSS funding applications and 
previous findings of the author on HSS concepts and metrics as discussed in previous 
chapters. To my knowledge, this is the first comprehensive listing of program-level 
intermediate results HSS indicators derived from country-driven HSS monitoring and 
evaluation results frameworks. The indicators were selected from HSS monitoring and 
evaluation frameworks that countries have committed to for monitoring their health systems 
strengthening progress. However, the list of indicators was developed from Gavi’s HSS 
assessments and for the context of immunisation-relevant health systems support. As such, 
other indicators were excluded due to language or search criteria. Some that were excluded 
may also be relevant for HSS monitoring and evaluation.  
 
As specified in the findings in Chapter Two, HSS indicators and benchmarks may need 
ongoing revision to enhance their responsiveness to health systems needs and should be 
adapted for different contexts (Gabrysch, Zanger, Seneviratne, Mbewe, & Campbell, 2011). 
This means that the indicators identified in this chapter are not universally relevant in all 
contexts. For example, the majority of indicators were available on a national and regional 
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scale, but its application to small areas may be limited (Gabrysch et al., 2011; Mulligan, 
Appleby, & Harrison, 2000). Restrictions on scalability, funding, periodicity, and availability 
of data sources also further limit the applicability of the list of indicators for HSS monitoring 
and evaluation despite its potential relevance. The definitions selected for each indicator were 
also the most commonly accepted. The sources of information for the calculation of the 
indicators were highly heterogeneous with the institutes of statistics, and information from 
health administrations and social welfare being the principal sources of data (Mulligan et al., 
2000). Furthermore, the reference year of these sources varies across countries. Moreover, 
this chapter only included data that were readily available within Gavi or its Alliance 
partners. For internal documents, country attempts to satisfy donor requirements may also 
create reporting bias for the definitions of each indicator may change with specific country 
contexts. Frequent communications and consultations with relevant Gavi experts were 
conducted to minimise the impact of these limitations. As much as possible, this research 
included triangulation of the findings with reports and recommendations of health systems 
experts within Gavi and its Alliance partners. Nevertheless, since the data sources were 
validated and agreed upon by the HSS-recipient countries, it has been assumed that country’s 
monitoring and evaluation capacities and specific contexts were taken into consideration 
when countries have agreed to be monitored against such performance framework. The 
listing of the indicators has so far encompassed quantitative indicators. Future work on this 
area may include more qualitative indicators that can then be more reflective of a country’s 
health systems performance, and to complement existing Gavi core and tailored health 
indicators. These indicators can then be more responsive to illustrate Gavi-supported 
countries’ health systems support needs and priority areas. The approaches used in this 
chapter can form the basis for further work on this research area.   
 
3.4 Conclusion 
 
The findings in this Chapter provide baseline information on how health systems 
strengthening can be assessed to inform grant applications and funding investments. These 
indicators can also then facilitate the creation of more standard measures not only for Gavi-
supported programs but also to aid other ongoing and future HSS programs. This list of 
indicators for HSS monitoring and evaluation can be a tool for program-focused or grant-
focused HSS, which is also necessary to support health systems accountability and 
governance mechanisms. The list of indicators also showed that many standard and 
Chapter Three 
 79 
commonly used indicators can then be updated or revised according to each country’s 
capacities and health systems priorities. The indicators identified were also agreed upon by 
both the funding organisation and the HSS-recipient countries using a bottom-up approach 
for HSS monitoring and evaluation wherein an appraisal of feasible indicators for countries 
was the first step in selecting indicators. The transparency in the approaches used, the data 
sources and other relevant information can support future work on this area. Other 
researchers can also provide more contextual information on each of the countries selected 
for the study, which may include further data verification, validation, indicator selection and 
screening, according to identified needs and purposes of its use. Proper translations to 
overcome language barriers in HSS M&E indicator selection and screening can also be 
considered for future work. More importantly, the inventory of indicators and the 
accompanying database developed in this research can be further enriched with additional 
information that can be gathered from other data sources or more updated versions of the core 
data sources used in this study. To assist in this goal, this research provided initial design 
phases and a set of indicators for HSS that can be used at different levels to aid in conducting 
more structured monitoring and evaluation frameworks and practices, and help countries in 
mapping and assessing their very own health systems performance.  
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Part B: Health systems strengthening initiatives and health outcomes 
 
Part B responds to the following research question:  
How significant are HSS initiatives for improving health outcomes?  
 
Using the concepts and measures identified from Part A, Part B first examines how these 
measures, controlling for socioeconomic factors, significantly influence health outcomes. 
Second, Part B develops an index for each of the health systems building block and an 
overall index for health systems performance to provide a global overview of health systems 
progress over the years. Third, Part B identifies taxonomies of health systems performance 
specifically in low- and middle-income countries using the index that was developed. Lastly, 
Part B moves from the global to the national context and examines a specific health system 
building block – leadership and governance – in two countries: the Philippines and 
Cambodia. 
 
The main aim of any health system is to improve health outcomes for the people it serves 
(WHO, 2007), and the key to such improvement is strengthening the national health systems  
(Liu et al., 2012; Sepúlveda et al., 2006). Health outcomes are often the first area considered 
when evaluating the performance of a health system, requiring aggregated data on the health 
status and any health improvements of the population. Assessing health outcomes can also be 
attractive from a political point of view because it demonstrates how key policy reforms are 
affecting the overall population health. Among all health outcome measures, a more 
immediate measure is infant mortality rates (IMR), which is accurately measured by birth 
registries (Kang, Cho, & Jung, 2012; Pascual & Cantarero, 2005; H. Uchimura, 2008; M. 
Uchimura, Kizuki, Takano, Morita, & Seino, 2014). Significant declines in IMR also allows 
understanding of which aspects of health systems have effectively contributed in addressing 
major health risks (Alwan et al., 2010; Beaglehole et al., 2011; Wilkinson & Marmot, 2003). 
However, long term health system interventions are needed before these interventions can 
create significant changes in health outcome measures. In other words, considering the long-
term nature of HSS, the impact of health systems interventions may not necessarily be 
captured yet in existing datasets because their impact may only be determined after a certain 
number of years (Ingram et al., 2012). This approach does not appeal to health systems 
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reforms that should be done rapidly to address pertinent health needs. Hence, relying on 
health outcomes measures alone to understand if a health system reform is effective or if the 
health system is performing well may not be adequate. This is specifically seen when 
policymakers and other practitioners would want to know the immediate effects of an 
intervention. Therefore, measuring how health systems influence immediate health outcomes 
remains a challenge for research (Tandon, Murray, Lauer, & Evans, 2010). This implies the 
need for other measures of health systems performance, which this thesis responds to by 
developing a composite indicator.  
 
Higher-performing health systems are expected to lead to better population health (Ingram, 
Scutchfield, Charnigo, & Riddell, 2012). However, in addition to health systems, national 
economic factors such as GDP and individual socioeconomic characteristics are also strong 
and immediate determinants of population health especially in resource-poor settings (OECD, 
2012). This influence of other health determinants may be more evident in LMICs, wherein 
wider social and health inequalities exist (Frenk et al., 1989; Wilkinson & Pickett, 2006). 
Given this complexity, confoundedness, and high spill-over effects of HSS interventions, 
examining how improving health systems alone led to better health was found to be difficult 
(Wilkinson & Marmot, 2003; Zakus & Bhattacharyya, 2007). In response, Part B controls for 
socioeconomic factors as it examines health systems performance in LMICs, while also 
accounting for comprehensive indicators for each of the health system builing blocks and the 
overall health systems performance in both global and national contexts. In particular, Part B 
includes three chapters: 
• Chapter 4: Health systems building blocks and key health outcomes 
• Chapter 5: Taxonomy of health systems performance in low- and middle-income 
countries  
• Chapter 6: Health systems strengthening in the context of decentralization 
 
  
  
 
82 
 
Chapter 4 Health systems building blocks and key health outcome indicators 
 
4.1 Health status in low- and middle-income countries 
 
Central to the work towards health systems strengthening is the analysis of how each health 
system building block affects health outcomes. In many low- and middle-income countries 
(LMICs),5 health outcomes have been continuously improving over the years but it remains 
unclear whether the overall status can be attributed to certain characteristics of HSS (Berger 
& Messer, 2002; Gani, 2009). Using survey datasets, this chapter examines the relationship 
between key health systems indicators identified in Chapters 2 and 3 in relation to the 
different measures of health outcomes, including infant mortality rates, child mortality rates, 
life expectancy rates, and diphtheria-pertussis-tetanus (DTP3) immunisation coverage.  
 
Child survival, indicated by infant, under-five, and child mortality rates, is an important 
measure of the overall health development of a country since it captures health of the most 
vulnerable group. Specifically, child survival often rises earlier and faster than other 
population health measures (UNHCR, 2013). In LMICs, under-five mortality rates 
significantly decreased from 1970 to 2010 from an average of 150 deaths per 1,000 live 
births in 1970 to almost half lower at 89 deaths per 1,000 live births in 1990. This further 
declined to 52 deaths per 1,000 live births in 2010, but still much higher compared with 7 per 
1,000 live births in high income countries (IJsselmuiden, 2007). Specifically, mortality 
remains high in Sub-Saharan Africa with 157 deaths per 1,000 live births on average from 
1970 to 2010. This average is followed by Asia (84 deaths per 1,000 live births), North 
Africa/Middle East (70 deaths per 1,000 live births), Latin America (54 deaths per 1,000 live 
births), Oceania (55 deaths per 1,000 live births), Caribbean (49 deaths per 1,000 live births) 
and Europe (25 deaths per 1,000 live births). Other than under-five mortality rates, neonatal 
mortality rates as another measure of child survival also showed a decline from 1970 to 2010. 
However, Sub-Saharan Africa was still lagging with an average of 41 deaths per 1,000 live 
births. Again, this is followed by Asia (33 deaths per 1,000 live births), North Africa/Middle 
                                                
5  LMICs refer to World Bank (WB) member economies and all other economies with populations of more 
than 30,000 that have a gross national income (GNI) per capita of $12,615 or less (as of 2012). GNI means 
gross national income converted to international dollars using purchasing power parity rates. An 
international dollar has the same purchasing power over GNI as a U.S. dollar has in the United States (T. 
World Bank, 2013).  
Chapter Four 
 
 
83 
East (28 deaths per 1,000 live births), Oceania (27 deaths per 1,000 live births), Caribbean 
(22 deaths per 1,000 live births), Latin America (20 deaths per 1,000 live births), and Europe 
(12 deaths per 1,000 live births) (Figure 4.1). 
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Figure 4.1 Child survival in LMICs as indicated by neonatal mortality rates (Panel A) and 
under-five mortality rates (Panel B)  from 1970 to 2010 showing decreasing trends at the 
global level with the regions of Sub-Saharan Africa and Asia having the highest rates 
compared to other regions calculated using estimates from the IHME Global Health Data 
Exchange  (IHME, 2014) 
 
Another health outcome measure is life expectancy, which reflects the overall population 
mortality. In terms of life expectancy, people in high income countries live on average seven 
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years longer than those in LMICs (WHO, 2013d). Another health outcome measure is disease 
burden, which is used to assess and compare the relative impact of different diseases and 
injuries on populations by quantifying health loss due to disease (AIHW, 2013; Boutayeb & 
Boutayeb, 2005). In LMICs, disease burden remains high and this poor health status further 
widen health inequalities as disease burden tends to be higher among those with lower 
socioeconomic status (Ataguba, Akazili, & McIntyre, 2011; Di Cesare et al., 2013; 
Hosseinpoor et al., 2012; Miszkurka et al., 2012).  
 
Another emerging concern is on population ageing. Population ageing refers to the increasing 
share of older persons in the population (Rechel et al., 2009). Life expectancies may 
significantly differ between countries, but populations of nearly all countries are ageing 
(Anderson & Hussey, 2000). The accelerated increase in aging and life expectancy 
influenced public health such that a substantial and rapid adaptation of the health system to 
the increasing demands for health care services is needed (Abrams, 2006; Jacobzone & 
Oxley, 2002). This ageing population further challenges an overburdened healthcare system 
(Beaglehole et al., 2008) and can lead to unprecedented demands in healthcare with 
detrimental economic and social impacts (Bloom, Canning, & Fink, 2010). Globally, 
population ages 65 and above was at 6% on average with the highest for Japan at 24.4% in 
2012 and the lowest for United Arab Emirates at 0.33% in 2011 (Table 4-1). Meanwhile, 
LMICs have 4.6% of its total population who are in ages 65 and above, more than twice 
lower than the 9.88% in LMICs (Figure 4.2).  
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Figure 4.2 Population ages 65 and above from 1960 to 2012 for each income group 
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Table 4-1 Countries with the highest and lowest percentage for population ages 65 and 
above in low- and middle-income countries 
 Wave 1 Wave 2 Wave 3 
Highest Latvia (12.36%) 
Bulgaria (11.57%) 
Serbia (11.19%) 
Ukraine (10.86%) 
Lithuania (10.77%) 
Uruguay (10.40%) 
Belarus (10.22%) 
Romania (9.79%) 
Russia (9.36%) 
Georgia (9.26%) 
Bulgaria (17.19%) 
Latvia (16.50%) 
Ukraine (15.16%) 
Lithuania (14.78%) 
Romania (14.37%) 
Belarus (14.32%) 
Georgia (13.97%) 
Serbia (13.69%) 
Uruguay (13.41%) 
Russia (13.38%) 
Bulgaria (18.27%) 
Latvia (18.24%) 
Ukraine (15.79%) 
Lithuania (15.48%) 
Romania 14.88%) 
Bosnia and Herzegovina 
(14.84%) 
Georgia (14.35%) 
Belarus (14.08%) 
Uruguay (13.85%) 
Lowest Eritrea (1.76%) 
Niger (1.97%) 
Afghanistan (2.18%) 
Palestine (2.18%) 
Papua New Guinea 
(2.25%) 
Timor-Leste (2.32%) 
Djibouti (2.52%) 
Rwanda (2.54%) 
Fiji (2.61%) 
Malawi (2.61%) 
Eritrea (1.92%) 
Afghanistan (2.03%) 
Sierra Leone (2.44%) 
Palestine (2.46%) 
Angola (2.46%) 
Niger (2.53%) 
Uganda (2.56%) 
Papua New Guinea 
(2.58%) 
Gambia (2.59%) 
Burkina Faso (2.62%) 
Eritrea (2.1%) 
Afghanistan (2.16%) 
Rwanda (2.32%) 
Angola (2.42%) 
Uganda (2.45%) 
Burkina Faso (2.49%) 
Gambia (2.51%) 
Chad (2.52%) 
Burundi (2.55%) 
Sierra Leone (2.55%) 
*Excludes the following countries: Palau, Tuvalu, Marshall Islands, Dominica and Kosovo 
Source: Author’s computations using Health Systems 20/20 project’s database 
 
 
Hence, to further examine how health systems in LMICs change and adapt to current 
demands for health care service delivery, this chapter aims to determine the similarities and 
differences in health systems performance across 135 low- and middle-income countries. 
25.17% of the data (n = 8640) came from countries under the low income category, 37.76% 
of the data (n = 12,960) came from countries under the lower middle income category, and 
37.06% of the data (n = 12,720) came from countries under the upper middle income 
category.  
Table 4-2 Number of observations collected per income group 
Income group Frequency Percent 
Low income 8,640 25.17% 
Lower middle income 12,960 37.76% 
Upper middle income 12,720 37.06% 
Source: Author’s computations using the Health Systems 20/20 data 
 
Chapter Four 
 
 
86 
Without a properly working health system, LMICs continuously suffer from poor health 
outcomes (Schell, Reilly, Rosling, Peterson, & Ekström, 2007). Although  increasing amount 
of official development assistance for health aims to achieve better health outcomes (OECD, 
2011), the per capita total health spending remains low for LMICs at $301 on average 
compared to the $3,370 average for high income countries (Frenk et al., 1989). This lack of 
resources compels evidence-informed resource allocation, implying the need to enhance HSS 
assessments that will best inform proper allocation and maximize limited health resources. 
Hence, health systems performance assessments will enable more health resources to be 
allocated to aspects of health systems that best improve health (Costa Font & Sato, 2012; Di 
Cesare et al., 2013). 
 
4.2 Methods 
 
To do a cross-country comparative analysis of each health systems building block from the 
framework developed in Chapter Two and examine how each of these block relate to health 
outcomes, this chapter uses three waves of data from the USAID Health Systems 20/20 
project for 137 LMICs. Using previous studies on health systems performance assessments as 
a starting point, this chapter updates and expands the health systems indicators that can be 
used to assess each building block and the overall health systems performance. The effects of 
building blocks and overall health systems performance were then compared against health 
outcome measures: infant mortality rates (IMR), under-five mortality rates (UMR), life 
expectancy (LE), and diphtheria-tetanus-pertussis (DTP3) immunisation coverage.  
 
4.2.1 Data Sources 
 
Data sources include the USAID Health Systems database (USAID, 2013), which compiles 
and analyses national-level health system data from multiple sources such as the 
Demographic and Health Surveys (Rutstein & Rojas, 2006),6 the World Health Organisation 
(WHO, 2015k),7 the World Development Indicators (World Bank, 2012),8 and the World 
                                                
6   The Demographic Health Surveys (DHS) were nationally-representative household surveys that provide data 
for a wide range of monitoring and impact evaluation indicators in the areas of population, health, and 
nutrition. The DHS has been implemented in overlapping five-year phases based on a stratified two-stage 
cluster design (Rutstein & Rojas, 2006).  
7  The World Health Surveys was built upon the WHO Multi-country survey study and was gathered using a 
valid, reliable, and comparable household survey instrument The total sample size, using nationally 
representative samples, included over 300,000 individuals aged 18+ years (WHO, 2015k). 
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Governance Indicators (World Bank, 2016d).9 Although the original data sources were 
coming from multiple surveys, the database used for this study was a single database used in 
the Health Systems 20/20 project. Further, I averaged the data into three or every five years. 
Specifically, the dataset has a pooled cross-sectional time series structure with country as the 
unit of analysis. The records are country-period observations with repeated observations for 
countries over time. 
 
4.2.2 Dependent variables  
 
I used four health outcome indicators: a) infant mortality rates (IMR), b) under-five mortality 
rates (UMR), c) life expectancy at birth (LE), and d) immunisation coverage for DTP3. IMR 
is the probability of dying before the 1st birthday (DHS, 2015b). It is considered to be the 
single most exhaustive indicator of health because it is based on birth registries, implying 
more complete and accurate measurements (Kang, Cho & Jung 2012: 1; Rubio 2011: 3907-
3917). CMR is the probability of dying between the 1st and 5th birthdays of a child (DHS, 
2015b). Based on extrapolations from child mortality data and assumed life-length tables 
(Cantarero, Pascual 2008: 109-111; Uchimura, Jütting 2009: 1926-1934), LE indicates the 
number of years a newborn infant would live if prevailing patterns of mortality at the time of 
birth were to stay the same throughout life (World Bank, 2016b). IMR and CMR were 
estimated using data from the Demographic Health Surveys (DHS, 2015b), while LE were 
estimated using data from the World Development Indicators (World Bank, 2016b).  
 
4.2.3 Independent variables 
 
Using the indicators identified from Chapters Two and Three, I used the indicators with 
existing data to represent each of the health systems building block: governance, financing, 
service delivery, workforce, medical products and technologies, and health information 
systems. Specifically, I used the following indicators:  
                                                                                                                                                  
8  The World Development Indicators is the primary World Bank collection of development indicators, 
compiled from officially-recognized international sources. It presented the most current and accurate global 
development data available, and included national, regional, and global estimates (World Bank, 2012). 
9  The World Bank’s Governance Indicators reported aggregate and individual indicators for 215 economies 
over the period 1996-2014 for six dimensions of governance: voice and accountability, political stability and 
absence of violence, government effectiveness, regulatory quality, rule of law, and corruption. These 
aggregate indicators combined the views of a large number of enterprise, citizen and expert survey 
respondents in industrial and developing countries (World Bank, 2016d).  
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Governance. I used six indicators collected from the World Governance Indicators, which 
uses six indicators aggregated at the national-level and are available from 1996 to 2014. 
These six indicators reflect the six dimensions of governance: control of corruption10, voice 
and accountability11, regulatory quality12, political stability and absence of 
violence/terrorism13, government effectiveness14, and rule of law15 (World Bank, 2016d). All 
indicators are reported as governance scores ranging from -2.5 to 2.5 with higher values 
corresponding to better governance index. These units are computed by combining into one 
score the views of a large number of enterprise, citizen and expert survey respondents across 
different countries (World Bank, 2016d). Specifically,  these scores are based on over 30 
individual data sources produced by a variety of survey institutes, think tanks, non-
governmental organisations, international organisations, and private sector firms (World 
Bank, 2016d).  
 
Financing. I used six indicators: external resources for health as a percentage of total health 
expenditure (WHO, 2015b), out-of-pocket expenditure on health as a percentage of private 
expenditure on health (US$) (WHO, 2016b), per capita government health expenditure 
(PPPint) (WHO, 2015e), per capita total health expenditure (WHO, 2015j), private 
expenditure on health as a percentage of the total health expenditure (WHO, 2016b), and 
private prepaid plans as a percentage of private expenditure on health (WHO, 2016b). 
External resources for health are funds or services in kind that are provided by entities not 
part of the country in question (World Bank, 2015b). The resources may come from 
international organisations, other countries through bilateral arrangements, or foreign 
nongovernmental organisations (World Bank, 2015b). Out of pocket expenditure, part of 
private health expenditure, is any direct outlay by households, including gratuities and in-
kind payments, to health practitioners and suppliers of pharmaceuticals, therapeutic 
                                                
10  Control of corruption refers to extent to which public power is exercised for private gain. 
11  Voice and accountability measures the extent to which countries are able to participate in selecting their 
government, freedom of expression and association, and free media. 
12  Regulatory quality measures the ability of the government to formulate and implement sound policies. 
13  Political stability and absence of violence/terrorism measures perceptions of the likelihood of political 
instability and/or politically-motivated violence, including terrorism 
14  Government effectiveness measures perceptions of quality of public services, civil service and the degree of 
its independence from political pressures, quality of policy formulation and implementation, and the 
credibility of the government’s commitment to such policies  
15  Rule of law measures the extent to which agents have confidence in and abide by the rules of society, and in 
particular, the quality of contract enforcement, property rights, the police, and the courts, as well as the 
likelihood of crime and violence  
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appliances, and other goods and services whose primary intent is to contribute to the 
restoration or enhancement of the health status of individuals or population groups (World 
Bank, 2016c). Private prepaid plans refer to the relative weight of voluntary health insurance 
payments in total health expenditure (WHO, 2015h).  
 
Medical products and technology. I used four indicators: pharmaceutical public spending 
per capita at US exchange rates, pharmaceutical private spending per capita at US exchange 
rates, and total pharmaceutical expenditure at US exchange rates. Pharmaceutical spending 
includes expenditures on prescriptions on medicines and over-the-counter products. In some 
countries, the data also include other medical non-durable goods adding approximately 5% to 
the expenditure (OECD, 2015b). The spending also includes pharmacists’ remuneration when 
the latter is separate from the price of medicines. Indicators related to the per cent of 
pharmaceuticals consumed per country were excluded in the analysis due to data availability 
(missing data >94%). Final expenditure on pharmaceuticals include wholesale and retail 
margins and value-added tax (OECD, 2015b).  
 
Service delivery. I used four indicators: pregnant women who attended at least one antenatal 
care visit, HIV test results received in the last twelve months of female population ages 15 to 
49 years old, improved sanitation facilities and improved water source.  
 
Workforce. I used three indicators: births attended by doctors, births attended by other health 
professionals, and births attended by skilled health staff as a percentage of total births.  
 
4.2.4 Control variables 
 
I used three control variables: fertility rate, gross domestic product (GDP) per capita, and the 
Gini index. Fertility rate is the number of births that occurred in the three years before the 
survey to women between the ages of 15 to 49 years divided by the number of women-years 
of exposure in the three years before the survey for women in the same age group (DHS, 
2015a). GDP per capita (constant 2005 US$), which is calculated by dividing the gross 
domestic product with midyear population, is the sum of gross value added by all resident 
producers in the economy plus any product taxes and minus any subsidies not included in the 
value of the products (World Bank, 2015c). The Gini index measures the extent to which the 
distribution of income among individuals or households within an economy deviates from a 
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perfectly equal distribution (World Bank, 2015d). A Gini index of zero represents perfect 
equality, while an index of 100 implies perfect inequality (World Bank, 2015d).   
 
4.2.5 Analysis 
 
Assuming that higher scores for each health systems building blocks lead to better health 
outcomes, I quantified the performance for each health systems building blocks and their 
effects on health outcomes  using fixed effects and random effects longitudinal regression 
models for 137 LMICs. These models consider the dependencies in the data associated with 
having repeated observations on countries over time. Using the fixed effects model makes the 
model consistent and unbiased and does not make any assumptions about the distribution of 
the country-level unobserved effects (Wooldridge, 2015). However, fixed effects models fail 
to directly estimate the impacts of time-invariant variables on the dependent variables and 
only use within-country variation. Hence, using fixed effects model is inefficient in cases 
when there are little within-country variations. Likewise, random-effects model may be 
useful to create an optimal combination of between and within country variations. However, 
such model assumes that the unobservable and observable variables affecting health 
outcomes are uncorrelated, which is unlikely for the variables included in the study. 
Therefore, considering these limitations of both models, findings for both random and fixed 
effect regression models were also discussed below. Following the work of Gani (2009), I 
examined the relationships between each health system building block and outcomes using 
the following structural equation: !"# = %('"#, )"#)      (4.1) 
where !  refers to the different health outcome indicators, reflecting health status of country !  ,!  refers to the different health system building block indicators for country !  in time !  , !  is a 
vector of the control variables used for country !  and time !  .  
 
In the regression analysis, equation 4.1 is expressed in four forms as follows: 
 !"#$% = 	( +	*+,-1$% + /0,-2$% +	*2,-3$% …+ *5,-6$% +	*789:;$% +	*<=>?$% +	*@=ABA$% +	C$ +	D$%   
 (4.2) 
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!"#$% = 	( +	*+,-1$% + /0,-2$% +	*2,-3$% …+ *5,-6$% +	*789:;$% +	*<=>?$% +	*@=ABA$% +	C$ +	D$%    
 (4.3) !"#3%& = 	) +	+,-.1%& + 01-.2%& +	+3-.3%& …+ +5-.6%& +	+789:;%& +	+<=!#%& +	+>=?@?%& +	A% 	+ 	B%&    
 (4.4) !"#$ = 	' +	)*+,1#$ + ./+,2#$ +	)1+,3#$ …+ )4+,5#$ +	)6789:#$ +	);<=>#$ +	)?<@A@#$ +	B# +	C#$    
 (4.5) 
 
In this model, !  is the health outcome variable of country i in year t. !"#  , where x is the 
corresponding health systems building block, include each of the indicators described above 
for each of the building block in country !  and year !  . I run separate models for every health 
system building block before running one model considering all blocks. I then controlled for 
the following variables: !"#$  is the fertility rate in country !  and year !  , !"#  is the gross 
domestic product in country !  and year !  , and !"#"  is the Gini coefficient in country !  and 
year !  . In the model, !"   is assumed to be independent and identically distributed with a mean 
of zero and constant variance and uncorrelated with any of the explanatory variables. The 
error term in the above equation is !"#   with the assumption that !"# ≈ %%&  (0, !"  ). The 
expected effects are that the indicators for each of the health systems building blocks are 
positively associated with health outcomes such that better health systems performance 
results to reduced mortality rates and improved immunisation coverage and life expectancy.  
To take into account country-specific differences, a fixed-effects estimation procedure 
including country-specific dummy variables was used. Given the nature of the data, the 
possibility of AR(1) errors is likely and so the fixed-effects estimation procedure corrected 
for AR(1) errors was used. Since outliers can cause bias results by pulling or pushing the 
regression line in a particular direction resulting to biased regression coefficients, I also 
removed outliers or countries with extremely high or low numbers for each of the indicators 
by testing for outlying observations, multicollinearity and regression stratification across 
income groups. Assuming all variables are linear, I initially examined exploratory scatterplots 
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of the variables of interest and transformed variables into its logarithmic form for data with 
evident curvature in the relationships. 
 
4.3 Results 
 
4.3.1 Descriptive statistics 
 
I run separate samples for each regression model and for every health system building block. 
I have different numbers of observations across variables. For some measures like GDP per 
capita, I have on average 40 waves of data per country, but for the outcome variables, with 
the exception of LE, I only have between two to three waves per country.  Appendix three 
indicates the overall mean for the variables included in the study or the mean of country-
years. The table also presents the between statistics, which are country level means, and the 
within statistics, which showed the deviations of the country by time scores from the country 
means. The following discussion presents the averages in the whole dataset: 
 
Health outcomes. Average IMR was at 67 deaths per 1000 live births. The maximum IMR 
recorded was at 152 deaths per 1000 live births. Average CMR is at 106 deaths per 1000 live 
births with the lowest recorded at 12 deaths per 1000 live births and the highest at 326 deaths 
per 1000 live births. Life expectancy at birth or the number of years a newborn infant would 
live is at 59 years old on average and can range from only 20 years old to as high as 80 years 
old. Specifically, San Marino and Sierra Leone had mean annual population growth rates of 
1.38% and 1.95% respectively, yet their mean life expectancies were at the extreme sides 
with San Marino having one of the highest life expectancy of 81.50% and Sierra Leone with 
only 37.80%. Highest mean life expectancies after San Marino were from Iceland (77.39%), 
Sweden (77.07%), Japan (76.99%) and Switzerland (76.69%). Meanwhile, lowest life 
expectancies were from Sierra Leone (37.80%), Angola (41.27%), Mali (41.88%), South 
Sudan (42.25%), and Mozambique (43.15%). Immunisation coverage for DTP3 for 1 year 
olds is at 60.45% on average and can range from only 2.60% to as high as 97.90%. 
 
Health systems building blocks. Almost all LMICs have negative scores for governance 
with an average score of -0.50 across all the six dimensions of governance. Of the 137 
LMICs included in the study, Chile scores the highest in terms of control of corruption with a 
mean of 1.44, followed by Antigua and Barbuda (1.09) and Uruguay (1.02). Least among all 
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these countries are Somalia (-1.72), Afghanistan (-1.58), North Korea (-1.54), Myanmar (-
1.46), and the Democratic Republic of Congo (-1.45). Government effectiveness is also 
highest in Chile with an average score of 1.21. This is followed by Malaysia (1.05) and 
Mauritius (0.674). Meanwhile, least scores were from Somalia (-2.18), North Korea (-1.92), 
Democratic Republic of the Congo (-1.70), South Sudan (-1.68) and Comoros (-1.58).  In 
terms of political stability (PS), five highest countries include: Tuvalu (1.36), Kiribati (1.35) 
and Palau (1.17). Least scores were from: Somalia (-2.83), Afghanistan (-2.43), Democratic 
Republic of the Congo (-2.29), Sudan (-2.26) and Iraq (-2.23). Regulatory quality is also 
highest in Chile (1.48) followed by Lithuania (1.02) and Latvia (0.96). Least scores were 
from: Somalia (-2.83), Afghanistan (-2.43), Democratic Republic of the Congo (-2.29), 
Sudan (-2.26) and Iraq (-2.23). Rule of law is also highest in Chile (1.26), followed by 
Antigua and Barbuda (0.97) and Tuvalu (0.96). Least scores were from Somalia (-2.36), 
Afghanistan (-1.81), Democratic Republic of the Congo (-1.71), Iraq (-1.64) and Zimbabwe 
(-1.57). In terms of voice and accountability (VA) or the extent to which citizens are able to 
participate in selecting their governments, highest scores were from the small islands: 
Marshall Islands (1.19), Palau (1.17) and Saint Lucia (1.12). Least scores were from North 
Korea (-2.17), Myanmar (-2.03), Turkmenistan (-1.96), Somalia (-1.95) and Uzbekistan (-
1.91).  Overall, average government resources in LMICs is at 46.7% for wave one of the data 
decreasing to 46.05% in wave two and then increasing to about 47.8% in wave three. Private 
health resources also contributed to health systems financing with an average of 44.9% in 
wave one, decreasing slightly to 43.02% in wave two, and further decreasing in wave three at 
40.96%. Most LMICs also receive external resources for health, which were continuously 
increasing with 8.40% in wave one to 10.93% in wave two and 11.25% in wave three.     
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Figure 4.3 Percent distribution of health resources for LMICs compared every five years 
Source: Author’s computations using Health Systems 20/20 project’s database 
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The total health expenditure for the 137 LMICs included in the study is comprised on average 
of 11.72% external resources for health and 47.87% private expenditure on health, while the 
rest are from government resources. Of the private expenditure on health, 80.29% of the total 
health expenditure is out of pocket expense, while 9.89% were from private prepaid plans. 
On average, the total expenditure on health is at 275.02PPPint with 159.14PPint coming from 
government expenditure. Overall, per capita public spending for pharmaceuticals is at 
10.37US$ using 2013 exchange rates, while private spending is at 19.35US$ on average. Of 
the total health expenditure for each country, total pharmaceutical expenditure on average is 
at 26.49% or at 28.68 US$. 
 
Further, 79.74% of pregnant women attended at least one antenatal care visit. The minimum 
recorded is at 24.50% and the maximum is at 98.70%. On average, 4% of female population 
aged 15 to 49 years old received HIV test results in the last 12 months and the highest 
recorded is at 40%.  In terms of sanitation, 58.02% have improved sanitation facilities, which 
also range from only about 2.3% to as high as 100%. Water sources have also improved for 
77.98% on average. This available water sources range from only 4.80% to as high as 100%. 
On average, 23.55% of the total births were attended by doctors, while 32.85% were attended 
by other health professionals, and 80.31% were attended by skilled health staff. Overall, 
average fertility rates were at 4.37% and range from 1.58% to 1.20%. Meanwhile, GDP per 
capita is at 1950.17 on average, while Gini index is at 43.29.  
 
4.3.2 Regression results per health system building block 
 
Given the data differences among the variables, each regression is run on a slightly different 
sample. Note that most of the significant effects are in the random effects models. Given the 
data used in the study, this probably reflects cross-national differences between countries 
such that countries with stronger health systems have better health outcomes than countries 
with weaker health systems. This section discusses the results from each of these models.  
 
Governance. I found that control of corruption has a significant effect on all health outcome 
indicators (IMR, CMR, LE, and DTP3) when using a random effects models with 
government effectiveness showing significant effects on child mortality rates and life 
expectancy. The random effects estimate is a weighted average of between and within effects, 
implying that it averages cross-sectional differences between countries and over time 
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differences within countries. I found that there is more cross-sectional variation (between 
country variation) in these governance measures than over-time (within) variation (Table 
4.1). Thus, the random effects estimates reflect that countries with better corruption control 
and government effectiveness have better health outcomes than countries with worse 
corruption control and government effectiveness. Every unit of increase in government 
effectiveness reduces child mortality rates by 0.17% (re) at p<0.05 to 0.33% (fe) at p<0.05 
and improves life expectancy by 0.25 (re) at p<0.01 to about 0.33 (fe) at p<0.01. Meanwhile, 
every unit of increase in the rule of law significantly improves immunisation coverage by 
0.47 controlling for fertility rates, GDP per capita, and Gini index. 
 
Financing. I found statistical significance for the health financing indicators when they are 
run separately for each health outcome indicator, while controlling for fertility rates and 
GDP. However, if all of the health financing indicators were added in the model, only 
external resources for health showed significance in improving health outcomes. Specifically, 
I found that external resources for health significantly improved life expectancy by 0.26 at 
p<0.05, while private expenditure on health significantly affects infant mortality rates by 0.27 
at p<0.05 controlling for fertility rates, GDP per capita and Gini index. Other than these, I 
found no significant influence of the other financing indicators on the different health 
outcome variables. 
 
Service delivery. The percent of pregnant women who attended at least one antenatal care 
visit significantly reduced IMR (0.56 for re, 0.86 for fe; p < 0.001) and CMR (0.41 for re and 
0.68 for fe; p <0.001). LE improved by 0.275 (re) to 0.38 (fe) at p<0.001, while DTP3 
immunisation coverage also increased by 0.34 at p<0.05 while controlling for fertility rates 
and GDP per capita. In the service delivery equation, I removed controls for Gini index 
because this leads to multicollinearity when using the indicator for pregnant women who 
attended at least one antenatal care visit. The multicollinearity was found only with the model 
for service delivery, but was not found for any of the separate models for the other health 
systems building blocks. 
 
Medical products and technologies. Pharmaceutical public spending significantly decreased 
IMR by 0.348 at p<0.05 in a random effects model, but showed no significance in a fixed 
effects model. Pharmaceutical public spending also significantly influenced DTP3 
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immunisation coverage by 2.45 at p<0.05, but showed to decrease coverage instead of 
improving it. No other variables showed significant relationships with any of the health 
outcome indicators while controlling for fertility rates, GDP per capita and Gini index. 
 
Workforce. Births attended by skilled health staff significantly influenced all health outcome 
indicators, decreasing IMR by 0.536 at p<0.01 in a random effects model and by 0.686 in a 
fixed effects model. CMR also decreased by 0.523 at p<0.001 (re) and by 0.578 at p<0.01 
(fe). The effect also includes an improved life expectancy by 0.372 at p<0.05 (re) and 0.477 
at p<0.01 (fe), while DTP3 immunisation coverage also increased by 1.243 at p<0.001 in a 
random effects model controlling for fertility rates, GDP, and Gini index. 
 
 
In summary, for the five out of the six health systems building blocks that I examined, I 
found the strongest associations for reduced corruption, improved government effectiveness, 
and enhanced rule of law. I also found that external resources are positively associated with 
life expectancy, while the availability of more private resources for health significantly 
reduced infant mortality rates. I also found that improving the percent of pregnant women 
who attended at least one antenatal care visit is associated with a significant improvement in 
health outcomes. Further, I found that the pharmaceutical public spending significantly 
reduced IMR and improved DTP3 immunisation coverage. Similarly, the percent of births 
attended by skilled health staff significantly improved all health outcome indicators. After 
running separate regression models for each of the health systems building blocks for every 
health outcome indicator, I created an index for each of the health system building blocks and 
then an overall index using factor analysis. These models are discussed in Chapter Five.  
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Table 4-3 Fixed effects and random regression results for governance and health outcome variables 
 IMR CMR LE DTP3 
re fe re fe re fe re fe 
Governance 
control of corruption 0.153* 0.22 0.192** 0.258* -0.124* -0.145 -0.338** -0.224 
-0.041 -0.082 -0.003 -0.029 -0.026 -0.076 -0.008 -0.612 
government effectiveness -0.124 -0.317 -0.177* -0.327* 0.249** 0.338** 0.154 0.292 
-0.225 -0.063 -0.042 -0.036 -0.001 -0.006 -0.366 -0.674 
political stability and absence of 
violence 
0.124 0.379 0.135 0.331 -0.153 -0.248 -0.078 -0.287 
-0.161 -0.085 -0.066 -0.089 -0.047 -0.08 -0.609 -0.618 
regulatory quality -0.044 0.009 0.002 -0.049 -0.068 -0.07 -0.292 0.057 
-0.729 -0.969 -0.988 -0.814 -0.504 -0.642 -0.216 -0.974 
rule of law 0.004 0.134 0.039 0.155 -0.061 -0.031 0.469** -0.111 
-0.969 -0.386 -0.618 -0.265 -0.398 -0.753 -0.007 -0.805 
voice and accountability 0.141 0.012 0.108 -0.021 -0.042 -0.025 0.022 0.588 
-0.129 -0.96 -0.153 -0.923 -0.611 -0.873 -0.888 -0.607 
Control variables 
fertility rate 0.703*** 0.794 0.740*** 0.826* -0.649*** -0.343 0.148 -1.405 
0 -0.07 0 -0.039 0 -0.2 -0.441 -0.384 
GDP per capita -0.188 -0.101 -0.133 0.087 0.103 0.098 0.308 0.002 
-0.176 -0.769 -0.251 -0.776 -0.372 -0.658 -0.21 -0.999 
GINI Index -0.062 0.177 -0.095 0.142 0.078 0.09 0.411 -0.544 
-0.543 -0.393 -0.263 -0.438 -0.354 -0.497 -0.064 -0.564 
N 54 54 54 54 54 54 41 41 
Standardised beta coefficients; p-values: * p<0.05, ** p<0.01, *** p<0.001; re means random effects model; fe means fixed-effects model 
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Table 4-4 Fixed effects and random effects regression results for financing data and health outcomes 
 
IMR CMR LE DTP3 
re fe re fe re fe re fe 
Financing         
external resources for health as % 
of total expenditure on health 
-0.094 -0.339 -0.077 -0.334 0.123 0.267* 0.161 0.132 
-0.426 -0.08 -0.472 -0.053 -0.192 -0.039 -0.445 -0.736 
OOP as % of private expenditure 
on health 
0.133 -0.391 0.196 -0.215 -0.058 0.122 -0.075 0.404 
-0.306 -0.278 -0.096 -0.491 -0.643 -0.596 -0.764 -0.64 
per capita government 
expenditure on health, PPPint 
0.323 0.49 0.203 0.339 -0.075 -0.105 0.183 0.084 
-0.251 -0.195 -0.428 -0.301 -0.721 -0.66 -0.775 -0.938 
per capita total expenditure on 
health, PPPint 
-0.311 -0.542 -0.112 -0.444 -0.066 0.217 0.344 0.585 
-0.285 -0.209 -0.673 -0.239 -0.758 -0.43 -0.648 -0.697 
private expenditure on health as 
% of THE 
0.277* 0.303 0.175 0.496 -0.016 -0.298 -0.183 -1.029 
-0.042 -0.505 -0.158 -0.224 -0.895 -0.317 -0.464 -0.477 
private prepaid plans as % of 
private expenditure on health 
0.236 -0.219 0.286 0.07 -0.192 -0.174 -0.205 -0.376 
-0.169 -0.629 -0.064 -0.86 -0.229 -0.555 -0.559 -0.782 
Control variables         
fertility rate 
0.777*** 0.488 0.845*** 0.457 -0.781*** -0.533* -0.023 -0.733 
0 -0.162 0 -0.138 0 -0.027 -0.93 -0.611 
GDP per capita 
-0.187 0.126 -0.249 0.411 0.324 -0.304 -0.032 -1.243 
-0.354 -0.857 -0.175 -0.51 -0.068 -0.508 -0.947 -0.509 
GINI Index 
-0.189 0.107 -0.219 -0.129 0.225 0.266 0.128 -0.32 
-0.139 -0.763 -0.058 -0.678 -0.058 -0.257 -0.588 -0.673 
N 57 57 57 57 57 57 41 41 
Standardised beta coefficients; p-values: * p<0.05, ** p<0.01, *** p<0.001; re means random effects model; fe means fixed-effects model 
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Table 4-5 Fixed effects and random effects regression results for service delivery data and health outcomes 
 
IMR  LE DTP3 
re fe re fe re fe re fe 
Service delivery         
pregnant women who attended 
at least one antenatal care visit 
-0.555*** -0.855*** -0.407*** -0.685*** 0.275*** 0.379*** 0.335* 0.364 
0 0 0 0 0 0 -0.047 -0.681 
HIV test results received in the 
last 12 months of female 
population aged 15 to 49 
0.112 0.165 0.05 0.107 -0.064 -0.085 0.018 0.295 
-0.373 -0.158 -0.638 -0.304 -0.15 -0.057 -0.918 -0.291 
improved sanitation facilities 
-0.747** -1.394** -0.659** -1.285** 0.319* 0.167 0.179 3.554* 
-0.002 -0.002 -0.002 -0.002 -0.024 -0.29 -0.606 -0.026 
improved water source 
0.112 0.136 0.118 0.205 0.055 0.142 0.145 -3.617* 
-0.484 -0.416 -0.384 -0.197 -0.492 -0.103 -0.604 -0.049 
Control variables         
fertility rate 
0.014 -0.722** 0.146 -0.491* -0.033 0.09 -0.113 -0.075 
-0.936 -0.003 -0.324 -0.013 -0.662 -0.215 -0.636 -0.932 
GDP per capita 
-0.422** -0.775*** -0.273* -0.408* 0.250*** 0.312** 0.003 -0.814 
-0.005 -0.001 -0.033 -0.016 -0.001 -0.001 -0.99 -0.217 
N 52 52 52 52 54 54 39 39 
Standardised beta coefficients; p-values: * p<0.05, ** p<0.01, *** p<0.001; re means random effects model; fe means fixed-effects model 
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Table 4-6 Fixed effects and random effects regression results for medical products and technologies data and health outcomes 
 
IMR  CMR LE DTP3 
re fe re fe re fe re fe 
Medical products and 
technology         
pharmaceutical public 
spending per capita 
-0.348* -0.088 -0.268 0.025 0.068 0.033 -0.34 -2.453*   
-0.034 -0.787 -0.068 -0.924 -0.551 -0.778 -0.544 -0.033 
pharmaceutical private 
spending per capita 
-0.569 -0.353 -0.329 -0.023 0.186 0.009 -0.923 -1.741 
-0.328 -0.721 -0.532 -0.977 -0.682 -0.986 -0.484 -0.314 
total pharmaceutical 
expenditure as % of THE 
-0.19 0 -0.208 0.087 0.11 -0.038 -0.288 -0.41 
-0.191 -0.999 -0.099 -0.794 -0.318 -0.798 -0.115 -0.511 
total pharmaceutical 
expenditure at US exchange 
rate 
0.753 0.381 0.553 -0.023 -0.302 0.088 1.519 3.539 
-0.288 -0.765 -0.386 -0.982 -0.582 -0.888 -0.354 -0.174 
Control variables         
fertility rate 
0.610*** 0.341 0.646*** 0.207 -0.554*** -0.268 -0.443** -2.549*** 
0 -0.219 0 -0.331 0 -0.092 -0.009 0 
GDP per capita 
-0.266 -0.545 -0.319 -0.384 0.379* -0.022 -0.578* -2.234 
-0.207 -0.426 -0.084 -0.483 -0.048 -0.951 -0.048 -0.198 
GINI Index 
-0.097 0.129 -0.112 0.14 0.027 -0.16   
-0.533 -0.766 -0.413 -0.692 -0.851 -0.501   
N 37 37 37 37 38 38 60 60 
Standardised beta coefficients; p-values: * p<0.05, ** p<0.01, *** p<0.001; re means random effects model; fe means fixed-effects model 
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Table 4-7 Fixed effects and random effects regression results for health workforce data and health outcomes 
 
IMR CMR LE DTP3 
re fe re fe re fe re fe 
Workforce 
births attended by doctors, % of 
total births 
-0.011 0.047 0.03 0.118 0.003 0.05 -0.869 -0.859 
-0.965 -0.872 -0.862 -0.566 -0.989 -0.836 -0.253 -0.218 
births attended by other health 
professionals, % of total births 
-0.065 -0.076 -0.025 -0.059 -0.039 -0.045 -0.346 -0.797 
-0.686 -0.676 -0.816 -0.645 -0.777 -0.762 -0.476 -0.109 
births attended by skilled health 
staff, % of total births 
-0.536** -0.686* -0.523*** -0.578** 0.372* 0.477* 1.243* 0.638 
-0.009 -0.014 0 -0.005 -0.033 -0.03 -0.04 -0.331 
Control variables         
fertility rate 
0.523*** 0.78 0.527*** 0.716* -0.397*** -0.043 -0.274 -2.308* 
0 -0.05 0 -0.016 -0.001 -0.883 -0.373 -0.031 
GDP per capita 
0.042 0.211 0.079 0.329 0.131 0.236 -0.586 0.382 
-0.731 -0.595 -0.421 -0.25 -0.25 -0.473 -0.09 -0.713 
GINI Index 
-0.018 0.127 -0.093 0.156 0.033 0.388 0.555* 0.645 
-0.857 -0.753 -0.272 -0.581 -0.731 -0.261 -0.034 -0.538 
N 42 42 42 42 42 42 37 37 
adj R-sq  0.463  0.592  0.069  0.347 
Standardised beta coefficients; p-values: * p<0.05, ** p<0.01, *** p<0.001; re means random effects model; fe means fixed-effects model 
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4.4 Discussion 
 
Findings demonstrate how each of the health systems building block are affecting health outcomes 
across LMICs, implying that recent progress on life expectancy and mortalities may have been to 
strengthening national health systems. Specifically, these findings support that improved health 
outcomes can be attributed to increasing income per capita (Li & Zhu, 2006), improved medical 
technologies and interventions (Papageorgiou, Savvides, & Zachariadis, 2007) and strengthened 
global collaborations (Chu, Jayaraman, Kyamanywa, & Ntakiyiruta, 2014; Elobu et al., 2014). 
Hence, strengthening national health systems may lead to further improvements in life expectancies 
and reduction in mortalities.  
 
4.4.1 Controlling corruption, ensuring government effectiveness, and implementing rule of law 
 
I found the different government attributes such as controlling corruption, ensuring government 
effectiveness, and implementing the rule of law that significantly influence health outcomes. These 
attributes may potentially provide an explanation why existing health systems reforms such as 
decentralization did not necessarily translate to better health outcomes. Specifically, previous 
literature has favoured more decentralized governments in maximizing health systems performance; 
and thereafter, improving health outcomes. In this view, health outcomes are better achieved 
because governments are controlled by the majority, leaders are more accountable for the benefit of 
all rather than minor groups of society, and mechanisms for selecting competent leaders to 
implement policies are deemed stronger (Walt & Gilson, 1994). However, findings showed that 
despite such transitions, LMICs may still be faced with poorer health outcomes and health statuses 
that are far beyond health targets if these key governance attributes of controlling corruption, 
ensuring government effectiveness, and implementing the rule of law are not addressed. Hence, 
these findings argue that proper conditions must first be met before claimed gains of health system 
reforms such as decentralized health care management are achieved.  
 
4.4.2 The importance of external and private resources for health 
 
Findings showed how important external resources for health are to improve health outcomes.  This 
is not to discount the importance of public spending on health, which has been widely emphasized 
in previous studies. For example, in India, it was found that increasing public expenditures with an 
additional US$6-US$7 per person per year or about 1% increase in gross domestic product would 
provide universal access to key health interventions and have a favourable effect on population 
health (Deolalikar, Jamison, Jha, & Laxminarayan, 2008). Although public spending on health may 
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as well be important to improve health outcomes in LMICs, majority of LMICs may need more 
external and private resources to create significant health outcomes. This may also be caused by the 
governments’ lack of capacity to spend more on healthcare. As such, boosting these sectors may be 
needed in the future. My results were consistent with findings in 2007 that emphasized how an 
additional US$20-US$70 billion annually may be vital in meeting targets for the Millennium 
Development Goals. At that time, only US$5 billion is spent on health by majority of LMICs 
(Schieber, Gottret, Fleisher, & Leive, 2007).  
 
4.4.3 Improving pregnant women’s access to antenatal care 
 
Findings also emphasized the importance for pregnant women to have at least one antenatal care 
visit. Good care during pregnancy has been shown to not only affect the health of the mother, but 
also the development of the unborn baby and life expectancy at birth (WHO, 2016a).  These are 
similar to the claims made by the WHO on the importance of increasing antenatal care coverage 
(WHO, 2016a). Antenatal care introduces the woman and her family with the formal health system 
(WHO, 2016a), which can then also increase the chance of using a skilled attendant at birth and 
contribute to good health throughout the life cycle. Empowering women and engaging them more in 
antenatal care has proven as a success story to improve health outcomes in many countries 
(Mbuagbaw et al., 2016; Phillippi, 2009; Shortall et al., 2013). The WHO recommends that all 
pregnant women receive at least four antenatal care visits evenly spaced from the first trimester, 
which include getting an essential package of health services such as infection screening, nutrition 
advice, education on pregnancy and birth warning signs, among others (Mbuagbaw et al., 2016).  
 
4.4.4 Increasing pharmaceutical public spending  
 
Findings showed how increasing pharmaceutical public spending significantly affects IMR and 
DTP3 immunisation coverage, supporting similar previous studies examining pharmaceutical 
spending and health outcomes evident in Canada (Crémieux et al., 2005), in many European 
countries (Blasquez-Fernandez, Gonzalez-Prieto, & Moreno-Mencia, 2013), and in the Eastern 
Mediterranean Countries (Enayatollah et al., 2013). In particular, these studies showed that 
pharmaceutical public spending improved health outcomes, while the private spending did not have 
significant relationship with health status (Enayatollah et al., 2013). However, previous studies have 
also raised concerns on an increasing pharmaceutical expenditure. For example, in Taiwan, 
pharmaceutical expenditure grew from 62.2 billion Taiwan new dollars ($NT) in 1996 to $NT94.5 
billion in 2003. The government has since then introduced many strategies to control 
pharmaceutical expenditure stating that conflict of interests have arisen because hospitals and 
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clinics were allowed to earn profit from the sale of pharmaceuticals leading to inappropriate 
prescribing of drugs and fraud on insurance claims (Yue-Chune, Ming-Chin, Yu-Tung, Chien-
Hsiang, & Sun-Bing, 2006). Hence, although increasing pharmaceutical public spending may result 
to improved health outcomes, management of pharmaceuticals is still essential to ensure that its 
potential health outcomes are achieved. This may include ensuring efficiency on which drugs have 
to be subsidized by the government and better ways to establish reference pricing of medical 
products and technologies (Braae, McNee, & Moore, 1999).   
 
4.4.5 Health workforce as key to improving health outcomes 
 
Findings showed how important improving the health workforce is to achieve better health 
outcomes. Previous studies have emphasized that limited studies have integrated the link between 
human resources for health and health outcomes, and that these studies arrive at different 
conclusions (Anand & Bärnighausen, 2004).  In this chapter, findings have consistently showed the 
importance of the health workforce across any health outcome measure. Similar to Anand & 
Bärnighausen (2004) study, I also found that the influence of the health workforce is reflected most 
significantly in child health outcome indicators, particularly when the measure of the density of 
health personnel is used. However, there are other factors that may be included when examining 
health workforce and outcomes such as the distribution of the health personnel. Limited data on 
health workforce distribution is available in many LMICs. Future studies may include how the 
geographical dimension of access to health workforce and health service delivery are both essential 
to maximize its full potential to improve health (Dussault & Franceschini, 2006). Addressing such 
inequities in the global health workforce were also found to be an important link to improve health 
in many Sub-Saharan African countries (Anyangwe & Mtonga, 2007). 
 
4.5 Limitations 
 
Some assumptions of multiple regression cannot be tested explicitly. As such, further sensitivity 
analysis should be done to test the robustness of the findings. To test the robustness of the final 
model, I used stratified analyses and explored whether health systems factors associated with health 
outcomes were consistent across regions and among country income groups. In addition, given the 
potential for high correlation among the large number of independent variables considered for 
inclusion in the models, Pearson correlation coefficients, variance inflation factors and tolerance 
estimates were calculated to test for multi-collinearity between groups of related covariates. As in 
many other cases of regression analyses, findings are focusing on statistical associations, and not on 
the underlying causal mechanisms. While I was able to control for a number of potentially 
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confounding variables, the study is limited because I could not include a few important potential 
determinants of health due to data availability. Future studies may consider using indicators for 
financing arrangements or strategies that are used in LMICs, which may also influence the outcome 
variables. Health systems financing arrangements vary from one country to another and may also 
influence the results on health financing and outcomes. Unfortunately, there is no available 
quantitative data on such financing arrangements that I can use to include in the model.  Hence, data 
availability and quality is also an important issue to consider. Further, the health systems data used 
is also mostly constrained by the aggregated national data compiled through each country’s national 
health accounts. Other studies have also found that mortality rates are dependent on the mix of 
health care expenditures and types of health insurance coverage and this is also a concern that has 
yet to be explored (Bennett, Creese, & Monasch, 1998; Skocpol, 1993; Van Damme, 2007). The 
empirical analysis here does not compare health outcomes between the rich and the poor or those 
living in urban or rural areas. It can be argued strongly that the rich may be able to access better 
healthcare services than the poor. Similarly, urban areas may have more accessible and advanced 
healthcare resources than those in rural areas or who may have been living in remote areas, which 
are mostly the case in many LMICs. The data utilised here are national aggregates that do not 
differentiate between these different strata. Hence, such data limitations constrain further analysis 
on the issue. Nevertheless, compared to other studies and despite these constraints, this study has 
attempted to examine a more exhaustive list of health systems and health outcome variables to 
demonstrate the importance of how addressing each of the health systems building blocks, while 
controlling for other socioeconomic measures, reflects significant improvements in health 
outcomes. Note that interaction terms were also initially added to the model, but the results were 
not significantly different from the findings presented above. There is also a high model 
specification error and multicollinearity when the different indicators for each block or the addition 
of interaction terms are run using the same models.  
 
4.6 Conclusion 
 
The results in this Chapter highlighted which areas of each health system building block 
significantly influence health outcomes. Discussions focused on how improving controls of 
corruption, ensuring government effectiveness, and implementing the rule of law, as well as 
increasing external and private resources for health are highly correlated with reduced child 
mortality rates and improved life expectancies. Findings also reiterated the particular importance of 
antenatal care coverage in LMICs and how pharmaceutical public spending may also aid in 
ensuring access for medical products and technologies; hence, further increasing health outcomes. 
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In summary, findings showed how every unit of increase in the scores for governance, service 
delivery and workforce leads to two to three more months of life for every child and how each unit 
of increase in health workforce saves seven more infants and 536 children per 1000 live births. 
These results highlight how essential it is to continue efforts to strengthen the different building 
blocks of the health system and also better understand how they relate to different health outcome 
indicators that are being used to assess the different health systems strengthening initiatives. As 
specified above, not all health outcome indicators may consistently reflect significance of the 
existing initiatives on health systems. Therefore, there is a need to understand how indicator 
selection may also influence findings; hence, affecting policy decisions for health systems 
strengthening. Future studies may also consider other outcome indicators such as amenable 
mortality or the combined indicator for health outcomes, which was initially proposed by Gerring et 
al (2013). Specifically, Gerring et al (2013) found that the combination of life expectancy and IMR 
(log) offers a more reliable, more sensitive and more insightful measure of public health than either 
would provide on its own (Gerring et al., 2013). To compensate for the lack of access to such 
outcome measures, I instead used four different health outcome indicators that measures health 
status at a population level.  
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Chapter 5 Taxonomy of health systems performance in low- and middle-income countries 
 
Previous chapters highlighted how each health systems building block and most commonly used 
indicators relate to health outcomes, particularly child mortality rates, life expectancies, and vaccine 
coverage. Findings provide evidence on how each health system characteristics influence the 
achievement of these health outcomes. However, more research has been called for to translate such 
findings into effective decision-making about strengthening health systems (Graham et al., 2006; 
Lavis, Robertson, Woodside, McLeod, & Abelson, 2003). Health systems are complex phenomena 
that are arguably more comprehensive, dynamic, and complexly interacting than merely additive 
functions of different components and building blocks. Therefore, research needs to assess health 
systems, wholly and comparatively rather than just examining them as the sum of their parts with 
the latter being the focus of Chapter 4 (Bowling, 2014; Checkland, 1983; Langley, 1999; Rotmans 
& van Asselt, 1999). Hence, an understanding of the combined components of health systems 
necessary for effective decision-making may need to be considered (Marchal et al., 2009; 
Shakarishvili et al., 2010). Previous research has also pointed out that the design and 
implementation of HSS requires the development of an adequate HSS classification (Peters, 2009). 
To do a more holistic comparison of health systems performance that will potentially be more 
useful for decision-making, this chapter develops a taxonomy of health systems strengthening to 
identify any new patterns of cluster configurations for health systems, differentiate these 
configurations of health systems performance in LMICs, and reveal common characteristics and 
distinctions for each configuration. 
 
5.1 The role of taxonomies for health systems strengthening 
 
Classifications allowed scientists to identify, group, and properly name organisms using a 
standardised system based on a variety of characteristics and understand how all living things were 
interconnected (Bowker & Star, 2000; Capra, 1996). As such, classifying living things made 
communicating science easier by conveying complex relationships about how organisms are related 
to each other (Bowker & Star, 2000; Capra, 1996). Such an approach is also beneficial for health 
systems. Previous studies recommended that classifying health system characteristics, different 
health interventions and program outcomes provided a framework for further research and a map 
for program developers who needed to examine how different factors were related and how the 
interplay among them led to behaviour change and outcomes (Nudelman & Shiloh, 2015). These 
classifications can also provide useful means for optimizing cost-effectiveness of promotion and 
intervention programs; hence, increasing health and decreasing health care burden (Nudelman & 
Shiloh, 2015).  
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The two basic approaches to classification outlined by Smith (2002) are typology and taxonomy. 
Typologies conceptually separated a given set of items multi-dimensionally representing concepts 
more than empirical cases (K. Smith, 2002). The dimensions of typologies were based on the notion 
of an ideal type, a mental construct that deliberately accentuates certain defining characteristics 
(Weber, 1949). Hence, typologies provide useful and systematic basis for comparisons and are 
technically a formal or conceptual classification system that comes from theoretical principles 
specified in advance (K. Smith, 2002).  However, typologies are neither exhaustive or mutually 
exclusive since they are often based on arbitrary or ad hoc criteria and indistinct boundaries 
between types. Typologies are also often descriptive rather than explanatory or predictive (Bailey, 
1994; K. Smith, 2002).  On the other hand, a taxonomy classifies items on the basis of empirically 
observable and measurable characteristics (Bailey, 1994).  Taxonomies were more often used in the 
biological than in the social sciences (Sneath & Sokal, 1972), but taxonomic methods, which 
include a family of methods generally referred to as cluster analysis, are useful tools for disciplines 
that need to derive classification schemes empirically from observed cases (Mezzich & Solomon, 
1980). 
 
Given these considerations, I used taxonomies to provide a way to classify health systems in terms 
of similarities and differences in health systems strengthening across countries with varied contexts. 
Taxonomies can be a useful similarity measure to explore mechanisms that lead to HSS successes 
and failures (Geisler, 2000; Klein et al., 2012). In a taxonomy, entities like countries can be 
classified on the basis of empirically observable characteristics (McKelvey, 1982; K. Smith, 2002). 
Taxonomies have been widely used for this purpose in the fields such as social sciences and urban 
planning, but few studies have developed taxonomies of HSS (Geisler, 2000; Klein et al., 2012). If 
used for HSS, taxonomies may be useful to guide allocation of resources and to get the most impact 
on improving outcomes (Geisler, 2000; Klein et al., 2012). In particular, taxonomies can be relevant 
for prioritising HSS initiatives, for defining the current focus and priorities of HSS, and for 
classifying HSS projects and funding schemes (Greenberg, 1987; Levasseur, Richard, Gauvin, & 
Raymond, 2010; Maroney, 2006). For example, previous efforts to develop an HSS taxonomy 
found that such taxonomies provided foundations for assessing current health policy issues 
(Bazzoli, Shortell, Dubbs, Chan, & Kralovec, 1999). Further, classifications of health systems 
provided insights on appropriate management and financial resources for each classification cluster 
making HSS assessments more tailored to their specific needs and purposes (Bazzoli et al., 1999). 
By highlighting the distinctive characteristics of HSS clusters, the developed taxonomy can provide 
insights about how to optimize existing health systems (Hammer & Burill, 2012; Nutley, Walter, 
Chapter Five 
 109 
Davies, & West, 2002). Taxonomies can also be the basis for tracking health systems performance 
progress over time (Bazzoli et al., 1999).  
 
5.2 Research gaps on classifications of health systems strengthening 
 
Classifying health systems has focused on assessing health system capacities through exploring the 
institutional context of healthcare (Burau & Blank, 2006). In the past, HSS was classified at the 
level of whole national systems or subsystems such as by health financing options or by healthcare 
delivery types (Bossert, 2012). For example, health systems were classified according to public 
funding of healthcare, which includes national health services, social insurance schemes, private 
insurance (Burau & Blank, 2006). However, a central drawback to classifications based on 
subsystems is the failure to consider components of health systems other than the subsystem being 
classified, which can impede the utility of such classifications. For instance, a classification based 
on financing that ignores the health workforce or leadership and governance factors may not be 
useful if these omitted factors themselves matter for performance outcomes that the classification is 
intended to inform (J. Smith et al., 2010). To address current uses and limitations of classifications 
of health systems, key dimensions of health systems should be complemented by others factors such 
as types of political systems, and wider cultural, economic, and social contexts since these factors 
are also significantly affecting health systems performance and outcomes. 
 
Despite its significance, empirically classifying health systems faces both conceptual and 
methodological challenges, including the difficulty of using sophisticated quantitative analysis to 
cluster health systems. This difficulty may be due to few comparable national systems and the many 
different characteristics and historical trajectories that confound the analyses (Bossert, 2012). 
Nevertheless, robust research on whole national systems can compare evidence, facilitate cross-
country learning, and inform policy choices on HSS across different contexts (Ember, 1970). In 
fields such as public policy, taxonomies have been central for comparative policy studies across 
countries (Burau & Blank, 2006; Ember, 1970; Lincoln, 2014). For example, a taxonomic 
classification scheme took a broad set of policy issues and sought to ascertain whether, among a 
general population of a political unit, they can be empirically divided into two categories on the 
basis of generally accepted characteristics (K. Smith, 2002). The traditional approach produced a 
set of hypotheses about the activity patterns that by the very act of classification have been assumed 
to exist within a policy arena (K. Smith, 2002). Meanwhile, the taxonomic approach created a set of 
hypotheses about differing patterns of behaviour between different arenas; hence, clearly generating 
comparative and predictive hypotheses (K. Smith, 2002). Taxonomic approaches were able to 
create policy categories and subsequently, can also generate comparative, empirically testable 
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hypotheses on the theoretical expectations of how the categories differ (Bradley, Curry, & Devers, 
2007; K. Smith, 2002). 
 
Although the demand for such comparative analyses is high, there are still ongoing debates about 
the appropriate methods and approaches to use, including debates on how to facilitate cross-country 
learning through its findings (Boonstra & Broekhuis, 2010; Castillo, Martínez-García, & Pulido, 
2010; Murray & Evans, 2006). For example, a taxonomy of health systems may have several 
limitations in their findings such that the data may affect the ability to fully assess the dimension of 
integration of health systems (e.g. number of specific mix of physicians participating in specific 
health service arrangements, number of contracts associated with efforts to integrate health care 
delivery) (Bazzoli et al., 1999). There is also a need to further refine the empirical framework and 
measures, as well as to collect new data recommending continuous validation and refinement of the 
taxonomy to keep pace with the rapid changes occurring for national health systems (Bazzoli et al., 
1999). Previous studies in taxonomy also gave rise to questions on what differences exist in key 
performance measures across different health system clusters (Bazzoli et al., 1999).  
 
To address this research gap specify health systems similarities and differences across countries, I 
develop a taxonomy of HSS through quantitative analysis of most recent health systems data. 
Chapters one to three of this thesis have clearly identified the key concepts and measures that can 
be used for HSS assessments. Across many countries, health information systems have also 
substantially improved (Travis et al., 2004). Such growth in health information has also led to a 
deeper understanding of the shared roles, responsibilities and health challenges countries worldwide 
were experiencing (Marmot et al., 2008). Maximizing these opportunities and using cluster 
analyses, this chapter adds to existing debates on taxonomies of health systems by exploring 
empirical classifications for health systems performance in LMICs. The chapter begins by 
discussing the theoretical framework used in previous studies and reviewing the approaches 
currently utilised in creating system taxonomies. The succeeding sections focus on creating clusters 
of health systems based on the WHO health system building blocks. Then, I explore existing 
taxonomies of health systems and how health system characteristics differ across clusters. Using 
factor analysis was a vital step before pointing out the similarities and differences of health systems 
across countries and examine their overall health systems performance. Since health systems are 
complex, factor analysis was needed to reduce a large number of variables into a few interpretable 
underlying factors (Loehlin, 1998; O'Rourke, Psych, & Hatcher, 2013; Thompson, 2004; Thurstone, 
1947). The concluding section focuses on how taxonomies of health systems based on system 
clusters can further facilitate cross country learning among countries with limited resources.  
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5.3 Theoretical framework 
 
To build a taxonomy of health systems, I used the theoretical framework proposed in Chapter Two , 
which build upon a common framework for analysis that is essential for any taxonomy (Sicotte et 
al., 1998). Using this proposed framework that applies across different countries also enables 
conducting cross country comparisons  (Hofstede & Hofstede, 2001).  To recap, Chapter Two of 
this thesis develops a comprehensive theoretical framework for HSS assessments based on existing 
country-driven HSS frameworks and other data sources from the WHO Member States. There are 
six dimensions of the proposed framework in Chapter Two that were common across all other 
health systems frameworks and were also widely used by the WHO (Murray & Frenk, 2000; WHO, 
2013a) and the OECD (Arah et al., 2006): governance, health financing, service delivery, 
workforce, medical products and technologies, and health information systems. These building 
blocks were also highlighted in Chapter Three when each Gavi HSS cost category and the 
indicators collected from the HSS-grant recipients’ monitoring and evaluation frameworks used the 
same building blocks to organize the HSS grant process. Further, the data source used in the study 
follows the same theoretical framework (USAID, 2015a). Hence, using the health systems building 
blocks and the identified measures discussed in Chapters Two and Three provides this research with 
the necessary requirements for developing taxonomies that are based on empirically observable and 
measurable characteristics. These characteristics also differentiates this taxonomy from other 
previous classifications of health systems because the setting used in the analysis is in a global 
context.  
 
5.4 Methods 
 
To support the argument that health systems should be assessed holistically or in sum rather than in 
individual parts, I used comparative cross-country factor and cluster analyses of the health systems 
building blocks in 135 low and middle income countries using three data waves from the USAID 
Health Systems 20/20 Database. In Chapter 4, I discussed how each of the health systems building 
block relate to health outcomes. In this chapter, I further describe how I used principal components 
analysis for each of the health system building blocks to develop components that can form the 
basis for a classification. To categorize health systems. I then used cluster analysis to group 
countries with similar health system characteristics together and examine how their overall health 
systems performance change across three time periods: before the year 2000, from 2001 to 2006, 
and from 2007 to 2012. 
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5.4.1 Data sources 
 
I used the same data sources for Chapter Four , which combines the data per health system building 
block and have 80 indicators (USAID, 2013). I normalized the datasets into three time periods 
(average for below the year 2000, from 2001 to 2006, and from 2007 to 2012) for 135 LMICs. 
Health information system was not represented in the Health Systems data. As a proxy, I used the 
WHO international health regulations (IHR) monitoring framework available from the Global 
Health Observatory (WHO, 2008a). Under the IHR, countries were required to have or to develop 
minimum core public health capacities to implement IHR effectively (WHO, 2008a). The IHR 
monitoring process involved a self-assessment questionnaire sent to States Parties, the 
implementation status of 13 core capacities (WHO, 2008a). Specifically, the IHR monitoring 
framework assessed country-level regulatory monitoring for legislation, coordination, surveillance, 
response, preparedness, risk communication, human resources, laboratory, points of entry, zoonosis, 
food safety, chemical and radio-nuclear (WHO, 2008a). 
 
5.4.2 Analysis 
 
I used two methods: a) principal components analysis (PCA);16 and b) cluster analysis.17 PCA 
investigates concepts that were not easily measured directly by collapsing a large number of 
variables into a few underlying components (Loehlin, 1998; O'Rourke et al., 2013; Thompson, 
2004; Thurstone, 1947). Since there were initially 80 indicators available in the Health Systems 
20/20 database that were all linked to each of the health system building blocks, I first applied PCA 
to reduce the number of indicators and to detect structure in the relationships between variables, 
similar with previous studies (Loehlin, 1998; O'Rourke et al., 2013; Thompson, 2004; Thurstone, 
1947). In mathematical terms, from an initial set of !  correlated variables, PCA creates uncorrelated 
indices or components where each component is a linear weighted combination of the initial 
variables such that (Vyas & Kumaranayake, 2006): !"#$%&'( = 	+,-, + +,/(-,/( + ⋯+ +,1-1      (1) ⋮ 
 !"# = %#&'& + %#(&*+)'(&*+) + ⋯+ %#.'#.      (2) 
                                                
16   PCA systematically reduces a large number of variables to a smaller, conceptually more coherent set of variables 
that are linear combinations of the original variables called principal components (Dunteman, 1989). 
17  Cluster analysis refers to the technique used to group entities into homogenous subgroups on the basis of their 
similarities across several observed characteristics. It can be used to partition data set into subsets or clusters that 
share common characteristics (Dush & Keen, 1995). Cluster analysis was the most important analytic tool in 
developing an organisational taxonomy (Bazzoli et al., 1999). 
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where !"#   is the weight for the !  th principal component and the !  th variable based on the 
eigenvectors of the co-variance matrix; (!  ) is the variance for each component calculated using the 
eigenvalue of the corresponding eigenvector. For further analysis, I chose the first principal 
component, which shows the largest possible amount of variation in the original data considering 
that the sum of the squared weights (!"# + !"%&# + ⋯+ !"(# )  is equal to one. Meanwhile, !"/$  is the 
proportion of the total variation in the original data set accounted by each principal component, 
given that the sum of the eigenvalues equals the number of variables (i = 80) in the initial data 
set!"/$  . Succeeding components (!"#  ) explains additional but less variation that the first 
component. 18The higher the degree of correlation among the original variables in the data, the 
fewer components required to capture common information (Vyas & Kumaranayake, 2006). Since 
the variables used have different units of measurement, I first standardised them by subtracting the 
mean and dividing the result by the variable standard deviation. In selecting the principal 
components, I selected the first PCA result. After doing PCA for each of the health systems 
building blocks, I then applied cluster analysis to the components since the goal of this chapter was 
to classify overall health systems performance based on the similarities and differences for the 
different health systems building blocks. As part of the initial explorations of the data, I mapped the 
component score for each health system building block.  
 
To partition observations into homogenous subgroupings and to assess reliability and stability of 
cluster observations, I used cluster analysis in a stepwise fashion by: a) dividing observations into 
randomized split halves to conduct separate cluster analysis so that cluster solutions can be 
compared; and b) conducting separate cluster analysis for observations grouped by the year of data 
collection to assess the stability of the cluster solutions over a certain time period (Bazzoli et al., 
1999). Specifically, I categorized the 135 countries on the basis of the indices of their health 
systems building blocks, which were calculated from the results of the PCA following the methods 
used by Bazzoli et al (1999). Further, I used k-means cluster analysis 19 to identified relatively 
homogenous subgroups while maximizing the variability between clusters. To examine the 
homogeneity of cases within a cluster, I calculated the total within-sum of squares and moved cases 
                                                
18  Subsequent components are uncorrelated with previous components and each component captures an additional 
dimension in the data, while explaining smaller and smaller proportions of the variation of the original variables 
(Vyas & Kumaranayake, 2006). 
19  K-means cluster analysis identifies relatively homogenous groups of cases based on the different health systems 
characteristics, using an algorithm that can handle large number of cases (Hearty & Gibney, 2012). This method 
starts by selecting !		 initial cluster seeds and subsequently assigns each observation to the nearest seed on the basis 
of Euclidean distance, forming temporary clusters (Lo Siou, Yasui, Csizmadi, McGregor, & Robson, 2011).  
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from one cluster to another so that the total within-cluster of squares was minimized (Hearty & 
Gibney, 2012). Differences between the resulting patterns were explored further by comparing the 
health systems composition and by plotting the mean component scores of components across 
clusters. In mathematical terms, the between-cluster variance for group j was defined as follows: !"#$%##&-()*+$#,-,/ = 1--1 × (45/-4/)789:1       (3) 
where !"#   was the centroid of the cluster !"   for the health systems performance group !  , based on !"   
observations in cluster !"   , and !"   refers to the overall mean. The optimal number of clusters was 
given by the cluster solution that has many health systems performance groups with large ratios.  
 
To calculate for the overall health systems performance index, I used two approaches. First, I run all 
the 80 indicators available in the dataset in one model, then repetitively run the indicators in the 
same model while reducing the number of variables used to decrease specification errors and avoid 
multicollinearity among the variables. Second, I run all the indices for each health system building 
block in one model, adding controlling factors and other interaction terms. I then repetitively did the 
same process by reducing the number of indices inputted in the model in each repetition. 
Afterwards, I examined the distributions of the component scores and grouped them per region and 
per income groups. I also did a scatterplot matrix for the four building blocks with three waves of 
data to determine if there is any linear correlation between the multiple variables and to pinpoint 
specific variables that are highly correlated. To explore how each component scores are related to a 
measure of health outcome, I also created scatterplots for the first component score of each building 
block and life expectancy at birth. 
 
5.5 Results 
 
5.5.1 Principal components of health systems 
 
Calculating the scores for each health system building block using their corresponding indicators 
discussed in Chapter Four, I found a wide variation in each of the health systems building blocks. 
When comparing per income groups, low income countries had the poorest performance, while 
upper middle income countries performed better, as expected. The lower middle income countries 
have relatively higher scores than low income countries, but these group of countries also have the 
highest variation in scores, particularly for health financing. Specifically, least scores were mostly 
found for countries in Africa. Further, the low income countries also have the least performance 
scores across all health systems building blocks (Table 5-1).  
Chapter Five 
 115 
 
Governance. Using the governance indicators (control of corruption, government effectiveness, 
political stability, regulatory quality, rule of law, and voice and accountability), I found a principal 
component with an eigenvalue = 2.2, difference: 2.28, and cumulative proportion = 1.08 (Figure 
5.1). Chile ranked highest across all waves with an average component score of 2.85 (average over 
three wave periods), followed by Antigua and Barbuda (mean = 2.24). Somalia ranked lowest with 
average score of -2.45, followed by Congo, Afghanistan, Iraq, North Korea, and Myanmar (Table 
5-1). Almost all these countries are conflict-affected areas, if not with a military-controlled 
government. Generally, the box plots for governance suggest a wide ranging governance 
performance across countries with an overall negative governance scores in LMICs. Distributions 
were most compressed in East Asia and the Pacific, suggesting that this region have a more similar 
governance performance. In contrast, the distributions had the longest spread in Latin America and 
the Caribbean followed by Sub-Saharan Africa, implying wide variations in governance (Figure 
5.2).  
 
Financing. Using financing indicators (per capita total expenditure on health at average US$ 
exchange rate, general government expenditure on health and total expenditure on health), I found a 
principal component with an eigenvalue = 0.99, difference = 0.95, and cumulative proportion = 
1.30 (Figure 5.1). Countries with highest health financing across three waves include Palau, 
Marshall Islands, Seychelles and Micronesia. Almost all these countries are small countries with 
low population. Meanwhile, countries with low health financing scores across all waves include 
Myanmar, Pakistan, and India (Table 5-1). There is least variability in scores for Sub-Saharan 
Africa. Countries in the Latin America and the Caribbean showed higher financing scores. Similar 
with findings in governance, financing scores were lesser for South Asia and Sub-Saharan Afric. 
East Asia and the Pacific also showed longer upper whiskers, which suggest higher variability for 
countries with positive financing scores (Figure 5.2).  
 
Service delivery. Using service delivery indicators (HIV test results, fertility rates, immunisation 
rates and improved sanitation), I found a principal component with eigenvalue = 1.97, difference = 
1.86, and cumulative proportion = 1.11 (Figure 5.1). Other indicators such as hospital beds per 
1000 people, contraceptive prevalence among women 15 to 49, births attended by health 
professionals, prenatal care, malnourished under-5 children and diarrhoea treatment were excluded 
due to large missing data. Across all waves, countries with the highest service delivery scores 
include Bulgaria, Belarus, Serbia, and Macedonia. Meanwhile, countries with the least service 
delivery scores across all waves include: Niger, Chad, Somalia, Ethiopia, Mali, and Congo (Table 
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5-1). In general, service delivery scores were higher in Europe and Central Asia and lowest in Sub-
Saharan Africa (Figure 5.3).  
 
Health workforce. Using workforce indicators (density of pharmaceutical personnel per 1000 
people and births attended by health professionals), I found a component with an eigenvalue = 0.65, 
difference = 0.89, and cumulative proportion = 1.61 (Figure 5.1). Countries with high workforce 
scores across all waves include Belarus, Ukraine, Lithuania, and Russia. In contrast, countries with 
least workforce scores across all waves include Chad, Niger, and Afghanistan (Table 5-1). In 
general, health workforce is higher for countries in Europe and Central Asia (Figure 5.3).  
 
Medical products and technologies. Using these indicators ( public spending on pharmaceuticals 
per capita at US exchange rate, private spending on pharmaceuticals per capita at US exchange rate, 
and total pharmaceutical expenditure per capita), I found a component with eigenvalue = 2.47, 
difference = 1.94, and cumulative proportion = 0.82 (Figure 5.1). However, no data was available 
for wave three. For wave one, countries with the highest scores included Argentina, Lebanon, 
Uruguay, Brazil, Chile, Mexico, Dominica, Jordan, El Salvador, and Jamaica. For wave two, 
highest countries include Mexico, Venezuela, Uruguay, Lithuania, Albania, Chile, Brazil, 
Dominica, Jamaica, and Bulgaria. Least scores were found for Papua New Guinea, Thailand, 
Romania, Samoa, Moldova, Mongolia, Turkmenistan, Belarus, Solomon Islands and Malawi for 
wave one and Thailand, Turkmenistan, Papua New Guinea, Samoa, Solomon Islands, Saint Vincent 
and the Grenadines, Malawi, Mongolia, Bhutan and Chad for wave two (Table 5-1).  
 
Overall health systems performance index. When running the initial model using all the 80 
indicators, no components were found. This resulted to high multicollinearity among the variables 
and prevented further analysis. On the other hand, running the indices for each of the health system 
building block was able to retain seven components. The first component shows eigenvalue = 6.9, 
difference = 6.32, proportion = 0.90 (Figure 5.1). Health information systems data were only 
available for wave three with Latvia having the highest score, followed by Kazakhstan, Romania, 
Lithuania, Niger, Indonesia, Jordan, Philippines, South Africa, and Malaysia. Least countries were 
Tonga, Haiti, Marshall Islands, Mozambique, Peru, Burundi, South Sudan, Papua New Guinea, Lao 
and Samoa (Table 5-1). Overall, I found that countries generally had higher scores in wave three of 
the data compared to wave one except for health workforce where there does not seem to be 
significant changes when comparing waves two and three (Figure 5.3). When placed in scree plots 
(the plot of !"  versus !  with the eigenvalues ordered), I found that the number of components were 
highest for health information systems and least for medical products and technology. The number 
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of component was determined at the point beyond which the remaining eigenvalues were relatively 
small and of comparable size (Appendix 2).  
 
Table 5-1 Component loadings and Keiser-Meyer-Olkin measure of sampling inadequacy 
 Variables Loadings* Uniqueness kmo 
Governance 
factor 
Control of corruption 0.89 0.20 0.70 
Regulatory quality 0.78 0.39 0.85 
Rule of law 0.91 0.17 0.68 
Financing 
factor 
Per capita total expenditure on 
health (average US$) 
0.70 0.51 0.52 
General government expenditure on 
health 
0.54 0.69 0.54 
Total expenditure on health 0.45 0.76 0.56 
Service 
delivery 
scores 
HIV test results 0.12 0.90 0.40 
Fertility rates 0.82 0.32 0.72 
Immunisation rates 0.79 0.35 0.72 
Improved sanitation 0.80 0.35 0.74 
Workforce 
scores 
Density of health personnel per 
1000 people 
0.57 0.67 0.50 
Births attended by health 
professionals 
0.57 0.67 0.50 
Medical 
products and 
technology 
scores 
Public spending on pharmaceuticals 
per capita (at US exchange rate) 
0.82 0.002 0.30 
Private spending on 
pharmaceuticals per capita 
0.89 0.0007 0.35 
Total pharmaceutical expenditure 
per capita 
0.10 0.0001 0.42 
Health 
information 
system 
Chemical 0.78 0.24 0.91 
Coordination 0.74 0.37 0.95 
Food safety 0.83 0.20 0.92 
Human resources 0.57 0.56 0.91 
Laboratory 0.73 0.41 0.95 
Legislation 0.75 0.31 0.90 
Points of entry 0.68 0.43 0.93 
Preparedness 0.81 0.25 0.93 
Radio-nuclear 0.66 0.37 0.91 
Response 0.82 0.25 0.94 
Risk communication 0.73 0.36 0.93 
Surveillance 0.66 0.39 0.90 
Zoonosis 0.65 0.44 0.92 
Note: Component loadings shown are the first component scores estimated based on data for 137 
low- and middle-income countries (Chapter Four: Data Sources). 
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Figure 5.1 Funnel representations for the PCA done per health system building block showing the 
different indicators available from the Health Systems 2020 and the Global Health Observatory 
and how these indicators were categorized into each building block.
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a) Component scores per WHO region      b) Component scores per World Bank income groups 
Figure 5.2 Box plots of four health systems building block factor scores: governance, financing, service delivery, and health workforce 
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5.5.2 Scores for health systems building blocks and health outcomes 
 
I found that life expectancy at birth increases along with higher performance scores for each of the 
building blocks with some countries lagging behind.  
 
a. Governance and life expectancy. Somalia (country id = 116) was substantially behind 
other LMICs, yet this inequality in scores seems to decrease over the years. Meanwhile, 
countries like Botswana (country id = 16) may have significantly improved governance 
scores in wave three, but life expectancy remained lower compared to other countries with 
similar or slightly higher governance scores (Figure 5.3). 
b. Financing and life expectancy. Across LMICs, scores reflected improved health financing. 
However, Botswana had much lower life expectancy rates compared to other countries with 
similar positive financing scores. For both waves one and two, Palau (country id = 97) and 
Seychelles (country id = 113) showed significantly higher financing scores and life 
expectancies compared to other LMICs.  In wave three, Lithuania (country id = 72) had high 
financing scores, but lower life expectancy rates compared to other countries.  
c. Service delivery and life expectancy. Scores substantially improved when comparing wave 
one and two, but plateaued after. Noticeably, Chad (country id = 25) had very low service 
delivery and life expectancy rates similar with Somalia.  
d. Workforce and life expectancy. There seems to be lesser gap for health workforce in 
LMICs when comparing wave one and two, but this also plateaued after. Belarus (country id 
= 10) Cuba had the highest workforce scores with also high life expectancies compared to 
other LMICs.  
e. Medical products and technologies and life expectancy. Scores were significantly higher 
in Argentina (country id = 6) and Lebanon in wave one, while the rest of the LMICs were 
lagging behind. Wave two showed that many LMICs had an increase in their medical 
products and technologies with others still lagging behind. Although Thailand ranked 
lowest, life expectancy of the country was also substantially higher compared to other 
LMICs.  
f. Health information systems and life expectancy. Due to data availability, scores were 
only available for wave three, but showed high variability for health information system 
scores across LMICs. 
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g) Graph matrix for all building blocks 
 
Figure 5.3 Scatter plots showing the component scores for each health system building block compared with life expectancy at birth for three waves of 
data collected from the Health Systems database 
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5.5.2 Mapping health systems performance per health system building block 
 
Using geographic information systems, I found the locations of each point in the plot and 
determined whether places with high component scores clustered in a particular region. 
Specifically, I found many countries in Africa and Asia lagging behind in terms of health systems 
performance and these scores did not seem to change substantially over the years when comparing 
across regions (Table 5-2). 
 
a. Governance. Before the year 2000, majority of countries in Africa, including Russia, had 
negative scores, implying poor governance performance (Figure 5.4). The countries with 
the lowest governance scores included Sudan, Democratic Republic of the Congo, Angola, 
Liberia, Guinea-Bissau, Tajikistan, Burma and Haiti. These countries also had the least life 
expectancy except for Iraq and Tajikistan. The least scores for both life expectancy and 
governance was found for Angola. However, positive governance scores were not 
necessarily accompanied by above average life expectancies. Countries like Botswana, 
Namibia, South Africa, Morocco, Mali, and Bolivia had positive governance scores but 
below average life expectancy. Meanwhile, the majority of the South American countries 
had positive governance scores with Chile had the highest and above average life 
expectancy, which may also be a function of per capita income in these countries other than 
governance. Life expectancy then significantly improved from 2001 to 2006 with South 
American and Asian countries having above average life expectancies.  
b. Financing. Before the year 2000, financing was lowest in many parts of Africa and Asia 
(Figure 5.5). The least was in the United Republic of Tanzania, Democratic Republic of 
Congo, Nigeria, Senegal, Gambia, Guinea-Bissau, Liberia, Cote d’Ivoire, Togo, Nigeria, 
Cameroon, Sudan, Uganda, Burundi, Iraq, Georgia, Armenia, Azerbaijan, Pakistan, India 
Tajikistan, Nepali, Bangladesh, Burma, Cambodia, and Indonesia. Financing then improved 
from 2001 to 2006 in Libya, Brazil and South Africa. In contrast, scores decreased in 
Mongolia and Argentina. After 2007, majority of the countries have improved financing and 
life expectancy. However, countries such as Chad, Guinea-Bissau, Cote d’Ivoire, Cameroon, 
Yemen, Azerbaijan, Tajikistan, Pakistan, India, Bangladesh, Burma, and Cambodia 
remained to have the least financing scores.  
c. Service delivery has improved over the years with mostly African countries left with 
negative service delivery scores (Figure 5.6). Mali, Angola and Sierra Leone were among 
the countries with poor service delivery scores and least life expectancies. Most European 
countries had positive scores for service delivery, while many Asia Pacific countries have 
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improved except for India, Papua New Guinea and Lao People’s Democratic Republic. 
Almost all countries with positive service delivery scores had above average life 
expectancies except for South Africa. From 2001 to 2006, all South American, Asian and 
European countries had positive service delivery scores and only countries in Africa, 
particularly Niger, Chad and Ethiopia, had least service delivery scores. This corresponds 
with low life expectancies in many African countries. After 2007, many African countries 
have improved in terms of service delivery, particularly Namibia, Angola, Congo, 
Mozambique, Ethiopia and Niger. These countries also have below average life 
expectancies.  
d. Workforce. Before the year 2000, Haiti, Bolivia and Paraguay had the lowest score 
compared to other South American countries (Figure 5.7). Despite almost similar workforce 
score, Bolivia had below average life expectancies compared to Paraguay and other South 
American countries. Guatemala and Nicaragua also had below average life expectancies 
despite positive workforce scores. Least workforce was concentrated in many African 
countries with Angola, Chad, Mali, Niger, Nigeria, Ethiopia, Yemen and other African 
countries having the least scores for both workforce and life expectancies. Among all Asian 
countries, only Lao and Vietnam had the least workforce scores. From 2001 to 2006, 
progress in workforce scores was seen particularly in many South American, Asian and 
European countries. Similar with other health system building blocks, workforce was, 
however, lowest in many African countries, particularly in Ethiopia and Chad. Life 
expectancy was also lowest in many African countries. From 2007, although further 
improvements can be seen in workforce scores even for many African countries, Chad 
remains to have poor workforce scores and life expectancy.  
e. Medical products and technologies. Most of Africa, Asia and Europe, have very low 
medical products and technologies scores (Figure 5.8). However, majority of countries in 
Africa have missing data on medical products and technologies before the year 2007. Scores 
improved from 2001 to 2006, particularly in Europe. In contrast, Africa still had very poor 
medical products and technologies performance scores from 2001 to 2006. In many 
countries, pharmaceutical spending in both public and private sectors also remained low.  
f. Health information systems. I found that many countries in South America, except for 
Peru, Belize, and Haiti, have positive health information system scores (Figure 5.9). In 
Asia, Lao, Bhutan, Viet Nam, Yemen, Timor-Leste, Papua New Guinea and Sir Lanka 
remain low. Many African countries have the least information systems score, particularly 
Angola, Chad, Djibouti, and Mozambique. Information systems are missing for Mali, 
Guinea, Sierra Leone, and Liberia. 
Chapter Five 
 124
Table 5-2 Countries with the highest and lowest factor scores for each health system building block per wave: governance 
Governance Average before the year 2000 Average for years 2001-2006 Average for years 2007-2012 
Highest Chile (2.80) Chile (2.85) Chile (2.90) 
Antigua and Barbuda (2.21) Antigua and Barbuda (2.10) Antigua and Barbuda (2.40) 
Mauritius (1.83) Botswana (1.93) Saint Lucia (2.14) 
Costa Rica (1.77) Mauritius (1.82) Saint Vincent and the Grenadines (2.09) 
Uruguay (1.75) Saint Lucia (1.77) Uruguay (2.03) 
Botswana (1.71) Dominica (1.77) Botswana (1.93) 
Dominica (1.70) Saint Vincent and the Grenadines (1.77) Mauritius (1.93) 
Grenada (1.53) Uruguay (1.76) Dominica (1.77) 
Malaysia (1.50) Costa Rica (1.54) Latvia (1.63) 
Saint Lucia (1.44) Samoa (1.50) Lithuania (1.61) 
Lowest Somalia (-2.46) Somalia (-2.29) Somalia (-2.59) 
Congo (-2.24) Myanmar (-1.78) Afghanistan (-1.82) 
Liberia (-2.14) Afghanistan (-1.71) Zimbabwe (-1.72) 
Afghanistan (-2.09) Zimbabwe (-1.65) Myanmar (-1.67) 
Iraq (-1.59) Iraq (-1.64) Turkmenistan (-1.57) 
Angola (-1.59) Haiti (-1.64) North Korea (-1.57) 
North Korea (-1.48) Congo (-1.57) Iraq (-1.49) 
Myanmar (-1.44) Turkmenistan (-1.53) Congo (-1.47) 
Burundi (-1.38) North Korea (-1.42) Venezuela (-1.38) 
Guinea-Bissau (-1.37) Angola (-1.30) Chad (-1.31) 
Missing data No data for Timor-Leste, Montenegro, Palau, 
Kosovo and South Sudan 
No data for Kosovo, South Sudan and 
Palau 
None 
Source: Author’s computations using Health Systems 20/20 project’s database
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Continuation…Table 5.2 Countries with the highest and lowest factor scores for each health system building block per wave: financing 
Financing Average before the year 2000 Average for years 2001-2006 Average for years 2007-2012 
Highest Palau (2.41) Palau (2.55)  Palau (2.91) 
Marshall Islands (2.22)  Tuvalu (2.12) Cuba (2.77) 
Seychelles (1.40)  Marshall Islands (2.11)  Tuvalu (2.70)  
Argentina (1.29)  Seychelles (1.60)  Marshall Islands (2.48)  
Uruguay (1.26)  Micronesia (1.37)  Lithuania (2.30) 
Tuvalu (1.058)  Cuba (1.14)  Costa Rica (1.96)  
Micronesia (1.02)  Costa Rica (1.05) Uruguay (1.92)  
Costa Rica (0.84) Antigua and Barbuda (1.04)  Micronesia (1.83)  
Antigua and Barbuda (0.79)  Lithuania (0.96)  Latvia (1.76)  
Kiribati (0.76) Botswana (0.95)  Turkey (1.74)  
Lowest Iraq (-1.39) Myanmar (-1.19) Myanmar (-1.21)  
Congo (-1.22) Afghanistan (-1.02)  Pakistan (-0.90)  
Myanmar (-1.19)  Congo (-0.96)  Chad (-0.89)  
Sudan (-0.95)  Pakistan (-0.92)  South Sudan (-0.84)  
Pakistan (-0.94)  Tajikistan (-0.90)  Cambodia (-0.84)  
Cameroon (-0.93)  Guinea (-0.90)  India (-0.81)  
Guinea (-0.88)  Guinea-Bissau (-0.90)  Cameroon (-0.76)  
Georgia (-.88)  Azerbaijan (-0.90)  Afghanistan (-0.76)  
Azerbaijan (-0.86)  India (-0.89)  Tajikistan (-0.74)  
India (-0.85) Laos (-0.88) Guinea (-0.74) 
Missing 
data 
No data for Palestine, North Korea, South 
Sudan, Afghanistan and Kosovo 
No data for North Korea, Palestine, 
Kosovo, and South Sudan 
No data for Somalia, Zimbabwe, 
North Korea, Palestine, Kosovo 
Source: Author’s computations using Health Systems 20/20 project’s database 
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Continuation…Table 5.2 Countries with the highest and lowest factor scores for each health system building block per wave: service delivery 
Service 
delivery 
Average before the year 2000 Average for years 2001-2006 Average for years 2007-2012 
Highest Bulgaria (1.23)  Latvia (1.17)  Bulgaria (1.30)  
Ukraine (1.23)  Bosnia and Herzegovina (1.17)  Thailand (1.29) 
Belarus (1.13)  Macedonia (1.17) Belarus (1.29)  
Serbia (1.05)  Serbia (1.19)  Serbia (1.26)  
Lithuania (0.97)  Seychelles (1.20)  Iran (1.26)  
Latvia (0.95)  Lithuania (1.22)  Mauritius (1.25)  
Macedonia (0.94)  Thailand (1.23)  Albania (1.24)  
Romania (0.91)  Belarus (1.27)  Cuba (1.24) 
Seychelles (0.89)  Bulgaria (1.33)  Bosnia and Herzegovina (1.23)  
Moldova (0.80) Ukraine (1.36) Macedonia (1.23) 
Lowest Niger (-2.25) Chad (-2.05) Chad (-1.93)  
Afghanistan (-2.15)  Niger (-1.88) Somalia (-1.65)  
Chad (-2.12) Somalia (-1.85) Niger (-1.44)  
Somalia (-2.05)  Ethiopia (-1.63) Ethiopia (-1.20)  
Ethiopia (-2.02)  Afghanistan (-1.61) South Sudan (-1.19)  
Mali (-1.88)  Nigeria (-1.48) Nigeria (-1.18)  
Congo (-1.84)  Congo (-1.45) Mali (-1.15)  
Yemen (-1.77)  Mali (-1.33) Liberia (-1.13) 
Burkina Faso (-1.71)  Liberia (-1.30) Congo (-1.07)  
Angola (-1.68) Guinea (-1.29) Guinea (-1.02) 
Missing 
data 
No data for Timor-Leste, South Sudan, 
Montenegro, Kosovo, Tuvalu and Palestine 
No data for Palau, Palestine, South 
Sudan, Kosovo and Tuvalu 
No data for Kosovo, Palau, Palestine, 
Dominica, and Tuvalu 
Source: Author’s computations using Health Systems 20/20 project’s database 
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Cont…Table 5.2 Countries with highest and lowest factor scores for each health system building block per wave: medical products and technologies 
Medical 
products 
Average before the year 2000 Average for years 2001-2006 Missing data 
Highest Argentina (5.89)  Mexico (2.93)  For wave 1: No data for Mozambique, Congo, 
Ghana, Togo, Libya, North Korea, Tuvalu, 
Timor-Leste, Seychelles, Comoros, Vanuatu, 
Zimbabwe, Benin, Sudan, Palestine, Syria, 
Marshall Islands, Liberia, Tanzania, South 
Sudan, Bosnia and Herzegovina, Ethiopia, Palau, 
Burundi, Tajikistan, Albania, Namibia, Congo, 
Swaziland, Yemen, Niger, Sao Tome and 
Principe, Eritrea, Botswana, Iraq, Tunisia, 
Venezuela, Iran, Mauritania, Morocco, Sierra 
Leone, Kiribati, Guinea-Bissau, Somalia, 
Gambia, South Africa, Kosovo, Micronesia, 
Mauritius, Madagascar, Montenegro, Nigeria 
Lebanon (5.59)  Venezuela (2.86)  
Uruguay (2.49)  Uruguay (2.58)  
Brazil (2.08)  Lithuania (2.34)  
Chile (1.60)  Albania (2.23)  
Mexico (1.22)  Chile (2.01) 
Dominica (1.06)  Brazil (1.98)  
Jordan (0.94)  Dominica (1.91)  
El Salvador (0.82)  Jamaica (1.50)  
Jamaica (0.68) Bulgaria (1.44) 
Lowest Papua New Guinea (-0.87) Thailand (-1.07) For wave 2: No data for Marshall Islands, 
Comoros, Liberia, South Sudan, Botswana, 
Swaziland, Kosovo, Iran, Somalia, Congo, South 
Africa, Timor-Leste, Guinea-Bissau, Cote 
d’Ivoire, Iraq, Tanzania, Mauritius, Mozambique, 
Sao Tome and Principe, Congo, Lebanon, Togo, 
Palestine, Tunisia, Zimbabwe, Montenegro, 
Tuvalu, Sudan, Mauritania, Niger, Madagascar, 
Kiribati, Eritrea, Sierra Leone, Micronesia, North 
Korea, Palau, Seychelles, Nigeria, Morocco, 
Libya, Angola, Vanuatu, and Ghana 
Thailand (-0.84)  Turkmenistan (-0.81)  
Romania (-0.84)  Papua New Guinea (-0.80)  
Samoa (-0.80)  Samoa (-0.76) 
Moldova (-0.79)  Solomon Islands (-0.75)  
Mongolia (-0.77)  Saint Vincent and the Grenadines (-0.74)  
Turkmenistan (-0.76)  Malawi (-0.73)  
Belarus (-0.75) Mongolia  (-0.72)  
Solomon Islands (-0.75)  Bhutan (-0.71)  
Malawi (-0.73) Chad (-0.70) 
Source: Author’s computations using Health Systems 20/20 project’s database 
Note: No available data for wave 3 (average for years 2007-2012) 
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Continuation…Table 5.2 Countries with the highest and lowest factor scores for each health system building block per wave: health workforce 
Workforce Average before the year 2000 Average for years 2001-2006 Average for years 2007-2012 
Highest Dominica (0.57) Belarus (2.16)  Belarus (2.22)  
Belarus (0.57) Uzbekistan (1.81)  Cuba (2.06) 
Ukraine (0.57)   Russia (1.69)  Uzbekistan (1.77)  
Antigua and Barbuda (0.51)  Cuba (1.67)  Kazakhstan (1.71)  
Lithuania (0.49)  Lithuania (1.60)  Russia (1.70)  
Saint Vincent and the Grenadines (0.46)  Ukraine (1.54)  Lithuania (1.53)  
Bulgaria (0.46)  Kazakhstan (1.47)  Uruguay (1.29)  
Latvia (0.45)  Seychelles (1.39)  Moldova (1.26)  
Russia (0.41)  Latvia (1.18)  Libya (1.24)  
Turkmenistan (0.39) Kyrgyzstan (1.15) Brazil (1.20) 
Lowest Chad (-1.50) Chad (-1.39)  Chad (-1.30) 
Niger (-1.45)  Ethiopia (-1.18)  Somalia (-1.04)  
Afghanistan (-1.43)  Somalia (-1.15)  Ethiopia (-0.92)  
Ethiopia (-1.42)  Niger (-1.10)  Gabon (-0.86)  
Somalia (-1.40)  Nigeria (-0.10)  South Sudan (-0.75)  
Congo (-1.30)  Afghanistan (-0.88)  Liberia (-0.74)  
Mali (-1.25)  Liberia (-0.83)  Haiti (-0.67)  
Laos (-1.20)  Central African Republic (-0.81)  Guinea (-0.67)  
Nigeria (-1.19)  Guinea (-0.80)  Central African Republic (-0.65)  
Angola (-1.17)  Congo (-0.79) Papua New Guinea (-0.64) 
Missing 
data 
No data for Palestine, Kosovo, South 
Sudan, Timor-Leste and Montenegro 
No data for Palestine, Kosovo, 
South Sudan 
No data for Kosovo and Palestine 
Source: Author’s computations using Health Systems 20/20 project’s database
Chapter Five 
 129 
Continuation…Table 5.2 Countries with the highest and lowest factor scores for each health system 
building block per wave: health information systems 
 
Health information systems  Highest Lowest 
Average for years 2007-2012 Latvia (1.62)  
Kazakhstan (1.61)  
Romania (1.58)  
Lithuania (1.57)  
Niger (1.45)  
Indonesia (1.35)  
Jordan (1.35)  
Philippines (1.34)  
South Africa (1.30)  
Malaysia (1.28) 
Tonga (-1.57) 
Haiti (-1.34)  
Marshall Islands (-1.30)  
Mozambique (-1.20) 
Peru (-1.18)  
Burundi (-1.17)  
South Sudan (-1.15)  
Papua New Guinea (-1.12)  
Lao People's Democratic Republic (-1.12)  
Samoa (-1.07) 
Source: Author’s computations using Health Systems 20/20 project’s database 
Note: No available data for waves 1 and 2 (average before the year 2000; average for years 2001-
2006)  
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a) Average governance scores before the year 2000 for 135 
LMICs
 
b) Average governance scores for years 2001 to 2006 for 135 LMICs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c) Average governance scores for years 2007 to 2012 for 135 LMICs 
Figure 5.4 Geographical distribution for the governance index for three data waves. 
Countries marked with lines have below average life expectancy rates. 
Chapter Five 
 131 
 
 
a) Average financing scores before the year 2000 for 135 LMICs 
 
b) Average financing scores for years 2001 to 2006 for 135 LMICs 
 
c) Average financing scores for years 2007 to 2012 for 135 LMICs 
Figure 5.5 Geographical distribution for the financing index for three data waves. Countries 
marked with lines have below average life expectancy rates. 
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a) Average service delivery scores before the year 2000 for 135 LMICs 
 
b) Average service delivery scores for years 2001-2006 for 135 LMICs 
 
c) Average service delivery scores for years 2007-2012 for 135 LMICs 
 
Figure 5.6 Geographical distribution for the service delivery index for three data waves. 
Countries marked with lines have below average life expectancy rates. 
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a) Average health workforce scores before the year 2000 for 135 LMICs 
 
b) Average health workforce scores for years 2001-2006 for 135 LMICs 
 
c) Average health workforce scores for years 2007-2012 for 135 LMICs 
 
Figure 5.7 Geographical distribution for the health workforce index for three data waves. 
Countries marked with lines have below average life expectancy rates. 
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a) Average medical products and technologies scores before the year 2000 
 
b) Average medical products and technologies scores for years 2001-2006 
Figure 5.8 Geographical distribution for the medical products and technologies index for 
three data waves. Countries marked with lines have below average life expectancy rates. 
 
Average health information system scores for years 2007-2012 for 135 LMICs 
Figure 5.9 Geographical distribution for health information systems index for three data 
waves. Countries marked with lines have below average life expectancy rates.
  
 
135 
5.5.3 Clusters of health systems in low and middle income countries  
 
By clustering the component scores discussed in previous sections, I found three potential clusters 
for the health systems building blocks: 20 a) stagnant health systems, b) transitioning health systems, 
and c) positive health systems. The clustering was done because the models discussed in previous 
sections may fail to account for the interactions among the different health systems building blocks. 
This failure was due to the resulting multicollinearity and high model specification errors when 
running all the building blocks in one model alone. In response, I applied cluster analysis to the 
resulting principal components. This approach allowed creating typologies based on the 
performance on each health system building blocks, potentially accounting for their interactions 
without resulting to model specification and multicollinearity. In other words, this may somehow 
account for interactions among the variables that needs to be done due to the very nature of health 
systems as complex and dynamic. Further, this will also guide further interpretation about what 
makes one country health systems differ from the others, leading to further differences in health 
outcomes. Solely relying on the scoring for each of the health system building block discussed in 
previous sections are not as useful for decision-making processes especially since the results 
showed weak performance across all health system building blocks. Hence, using this approach 
provides not only an overview of health systems, but also represents how each of the building 
blocks interact to form clusters:  
 
a. Stagnant health systems performance. The term stagnant was used since these countries 
did not show significant changes in mean performance scores for each health system 
building block across the three waves of data. This cluster includes: Angola, Bangladesh, 
Benin, Bolivia, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, 
Chad, Comoros, Democratic Republic of the Congo, Republic of the Congo, Cote d’Ivoire, 
Djibouti, Eritrea, Ethiopia, Gabon, Ghana, Guinea, Guinea-Bissau, Haiti, India, Indonesia, 
Iraq, Kenya, Laos, Liberia, Madagascar, Malawi, Mali, Mauritania, Mozambique, Myanmar, 
Nepal, Niger, Nigeria, Pakistan, Papua New Guinea, Rwanda, Sao Tome and Principe, 
Senegal, Sierra Leone, Solomon Islands, Sudan, Tanzania, Togo, Uganda, Vanuatu, Yemen 
and Zambia.  
                                                
20  The building blocks exclude medical products and technologies, which were dropped from the analysis due to 
insufficient number of observations, but average scores were provided for medical products and health information 
systems by cluster after clustering. Twelve countries were also excluded due to insufficient data: Afghanistan, 
Dominica, Kosovo, Montenegro, North Korea, Palau, Palestine, Somalia, South Sudan, Timor Leste, Tuvalu, and 
Zimbabwe. 
Chapter Five 
 136
b. Transitioning health systems performance, which means that these countries had moved 
from low to high scores in some health system dimensions. Overall, these countries had 
noticeable increase in one or two building blocks shifting from negative performance scores 
to positive performance scores, particularly in terms of financing (from -0.23 in wave 1 to 
0.15 in wave 3) and in service delivery (from 0.087 in wave 1 to 0.85 in wave 3). This 
cluster includes: Albania, Algeria, Armenia, Azerbaijan, Belarus, Belize, Bosnia and 
Herzegovina, China, Colombia, Dominican Republic, Ecuador, Egypt, El Salvador, Fiji, 
Gambia, Georgia, Guatemala, Guyana, Honduras, Iran, Jamaica, Kazakhstan, Kyrgyzstan, 
Lebanon, Lesotho, Libya, Macedonia, Mexico, Moldova, Mongolia, Morocco, Nicaragua, 
Paraguay, Peru, Philippines, Russia, Serbia, Sri Lanka, Suriname, Swaziland, Syria, 
Tajikistan, Tonga, Tunisia, Turkmenistan, Ukraine, Uzbekistan, Venezuela, and Vietnam. 
c. Positive health systems performance. On average, these countries have maintained 
positive performance scores until wave three. This cluster includes:  Antigua and Barbuda, 
Argentina, Bhutan, Botswana, Brazil, Bulgaria, Cape Verde, Chile, Costa Rica, Cuba, 
Grenada, Jordan, Kiribati, Latvia, Lithuania, Malaysia, Maldives, Marshall Islands, 
Mauritius, Micronesia, Namibia, Panama, Romania, Saint Lucia, Saint Vincent and the 
Grenadines, Samoa, Seychelles, South Africa, Thailand, Turkey and Uruguay. 
 
Table 5-3 Taxonomies of health systems performance 
Health system building 
blocks 
Wave Stagnant Health 
Systems 
Performance 
Transitioning 
Health Systems 
Performance 
Positive Health 
Systems 
Performance 
n = 51 n = 49 n = 31 
Governance 1 -0.49 -0.10 1.15 
2 -0.54 -0.12 1.17 
3 -0.48 -0.14 1.18 
Financing 1 -0.58 -0.23 0.43 
2 -0.48 -0.14 0.58 
3 -0.34 0.15 1.18 
Service delivery 1 -1.31 0.087 0.20 
2 -0.75 0.73 0.76 
3 -0.48 0.85 0.86 
Workforce 1 -0.90 -0.13 0.02 
2 -0.43 0.56 0.51 
3 -0.27 0.60 0.52 
Medical products and 
technologies 
1 -0.53 -0.07 0.33 
2 -0.45 0.22 0.45 
Health information 
systems 
3 -0.25 0.23 0.11 
Source: Author’s computations using Health Systems 20/20 data for three time periods: average 
scores before the year 2000, average scores from 2001 to 2006, and average scores from 2007 to 
2012. 
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In summary, stagnant countries have negative performance scores across all building blocks and 
across all waves of data. Although increases can be noted in performance scores within the cluster, 
such increase remained to be negative with life expectancy at 55 years old. Meanwhile, 
transitioning countries have higher performance scores in select building blocks with average life 
expectancy at 68 years. Lastly, positive health systems performance includes countries that have 
started with a positive performance score in wave 1 and has maintained or improved such scores 
over time. These countries have a life expectancy of 69 years.  
-4 -2 0 2 4
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Figure 5.10 Health system performance clusters per wave and building blocks computed using the 
Health Systems 2020 data 
      
When these clusters are mapped, stagnant health systems performance are mostly from most 
countries in the African and Asian region except for South Africa that had a positive health system 
performance compared with its neighbouring countries. Despite having a positive health systems 
performance, child health outcomes in South Africa still remain below average compared to all 
other countries with positive health systems performance. These countries with positive 
performance are mostly concentrated in Latin American countries and some parts of Asia. Except 
for South Africa, none of the countries with positive systems performance had below average child 
health outcomes. Meanwhile, transitioning health systems were mostly in Asia, Russia and some of 
the northern parts of Africa and Latin America. However, none of these countries had below 
average infant mortality rates.   
Wave 
Performance 
scores 
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Figure 5.11 Geographical distribution of clusters of health systems performance mapped using 
Health Systems data. 
 
5.6 Discussion 
 
In the past, health systems researchers have worked on creating performance assessment 
frameworks and parameters that can be used, considering the complexities of health systems and the 
many dimensions of its health systems building blocks (Glanz, Rimer, & Viswanath, 2008; Lee, 
2006; Mossialos, 2010; Murray & Frenk, 2000). Using PCA and cluster analyses allowed reducing 
the number of these dimensions without much loss of information. Specifically, I found the 
similarities and differences of health systems performance across countries, showed how these 
differences affect health outcomes, and examined how overall health systems strengthening 
progressed over the years. I also found Africa and Asia to have the least health system performance 
scores, which calls for more health systems strengthening initiatives in these areas.  In particular, 
the model showed lower service delivery scores in Sub-Saharan Africa and lower health workforce 
scores in Asia. In addition, I found how many countries in Africa and some parts of Asia had 
weaker health systems and how these systems performance are also related to poorer health 
outcomes. Findings can provide evidence in guiding existing and future health system policies and 
priorities particularly at the global level.  
 
Past studies have attempted to also do similar country-level taxonomies (Bazzoli, Shortell, & 
Dubbs, 2006; Castillo et al., 2010; Dubbs et al., 2004; Hernández et al., 2015; Ikezuagu, Yang, 
Daghstani, & Kaelber, 2012; Luke, 2006; Montes & Webb, 2015; Najaftorkaman, Ghapanchi, 
Talaei-Khoei, & Ray, 2015; Pallas, Curry, Bashyal, Berman, & Bradley, 2012; Salvador-Carulla et 
al., 2010; Shay & Mick, 2016; Xie & Zhang, 2006). For example, a previous taxonomy of health 
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systems using survey data from hospital respondents created three clusters of integration, 
differentiation, and centralization (Bazzoli et al., 1999). However, these taxonomies focused more 
on strategically important dimensions for hospitals, but not necessarily on systems. Compared to 
other studies, the taxonomy I developed was based on a more expanded set of health systems 
dimensions using a framework that has been widely accepted for health systems analysis and that 
was found to be appropriate for global health monitoring and evaluation. Mapping the results of the 
cluster analysis, I found that health system performance in South Africa is also a case to be further 
examined. Evidence from this study showed that overall health systems performance in South 
Africa was much better than the rest of the LMICs, yet health outcomes remain weak. This may 
imply that there are other factors outside the health systems building blocks that should further be 
examined as a key contributor to health outcomes. These findings supported claims that although 
the health system in South Africa successfully transformed into an integrated, comprehensive 
national service system, many failures remain in the system burdened by the massive HIV epidemic 
and poor health outcomes (Chopra, Daviaud, Pattinson, Fonn, & Lawn, 2009; Coovadia, Jewkes, 
Barron, Sanders, & McIntyre, 2009; Kahn et al., 2007; Leon, Arana, & de Leon, 2013; D. L. Marais 
& Petersen, 2015; H. Marais, 2011; Seedat, Niekerk, Jewkes, Suffla, & Ratele, 2009).  
 
Many others view health systems as too comprehensive, complex and even as chaotic systems 
(Bazzoli et al., 1999), but I found important and meaningful similarities that exist across health 
systems despite different contexts. The resulting taxonomy provides a new lexicon for 
characterizing global health systems and better understanding of its structural characteristics, 
providing a potential tool for global decision-making processes and priority-setting. Hence, these 
taxonomies of health systems may lead to more appropriate and responsive evidence-informed 
policy decisions and can serve as a roadmap for HSS initiatives.  
 
Future studies may consider updating the database. Data quality and availability remains a 
challenge for many LMICs (Lopez, Mathers, Ezzati, Jamison, & Murray, 2006; WHO, 2010b) 
because many data reporting mechanisms are neither sufficiently standardised nor reported 
accurately (Mechael et al., 2010). Specifically, I found insufficient number of observations for two 
building blocks: medical products and technologies and health information systems. Other than data 
constraints, conceptual and methodological constraints may arise from the choice of the framework 
used for analysis. My findings were only limited to six building blocks and failed to include other 
variables that also affect health systems performance and outcomes. Consequently, the framework 
determines the choice of variables for the analysis. In as much as health systems performance can 
include many other factors that may be outside the scope of the health systems building blocks, the 
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framework used was based on the commonly used framework for health systems research and 
derived from the previous studies discussed in Part A of the thesis. The analysis also has various 
methodological limitations. PCA and cluster analysis tend to give more emphasis to variables that 
have higher variances than variables with very low variances. In effect, the results of the analysis 
depend substantially on how much variation exists on different health systems variables. 
Nevertheless, the analysis done covered a broad range of countries and contexts and additional data 
and indicators were added to a point of reaching saturation, suggesting that incorporating additional 
data may not yield to substantially new information. 
 
Hence, using observable characteristics provide insights about cross-national and temporal 
variations in health systems performance. Specifically, findings showed the characteristics and the 
geographical locations of least performing health systems, which were not yet examined in the 
current literature. The results can serve as quality scorecards used in healthcare delivery showing 
variation in performance that can be used to determine characteristics of poorly performing health 
systems and identify health systems barriers. Resulting information can then guide existing and 
future strategies for health systems strengthening.  
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Chapter 6 Health systems strengthening in the context of decentralization 
 
Compared to previous chapters that focus on global health systems monitoring methods, this 
chapter examines health systems strengthening in a national context. Global-level methods are often 
critiqued for failing to consider context-specific information that can be useful for national-level 
policymaking and practices (Bevan & Hood, 2006; Gilson et al., 2011; Musgrove, 2003). For 
example, previous studies argued that indicators may not be comparable across countries and that 
general attainment and performance estimates are of no use for judging how well a specific health 
system performs (Musgrove, 2003). Hence, the performance of a health system should be based on 
a methodological consensus and specific to the national priority areas for the evidence to be useful 
(Musgrove, 2003). In other words, examining why other countries have better overall health 
systems than poorer countries is of little significance to the latter and will not guide existing and 
future HSS initiatives in the country (Musgrove, 2003). Nevertheless, international comparisons 
may still be useful for reforming global health care systems (Murray & Frenk, 2010). The 
international comparisons show the big picture that can be used for routinely tracking performance 
and comparing results across countries over time (Murray & Frenk, 2010). Breaking down 
performance along one or more of the health systems building block or making it more focused than 
an overall assessment may then make it more useful for policymaking. Using a more specific 
scenario, I focused on one health system building block – governance – in Cambodia and the 
Philippines. Specifically, I focused on the transitions from centralized health systems to a more 
decentralized health system. In particular, I examined how decentralized health systems relate to 
infant mortality and fertility rates and determined how health systems operate in a decentralized 
system.  
 
I chose governance as the health system building block because one key health system reform that 
has happened over the years is decentralization. However, decentralization has not been studied in 
previous chapters. To recap, the governance data used in previous studies include only six 
dimensions of governance: voice and accountability, political stability and absence of violence, 
government effectiveness, rule of law, and control of corruption (World Bank, 2016d). Hence, it did 
not capture decentralization, which is also vital yet debated issue in the context of health system 
reforms (Bossert, 1998; Huther & Shah, 1998; Tobi & Regmi, 2014). Although greater 
decentralization may make governments more honest and efficient while making systems more 
responsive (Azfar, Kahkonen, Lanyi, Meagher, & Rutherford, 1999), decentralization can also 
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create coordination problems and obstacles to reform, leading to less effective provision for public 
healthcare services (Treisman, 2000).  
 
I selected Cambodia and the Philippines as the cases for this study. The Philippines has the widest 
range of functions devolved to local government units (Bossert & Beauvais, 2002). In general, 
devolving more government functions was found less effective in providing public healthcare 
services and infrastructure (Treisman, 2000). However, the Philippines has achieved substantial 
progress towards its health goals, particularly in reducing child mortality despite devolving more 
government functions (Kraft, Nguyen, Jimenez-Soto, & Hodge, 2013; Wagstaff, 2000). Similarly, 
decentralization in Cambodia contracted healthcare services to nongovernmental organisations and 
claimed to have substantially positive health implications (Mills, Rasheed, & Tollman, 2006). 
However, other studies claimed that the current health system structure affected by decentralized 
government functions did not actually show any marked improvement in healthcare; hence, less 
progress in achieving better health outcomes (Arsenio Balisacan, Hill, & Piza, 2008; Rodan & 
Hughes, 2012; Turner, 2006). Hence, in this chapter, I will examine the two contesting findings 
about the effect of fiscal decentralization on health outcomes in the Philippines and Cambodia and 
determine whether decentralizing government functions have a positive impact on healthcare 
service delivery.  
 
6.1 The role of decentralization for health systems strengthening  
 
Critical to HSS initiatives is to ensure the quality and effectiveness of public health systems in the 
context of decentralized health care functions (Hotchkiss, Eisele, Djibuti, Silvestre, & Rukhadze, 
2006). Decentralization is the transfer or sharing of decision-making power from a central authority 
to lower-level units or the end users (Béné et al., 2009). The term is associated with the theory of 
fiscal federalism (Oates, 1972), which states that allocative and productive efficiency increases as 
the provision of public goods and services become more responsive to local needs and more 
competitive across regions (Oates, 1972).  There are different types of decentralization: First, 
devolution looks at decentralization as a political reform designed to promote autonomy at the local 
level (Jiménez-Rubio, 2011; Rubio, 2011). In devolution, locally elected government bodies 
exercise full powers in regulating, financing, and delivering public goods and services (Martinez-
Vazquez & Timofeev, 2008). Budget devolution was identified as the most important step in 
decentralization and most studies synonymously used decentralization with devolution (Rubio, 
2011). Second is delegation, wherein locally elected government bodies assume new 
responsibilities subject to strict regulations by the upper-level government (H. Uchimura & Jütting, 
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2009). Third, de-concentration provides the local government with some autonomy, particularly on 
the delivery of services, while the central government reserves the powers to regulate and raise 
finances (Martinez-Vazquez & Timofeev, 2008; H. Uchimura & Jütting, 2009). To date, there is no 
agreed-upon single indicator of the extent of decentralization in a country.  
 
 
Figure 6.1 Types of decentralization 
 
There are two conflicting views about the effects of decentralization on health care systems: 
 
First, some claim that decentralization improves health systems. Decentralized healthcare system is 
asserted to ensure increased government accountability to the population (Bossert, Larranaga, 
Giedion, Arbelaez, & Bowser, 2003; Jiménez-Rubio, 2011; Kang et al., 2012). This increased 
accountability expedites the bureaucratic process and induces policy innovation as regions become 
more competitive (Kang et al., 2012). Further, it improves community participation in decision 
making and implementation, increasing the level of representation of local populations (Mansuri & 
Rao, 2004) and aligning public services more closely with local preferences (Kang et al., 2012). In 
addition, corruption was also said to be lower in countries wherein subnational governments have a 
larger share of fiscal revenues and expenditures (Altunbaş & Thornton, 2012; Thornton, 2012). 
Hence, decentralization, along with stronger national political parties, increases economic growth, 
quality of government, and public goods provision (Enikolopov & Zhuravskaya, 2007). 
 
In contrast, decentralized health systems were said to widen health inequalities among regions  
when competitiveness across the regions becomes detrimental to national unity (Collins & Green, 
1994). Specifically, as poorer regions with insufficient revenues struggle to compete with others, 
lesser investments are also placed in healthcare (S. Fan, Zhang, & Zhang, 2002; Fukasaku, 1999). It 
can also reduce national bargaining, increasing prices of services delivered locally (Azfar et al., 
1999). Relying on local governments increases risks for corruption and may also lead to inefficient 
planning and management of public goods and services (Rubio, 2011; Prud'Homme, 1995; 
Treisman, 2000). Hence, decentralization can lead to poor economic growth (Prud'Homme, 1995)  
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In between these two contrasting ideas, some claim that the effects of decentralized health systems 
on population health are positive to a certain level of decentralization, but beyond this level, gains 
from decentralization may no longer be realized (Kang et al., 2012). Further, there seems to be a 
pressure to decentralize government functions given that most advanced economies have 
decentralized governance systems such as the United States, United Kingdom, Italy, and Spain 
(Bray, 1999; Keating, 1998; Saltman & Figueras, 1998). Many international donor organisations 
have also promoted decentralized health systems as key to improved population health, but some 
have argued that this is primarily politically driven (Cassels, 1995; Walt & Gilson, 1994).  
 
6.2 Decentralization and child health in the context of the Philippines 
 
Despite its long tradition of centralism, the Philippines is the first country to decentralize its 
services in the Southeast Asian region and has done so more rapidly than others (Turner, 2007). 
However, devolving health care was the last (Grundy, Healy, Gorgolon, & Sandig, 2003). Seven 
years after devolution, the Philippine Department of Health (DOH) is still restructuring itself to 
complement the devolved system and help local governments implement public health programs 
and services (Brillantes & Fernandez, 1986; Grundy et al., 2003). Despite its efforts to devolve 
health functions, 72 devolved hospitals were again re-nationalized in 2003 (Capuno, 2013; Langran, 
2011). Twenty years after decentralization, debates about whether health systems should be 
decentralized are still on-going (Bossert & Beauvais, 2002; Lieberman, Capuno, & Van Minh, 
2005; Veljanovski & Stojkov, 2013). Further, decentralization also led to double spending on 
health, resulting to high levels of government spending (Bossert & Beauvais, 2002). 
 
The Philippines is divided into local government units (LGUs), which include regions divided into 
provinces (Grundy et al., 2003) (Figure 6.2). Except for the National Capital Region, provinces can 
be further subdivided into cities and municipalities, which are then composed of barangays 
(Wallich, Manasan, & Sehili, 2014) (Figure 6.3). Each LGU is run by a governor (province), mayor 
(city or municipality), or captain (barangay) with a three-year term of office and three term limits 
(Rood, 1998). In 1991, the Philippines enacted the Local Government Code that formalized 
decentralization (Brillantes, 1998), transferring the provision of major government functions and 
services such as public health to LGUs (Wagstaff, 2000). The Code was envisioned to make LGUs 
more financially viable and independent by allowing them to impose their own local taxes and 
giving them increased borrowing power such as in contracting loans, credits or bonds (Ishii et al., 
2007).  Specifically, the LGUs are responsible for any regulations and delivery of basic public 
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services. the while the central government provides additional resources (Brillantes, 1998). In terms 
of resources, central governments are exclusively assigned with major taxes from individual and 
corporate taxes, while LGUs are allowed to collect real property taxes, local business tax, and other 
specified taxes (Yilmaz & Venugopal, 2013).   
 
Figure 6.2 Local governance structure in the Philippines 
Source: Author’s illustration 
 
The transfer of resources from the central government to the LGUs is done through the Internal 
Revenue Allotment (IRA), which has been questioned for its inadequacy and predisposition to 
corruption (Diokno, 2009). Specifically, central governments should transfer 40% of the revenues 
collected three years before the year of the distribution to the LGUs (Guevara, 2004). As long as the 
LGUs earmark their annual budgets an amount of no less than 20% for local development projects, 
LGUs can decide on how to utilize their IRA (Guevara, 2004). Meanwhile, there is no specific 
threshold for LGU allocation on specific healthcare services (Guevara, 2004).  
 
There are two contrasting views on the decentralization in the Philippines. Others claim that 
decentralization negatively affected resource allocation. In the end, provinces received substantially 
reduced resources despite having the most government functions (Diokno, 2009). Further, 
decentralization increased government inequities with some LGUs receiving less resources for local 
income generation and weaker ties at the national level than other LGUs (Langran, 2011). In 
addition, health inequities also increased because LGUs least prioritised healthcare services 
(Langran, 2011). In contrast, others argue that decentralization led to better health outcomes, 
specifically lowering infant mortality rates (Asfaw et al. 2007: 17-35). However, the decline in 
infant mortality rates in the Philippines was said to be slower than expected at 22 deaths per 1000 
live births in 2015 (La Vincente et al., 2013).  
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Figure 6.3 Map of the Philippines showing 17 regions (in capital letters) and their provinces 
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6.3 Decentralization and child health in the context of Cambodia 
 
Cambodia was under the Khmer Rouge from 1975 to 1979 and in a state of civil war until 1991. 
Afterwards, the United Nations in Cambodia oversaw a transition leading to the restoration of civil 
rule after years of civil war and foreign intervention (Anon, 2015). When the election was held in 
1993, the Cambodian People’s Party refused to accept the election results instigating violence and 
leading to the UN backing down (Anon, 2015). Since then, Cambodia has endured traumatic and 
violent elections almost every five years (Anon, 2015). Although Cambodia still faces a number of 
development challenges, the country has attained the lower middle-income status in 2015. In 
particular, its economy grew rapidly with a change from central to a market-driven economy 
(Annear, 1998; Hill & Menon, 2013) (Figure 6.4). With these economic reforms, Cambodia has 
begun significant health systems transformations to address increasing disparities (Helman & 
Ratner, 1992; Annear, 1998), particularly by improving distribution of its limited health resources 
(Helman & Ratner, 1992). Specifically, health reforms included expanding rural health services, 
rebuilding the district health infrastructure and implementing market-based financing practices 
(Annear, 1998). Reforms also include increasing active international and non-government aid 
organisations and different policy innovations in planning, contracting, and financing healthcare 
(Grundy, Yi Khut, Oum, Annear, & Ky, 2009). Since 1996, more policy shifts towards 
strengthening health systems were implemented (Peat, 2013). In 2001, Cambodia has started 
decentralization with an approved basic legal framework called Commune Law, which establishes 
and operates democratically elected local councils called Sangkat Councils (Romeo & Spyckerelle, 
2004).21 Although prevented from direct borrowing, communes have their own financial resources, 
budget and assets and have the  right to collect direct revenues from local taxes, fees, and other 
service charges (Romeo & Spyckerelle, 2004).   
                                                
21 The ‘Sangkat’ is the equivalent of a commune in a municipality. Communes are predominantly rural, and Sangkats 
are normally urban, but there are also “urbanized” Communes and “rural” Sangkats (Romeo & Spyckerelle, 2004) 
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Figure 6.4 Map of Cambodia showing the boundaries for the 24 provinces 
 
The creation of commune councils was found to improve local governance, as well as access to 
resources for local development and service delivery. In contrast, the commune councils has also 
been questioned for the lack of clearer assignment of responsibility as councils do not have a 
specific service delivery mandate (Romeo & Spyckerelle, 2004). Further, decentralized health 
systems were found to favour areas where elected members reside or from which they originate 
(Romeo & Spyckerelle, 2004). Despite health reforms, the high incidence of preventable diseases, 
poor quality of health workforce, low availability of health facilities, and lack of access to 
medicines remain (Annear, 1998). However, overall child mortality rates decreased faster than 
expected in Cambodia (Estanislao Castro et al., 2014). Specifically, average IMR was at 101 deaths 
per 1000 live births before decentralization, which decreased to 24 deaths per 1000 live births in 
2015.  
 
This chapter has two research objectives: a) to examine how decentralized health systems in 
Cambodia and the Philippines relate to infant mortality rates; b) to determine how different health 
systems strengthening initiatives in Cambodia and the Philippines operate in a decentralized health 
system. Using fixed effects regression analysis, I examined how decentralized health systems relate 
to infant mortality rates using regional-level income and expenditure data for Cambodia and the 
Philippines.  
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6.4 Methods 
 
6.4.1 Quantitative analysis 
 
Data sources. To model the relations between decentralized health systems and health outcomes in 
Cambodia and the Philippines, I used data from the national demographic health surveys (NDHS),22 
the Philippine Statement of Income and Expenditure,23 and the Cambodian national health accounts 
available from 1960 to 2012. I used regions as the unit of analysis considered over waves of data 
about five years apart.  
 
Independent variables. To measure decentralization, I computed for vertical balance (VB) adapted 
by Martinez-Vazquez & Timofeev, 2008. Vertical balance (VB) indicates the degree of local fiscal 
autonomy calculated as the ratio of the local government’s total expenditure across all activities to 
their total revenue from all activities (Helman & Ratner, 1992; Pascual & Cantarero, 2007). In this 
study, I used vertical balance based on health revenue and expenditure. To measure VB:  VB# 	= &'()*+,)       (6.1) 
where the subscript  refers to the local government or commune, Exp$   is the local government’s 
total expenditure and Rev$  is the local government’s total revenue. A VB which is less than one 
indicates that the local government’s resources are sufficient to cover its total expenditures. If VB is 
greater than one, the local government’s expenditure exceeds the local government revenue for 
health. The higher the VB, the more local dependence there is to the central government. This high 
VB implies that other external resources such as IRA, shares under special laws, grants, and aids are 
needed to address the fiscal gap at the local level (Schwartz, Guilkey, & Racelis, 2002). 
 
Dependent variable. First, I used infant mortality rates (IMR) or the number of infants who die 
within the first year of life expressed as a rate per 1000 live births. Second, I used total fertility rates 
(TFR) or the average number of children that would be born per women if all women lived to the 
                                                
22 The NDHS is a nationally representative survey conducted by the National Statistics Office and ICF Macro every five 
years since 1968 to assess the demographic and health situation in the country. It was designed to collect information on 
health-related topics such as fertility, and maternal and child health (MEASURE & Calverton, 2004).  
23 The SIE provides the LGUs fiscal and financial performance and includes details on tax revenue, non-tax revenue (or 
receipts), and other sources of income such as loans, grants, transfers, borrowings, and shares from the national 
government. Locally-sourced income includes tax revenues from real property, business, and other local taxes, and non-
tax receipts from fees and charges, government business operations, and other miscellaneous income. Externally 
sourced income includes the Internal Revenue Allotment (IRA), shares under special laws, grants, and aids and other 
transfers to LGUs. It also provides expenditure data for each basic services, any surplus, and the amount of resources to 
be carried forward by the local government to the subsequent budget year (Virola et al., 2010). 
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end of their childbearing years and bear children in accordance with age-specific fertility rates of 
the specified year (World Bank, 2016a). TFR was used because previous studies showed strong 
associations between decentralization and reproductive health policies (Aitken, 1998). IMR is 
calculated as (Benfeng & Yu, 2011): !"# = % &,()& *	1000 = . /-1,/,2 + % &,&,()& *	1000    (6.2) 
where !(#-%,#,')  is the number of babies born in the year of (t-1) who die in the year of t, !(#,#,%)  is 
the number of babies born in the year of t and die in the year of t.  
TFR is calculated as:    !"# = 	 &'"#(	  for 5-year age groups   (6.3) 
where !"#$%   = age-specific fertility rate for women in age group a expressed as a rate per woman.  
 
Control variables. I controlled for antenatal coverage, percent distribution of live births assisted by 
a doctor during delivery (Asst), percent distribution of live births delivered in a health facility 
(Place), percent of married women who know at least one contraceptive method (Cont), and percent 
distribution of the de facto female household population age six and over who at least completed 
elementary (Educ) (Table 6-1).  
Table 6-1 Descriptions of the variables used 
Variables Description 
Infant mortality rates 
(IMR) 
Number of deaths of children less than 1 year of age per 1000 live 
births 
Vertical balance (VB) Summation of the provincial expenditure over summation of the 
provincial revenues 
Antenatal coverage 
(ANC) 
Percent distribution of women who had a live birth in the five years 
preceding the survey receiving at least one antenatal care visit 
during pregnancy. ANC is an intervention vital to maternal and 
child health.  
Assisted births (Asst) Percent distribution of live births in the five years preceding the 
survey receiving assistance from a skilled birth attendant. It shows 
use of delivery care services and is mostly used as a measure of the 
health system’s functioning.  
Place of birth delivery 
(Place) 
Percent distribution of live births in the five years preceding the 
survey delivered in a health facility. It is the optimal long-term 
objective of all births to ensure any obstetric complications can be 
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treated when they arise.  
Knowledge of 
contraceptive methods 
(Cont) 
Percentage of currently married women who know at least one 
contraceptive method 
Educational Attainment 
(Educ) 
Percent distribution of the de facto female household population age 
six and over who had no education 
Total Fertility Rates 
(TFR) 
Total fertility rate for the five years preceding the survey 
Source: (WHO, 2010b, p. 85) 
 
Analysis. To do a fixed effects regression model, I built a pooled region-period data set for 
Cambodia and the Philippines. I have data on 36 regions at about 4.4 time periods each with each 
wave about 5 years apart. In total, I have 159 observations with about 4.4 observations per region. 
Assuming that local governments have full fiscal autonomy in health resource distribution:  IMR$% = 	 	α + α$ +	β+%VB$% +	β.%ANC$% +	β2%Asst$% + 		β5%Place$% +	β5%Cont$%	+	β5%Educ$% + 	ε$%  
  (6.4) Fert%& = 	α + α% +	β,&VB%& +	β/&ANC%& +	β3&Asst%& + 		β5&Place%& +	β5&Cont%&	+	β5&Educ%& + 	ε%&  
   (6.5) 
where IMR  is the infant mortality rate per region  and year  and Fert  is the total fertility rate per 
region  and year t;  α"  is the region-specific effect; VB  represents vertical balance per region i	  and 
year ; !"#$%   is the antenatal coverage per region i and year t; !""#$%   is the percent distribution of 
live births assisted by a doctor during delivery; !"#$%&   is the percent of married women who know 
at least one contraceptive method; !"#$%&   is the percent distribution of the de facto female 
household population age six and over who at least completed elementary. 
 
6.5 Results 
 
6.5.1 Summary results for the Philippines 
 
Infant mortality rates. Seventeen regions were included in this study from time periods from 2001 
to 2008 at approximately five year intervals.  From 2001 to 2008, the average infant mortality rate 
was 32.65 per 1000 live births. The highest IMR was in Region VIII at 61.4 per 1000 live births in 
2001 and 60.8 per 1000 live births in 2003. The lowest IMR was in Region IX and CAR both with 
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14 per 100 live births in 2005 and in 2004, respectively. Overall, IMR decreased from 40.77 per 
1000 live births in 2001 to 26.71 per 1000 live births in 2008.  
 
Total fertility rates. TFR was at 3 births per woman aged 15 to 49 years old. The highest TFR ever 
recorded was at 5.91 in 2003 for Region VIII and 5.87 in 2001 for Region VIII. The lowest 
recorded TFR was 2.3 for NCR in 2008 and 2013.  
 
Vertical balance. The average vertical balance was less than one throughout the Philippines, 
although this has been improving over the years. Average VB decreased from 0.98 in 2001 to 0.86 
in 2008, implying lesser fiscal gaps across regions. The highest ever calculated was from 2001 to 
2003 at 1.049 for Region VI, 1.043 for Region IV-B, and 1.043 for Region III. The lowest ever 
calculated was a VB of 0.77 for Region I in 2008 and 0.79 for Region II in 2005.  
 
Control variables. Average antenatal coverage was at 32.85% ranging from 11.3% to 81.3%. The 
highest ever recorded was for NCR from 81.3% in 1993 to 75.3% in 1998, and 74% in 2003 and 
2013. The lowest ever recorded was in ARMM from 11.6% in 1998 to 12.4% in 2013. Region XII 
and Region IX followed with 12.1% in 2008 and 12.5% in 2004.  
 
On average, assisted birth deliveries were at 28.87% with the highest ever recorded for Region III at 
39% in 2001 followed by Region IV-A at 43.1% in 2005. The lowest ever recorded was at ARMM 
from 3.4% in 1998 to 9% in 2013 followed by Region IX with 10.1% in 2001. Average percentage 
of assisted birth deliveries was from 20.67% in 2001 to 28.4% in 2013.  
 
On average, the percentage of women who know at least one contraceptive method was at 98.21%  
ranging from 77.9% to 100%. Regions that reached 100% include CAR in 2008, CARAGA from 
2003 to 2008, Region I from 2003 to 2008, Region II in 2004, Region II from 2005 to 2008, Region 
IVA in 2008, Region V in 2005, Region VI from 2003 to 2008, Region VII in 2005, Region VIII in 
2008, Region X in 2003 and 2005, and Region XI in 2008. The lowest ever recorded was in the 
ARMM from 77.9% in 1998 to 82.6% in 2008.  
 
Six percent of the de facto female household population had no education with the highest in 
ARMM at 30.4% in 1998 and 23.1% in 2003 followed by Region XII with 20.4% of its population 
who did not received any formal education. Region I and NCR had 100% of its population able to 
attend at least some primary education. Less than 0.5% of the populations in Region II, Region III, 
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Region IV-A, and Region V did not receive any formal education. Overall, 9.35% did not received 
any formal education in 2001, which decreased to 5.39% in 2008 and increased to 11.05% in 2013.  
 
6.5.2 Summary results for Cambodia 
 
Infant mortality rates.  Twenty-four regions were included. From 2001 to 2014, the average IMR 
was at 72.80 per 1000 live births ranging from 95.85 per 1000 live births in 2000 to 42.5 per 1000 
live births in 2014. The highest recorded was in Ratanak Kiri (id = 20) and Mondul Kiri (id = 19) 
both with 169.80 per 100 live births in 2000 and 122 per 1000 live births in 2005. This was 
followed by Pursat (id = 10) and Kampong Chnang (id = 3) with mortality rates at 139.4% and 
129.3%, respectively. The lowest ever recorded was in Phnom Penh (id = 8) with 13% in 2008 and 
17% in 2014. This was followed by Kampong Speu (id = 4), Battambang (id = 15), and Pailin (id = 
22) with IMR less than 30% in 2014.   
 
Total fertility rates. Total fertility rates were almost similar for the Philippines and Cambodia with 
TFR at an average of 3% for Cambodia from 2000 to 2014. The highest recorded TFR was 6.3% in 
2000 for both Mondul Kiri (id = 19) and Ratanak Kiri (id = 20) followed by 5.2% for the same 
areas in 2005. The lowest ever recorded was in Phnom Penh with an average of 2% from 2000 to 
2014, then by Kampong Speu (id = 4) with 2.1% and Kampong Chnang (id = 3) at 2.4%. 
 
Vertical balance. Using the Cambodian government budget and financial audit reports, none of the 
regions had a vertical balance of more than 1 and average VB was at 0.76 . The lowest VB was at 
0.36 and the highest was 1.0 for Takeo (id = 13) in 2005, 2008 and 2014; Kampong Chnang (id = 3) 
in 2000 and 2005; Pursat (id = 10) in 2000 and 2012; Prey Veng (id = 9) in 2014; and Svay Rieng 
(id = 12) in 2013 and 2014. The lowest recorded VB was 0.36 for Preah Vihear (id = 18) in 2005, 
followed by Otdar Meanchey (id = 14) at 0.40 in 2000 and Prey Veng (id = 9) at 0.44 in 2013. 
Average VB started from 0.72 in 2000 and increased to 0.80 in 2008, before it decreased again in 
2014 at 0.79.  
 
Control variables. Antenatal coverage improved from 1% in 2000 to 6.14% in 2008. The highest 
antenatal coverage was in Phnom Penh from 11.9% in 2005 to 67.2% in 2008. The least coverage 
was in Stung Treng, Kampong Speu, and Kamping Thom with an average of less than 0.5% 
antenatal coverage. Assisted births only grew from 1.9% in 2000 to 8.1% in 2008 with the highest 
recorded in Phnom Penh at 73.2% in 2008 and lowest in Mondul Kiri and Ratanak Kiri at 0.1% in 
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2005. Births delivered in a health facility grew from 9.24% in 2000 to 39.50% in 2008. The highest 
recorded was in Phnom Penh at 1.9% and least in Otdar Meanchey and Siem Reap at 1.9% in 2000.  
 
Knowledge of at least one contraceptive method was highest in Phnom Penh, Kampng Chnang, 
Kampong Thom, Prey Veng, Pursat, Siem Reap, Svay Rieng, Otdar Meanhchey, Kampot and Kep 
with 100% coverage. Least coverage was in Mondul Kiri and Ratanak Kiri at 21.5%, followed by 
Siem Reap at 29.3%. Overall, contraceptive knowledge increased from 91.66% in 2000 to 99.67% 
in 2014. The highest proportions of the population with no formal education were in Mondul Kiri 
and Ratanak Kiri where 75.1% of the population reported not receiving any formal education in 
2000. Only less than 15% of the population in Phnom Penh did not receive any formal education 
from 2000 to 2014.  
 
6.5.3 Estimation results for infant mortality rates, total fertility rates, and vertical balances in 
Cambodia and the Philippines 
 
I fitted six equations using fertility rates and infant mortality rates as the dependent variables and 
the vertical balance as the independent variable. I used the same controls for each equation. Two of 
the equations were limited to data from Cambodia, two of them were limited to data from the 
Philippines, and the last two equations used combined both datasets from Cambodia and the 
Philippines. A change in vertical balance for Cambodia was significantly associated with infant 
mortality rates such that every unit of increase in vertical balance implies 0.135 decrease in infant 
mortality rates controlling for births assisted, place of delivery, ANC, contraceptive knowledge and 
educational attainment. Place of birth delivery also showed significant associations with the total 
fertility rate and infant mortality rate in Cambodia and the pooled dataset, but not in the Philippines 
at p<0.001. In the Philippines, only assisted birth deliveries and contraceptive knowledge showed 
significance at p<0.01 for both total fertility rates and infant mortality rates. Across all datasets, 
vertical balance was not significantly associated with fertility rates in either country. 
 
Table 6-2 Estimation results for infant mortality rates, total fertility rates, and vertical 
balances in Cambodia and the Philippines 
 
Cambodia Philippines 
 
1 2 3 4 
 
TFR IMR TFR IMR 
VB 0.016 -0.135* 0.062 0.123 
 
(0.31) (1.97) (0.56) (0.82) 
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ANC 0.069 0.118 0.234 -0.346 
 
(0.71) (0.91) (0.79) (-0.91) 
Asst -0.097 -0.185 -1.219** -0.114 
 
(-0.81) (-1.15) (-3.22) (-0.23) 
Place -0.375*** -0.471*** 0.318 0.164 
 
(-4.52) (-4.26) (1.51) (0.59) 
Cont 0.012 -0.081 -0.223 -0.757** 
 
(0.20) (-1.07) (-1.34) (-3.11) 
Educ 0.611*** 0.369*** -0.203 -0.354 
 
(8.48) (4.26) (-1.27) (-1.58) 
N 64 64 34 34 

6.5.2 How the different health systems strengthening initiatives in Cambodia and the Philippines 
operate in a decentralized system? 
 
Decentralization, as indicated by vertical balance, was found to significantly affect the infant 
mortality rates in Cambodia, but did not seem to have major contributions to the reductions in infant 
mortality rates in the Philippines. Meanwhile, total fertility rates were not affected by vertical 
balances. The influence of decentralization may be more apparent in Cambodia, wherein none of 
the financial reports showed a vertical imbalance, implying no fiscal gap between the local 
government’s revenues and expenditures.  
 
Further increasing vertical balance in Cambodia would lead to significant decrease in infant 
mortality rates. At the start of decentralization, the infant mortality rate in Cambodia was at 95.85 
with a vertical balance at 0.72. Five years later, infant mortality rate had decreased to 91 with a 
vertical balance increasing at 0.74. In post-conflict Cambodia, contracting of health services to 
other non-government organisations was the key health strategy used by the government (Soeters & 
Griffiths, 2003). The contracting of health services was initially an experimental strategy, wherein 
contracts were called from non-government organisations to attain specific health coverage targets 
for selected groups of the population (Gwatkin, Bhuiya, & Victora, 2004). This contracting may 
have led to competition in awarding contracts resulting to increased service delivery output and 
better quality of health services (Gwatkin et al., 2004; Soeters & Griffiths, 2003; Jacobs et al., 
2010) . Since implementation of this approach, coverage in the poorest 20% of the population of 
eight basic services improved from 15% to 40% (Gwatkin et al., 2004), resulting to increased health 
service utilization (Soeters & Griffiths, 2003). Although the strategy was found to have positive 
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impacts, the challenge was in transitioning back private services into government systems, 
particularly in ensuring that proper financial remuneration still remains for its health workers 
(Jacobs et al., 2010).  
 
Health equity fund schemes (HEFs) was another strategy used by Cambodia for financing health 
systems. HEFs were supported through the Health Sector Support Program, wherein funds from 
various development partners and the Royal Government of Cambodia pays for the bill for each 
patient’s treatment fee, meals, transport, and other additional costs (World Bank, 2015a). However, 
studies on their outcomes have mixed findings. Some have found HEF to improve financial access 
for the poor with a support for 16% of hospitalized patients in 2004 alone (Hardeman et al., 2004). 
Others claim that HEFs still have weak performance, poor policy design, and underfunding 
(Meessen, Damme, Tashobya, & Tibouti, 2007). Despite mixed findings, HEF were consistently 
found to be effective if there was local involvement in its management and implementation. Other 
studies also found that identification of HEF fund recipients would have been more successful and 
effective if done by community members. Such community involvement was found to be feasible 
and accrues minimal direct costs (Jacobs & Price, 2006; Noirhomme et al., 2007). Specifically, 
pagoda-managed equity funds resulted to higher community participation, while indigenous 
community-based organisations resulted to reduced administrative costs (Noirhomme et al., 2007). 
 
Results also showed the regional differences in terms of vertical balances, infant mortality rates, 
and total fertility rates in Cambodia and the Philippines. In both countries, results consistently 
showed that areas with more fiscal gaps, which were mostly in rural areas or conflict-affected areas 
like ARMM for the Philippines and Mondul Kiri and Ratanak Kiri for Cambodia also had poorer 
health outcomes, implying also that the potential of decentralized health systems may not 
necessarily be fully achieved in areas with larger vertical imbalances. According to previous 
studies, one of the factors that likely affected the lack of rural development in the Philippines 
appears to be the continuous industrial protection that lowers the relative price of agricultural 
products and acted as a disincentive to agricultural sector development (A Balisacan, 2004). Hence, 
as long as an LGU spends more than its revenues, healthcare is most likely least prioritised despite 
increasing intergovernmental transfers and fiscal capacity. With decentralization, a heavy reliance 
on local government units emerged, raising issues on the direction of public health management 
(Fukasaku, 1999). Alternative approaches for financing may be able to address the fiscal gap: a) 
increasing local revenues; b) increasing LGU taxing authority; c) increasing transfers from national 
government; and d) more efficient use of existing financial resources in service delivery (Manasan, 
1997). With the vast taxing powers given to the LGUs, the level of total income was inherently 
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dependent on the capacities of LGUs on the different areas of tax administration: registration, 
collection, and compliance (Bird, Ebel, Wallich, & Oates, 1998). 
 
6.6 Conclusion 
 
I found that decentralization played a significant role in reducing infant mortality rates in 
Cambodia, but not in the Philippines. For both countries, I also found substantial inequities among 
regions in terms of the fiscal transfers, infant mortality rates, and total fertility rates. Results also 
showed that areas with more fiscal gaps were mostly in rural or conflict-affected areas like ARMM 
for the Philippines and Mondul Kiri and Ratanak Kiri for Cambodia. These areas also had poorer 
health outcomes; hence, the potential of decentralized health systems may not necessarily work in 
these areas with larger vertical imbalances. Although as Hill and Menon (2013)  note Cambodia’s 
‘policy settings were unusual, owing to its history, size, location, and also deliberate policy 
choices’, lessons from these health systems reforms can play a key role in guiding health system 
reforms of other similar post-conflict affected or low and middle income countries wherein 
disparities, particularly in terms of health, were very similar with that of Cambodia and the 
Philippines. In both countries, corruption and differences in political priorities with least priority 
given for health were also identified as a potential barrier for effective health service delivery 
leading to less effects of vertical balances on infant mortality rates. It is apparent that local 
economic development needs strong leadership from the local government to continually manage 
the flow of financial resources.  
 
The benefit of decentralization is not only in encouraging people to participate in local government, 
but also in providing them with an avenue to increase the demand for health services by putting 
pressure to their leaders. Studies in Cambodia identified that contracting services to non-
governmental organisations and increasing community participation may have contributed to health 
outcomes. Hence, other than ensuring vertical balances across regions, countries like the Philippines 
may also consider health systems strengthening initiatives encouraging increased community 
participation for local health service delivery and decision-making processes. For example, citizen 
watchdog or an involved/informed constituency for financial planning, budgeting, expenditure and 
accountability, may be able to translate to increased demand for health services, leading to lower 
IMR.  
 
Simplifying decentralization into a single dimension becomes more complicated when other aspects 
of decentralization are considered at the same time. For example, the level of autonomy becomes 
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unclear when we compare a local government with significant fiscal decentralization and 
deconcentrated authority to a local authority with few resources but devolved authority. These 
measures may require taking into account the interrelationship of the dimensions. In cases in which 
there was no fiscal data available in certain years but data were available for others, linear trends 
obtained through regression analysis of available data also filled the missing years. As most fiscal 
indicators are variables that change incrementally over time, this approach was not likely to change 
the results. Interpolating the data across years provided more cases for analysis, though the results 
were unchanged by using data from a single year alone. Further, understanding that confounders 
may be able to distort the relationship between the independent and dependent variables and that 
this distortion can lead to erroneous conclusions, I controlled for confounding in this research. 
Confounding can be controlled through the design and analytical stages. For the design stage, 
randomization, restriction, and matching of the dependent variables can be done (Ashengrau & 
Seage, 2014). I controlled for confounding at the analytical stage through standardization by urban 
and rural classification and regions, stratified analysis, and multivariate analysis. Although 
matching allowed balance distribution of data in each strata, smaller standard error, and narrower 
confidence interval, my analysis of the dataset did not find an exact match.  
 
In both countries, findings also showed that local financial resources and fiscal capacity as indicated 
by VB have been steadily improving since decentralization. Tax revenues have been the single 
source of income among affluent areas. In contrast, poor provinces are still highly dependent on 
national transfers like the Internal Revenue Allotment, implying a need to further strengthen the 
taxing capacities of the local governments to make them more financially viable and ultimately 
achieve financial independence. With this, emphasis on capacity building in the major areas of local 
taxation like property valuation, land administration and tax collection were deemed necessary. 
LGUs can then expand their fiscal space and be able to put more resources in strategic development 
programs on health and education. Equally important, low-income provinces have been struggling 
to provide social services at a wider coverage as evident for both Cambodia and the Philippines 
with the same areas getting the poorest values for almost all measures used in this study. These 
areas, which were also mostly ravaged by past or ongoing conflicts, consistently had poorer health 
outcomes and may need more attention from central governments. On the expenditure side, local 
government units have traditionally allotted their expenses to general public services with little 
priority to health and education services. If this trend continues, the inefficiency on local 
government spending was counterproductive in achieving the national targets in improving health 
outcomes. Reforms in the budgeting and expenditure process should be introduced across the 
internal systems of local governments to make them more responsive and impact-oriented to public 
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health outcomes. The policies on budget excesses and debt servicing can be revisited as another 
way to improve the financial management of LGUs (van Olmen et al., 2012). In the final analysis, 
the health care systems in the Philippines and Cambodia need to be continually refined to remain 
responsive to the needs of the people especially in the face of the devolution of health service 
delivery to the LGUs. Financing is certainly a big part of the issue. Equally important is the 
combined leadership and motivation of the local government officials, the support of the national 
government, and participation of the people in the community (Valdez-Vivas et al., 2015; Veillard 
& Maurice, 2012).   
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Chapter 7 Summary, Conclusions, and Recommendations 
 
Health Systems Strengthening (HSS) is about improving the overall system that is directly 
responsible for better health outcomes, and if HSS is done in an evidence-informed way, health 
outcomes will improve. In this thesis, I contributed to HSS research by improving 
conceptualisations, measurement and accountability reporting, and also carried out empirical 
examinations to see if HSS was associated with health outcomes relating to child and infant 
mortality and life expectancies. In particular, this thesis examined the relations between HSS 
initiatives and child health outcomes, as well as life expectancies. This thesis also examined HSS 
concepts, frameworks, and measures that can be used for assessing HSS initiatives to inform global 
and national policymaking and practices.  
 
Millions of dollars are allocated annually under the umbrella of HSS. However, conducting HSS 
monitoring and evaluation is difficult because of the complexity involved (De Savigny & Adam, 
2009). For example, other socioeconomic factors and health service interventions may also 
significantly affect a country’s health systems performance and health outcomes (Adam & de 
Savigny, 2012). Hence, assessing progress on HSS and determining whether these HSS initiatives 
are effectively achieving their goals remain challenging (Adam & de Savigny, 2012).  Further, HSS 
concepts, frameworks, and measures that are required to guide HSS monitoring and evaluation 
highly vary across countries (Gerring et al., 2013). To this end, there are no widely accepted HSS 
assessment concepts, frameworks, and measures (Hong & Huibin, 2002). Countries also have 
varying capacities to conduct HSS monitoring and evaluation with some countries conducting more 
comprehensive HSS assessments than others primarily due to resource constraints. As such, more 
evidence is needed to help set the minimum standards for HSS monitoring and evaluation to ensure 
its quality and usefulness for policymaking and practice, while still considering existing country 
capacities and health systems challenges. Addressing these research gaps in HSS monitoring and 
evaluation will also help guide decisions for HSS grant allocations, which are mostly subjected to 
performance-based funding approaches.  
 
By determining the key concepts, frameworks and indicators that can be used for HSS monitoring 
and evaluation based on existing documents from HSS grant recipient-countries, I found that this 
monitoring and evaluation involves a comprehensive and complex picture of HSS to include 
assessments across the different health systems building blocks (governance, financing, service 
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delivery, workforce, medical products and technologies, and health information systems). Using 
results from systematic analyses of HSS concepts and measures, I also created and developed 
taxonomies of health systems performance that can be used to inform global and regional-levels of 
HSS monitoring and evaluation.  However, I found that these global and comparative methods also 
faced multiple constraints, which influence their effective use in national policymaking. In 
particular, ranking a country’s health systems performance may not necessarily inform the health 
system reforms needed by these countries. Due to different country contexts, HSS assessments may 
be better applied to a narrower and more specific context than to overall global and national 
assessments. To apply these methods in a national context, I examined HSS initiatives in the 
context of decentralized health systems and determined how decentralizing health services may 
have affected child health outcomes, particularly infant mortality rates, using the cases of Cambodia 
and the Philippines. 
 
Research Question 1: How should we conceptualize and assess HSS initiatives? 
 
The concept of HSS and its relations to global priority areas for health 
 
Previous studies mapped how the concept of HSS may have evolved from a disease-specific 
approach for healthcare service delivery to a more system-wide approach for improving health 
(Galichet et al., 2010). I supported such findings with evidence identifying how key public health 
conferences and events have pushed the global health agenda towards more preventive and 
promotive aspects of health care.  Chapter One presented the results from this review of key public 
health statements made over the past four decades. Specifically, I found nine key themes: a) 
improving equity, access, and social justice; b) increasing funding and better priority setting to 
achieve UHC; c) improving governance for health; d) building capacities for research, health 
workforce, and health systems; e) creating better collaboration and cooperation, as well as 
integrating and embedding health across sectors; f) reorienting towards improved community action 
and people-centeredness; g) determining appropriate metrics, and developing better monitoring and 
evaluation processes for health systems; h) creating supportive environment for health and 
addressing key health determinants; and i) calling for action from different health system actors. 
These nine themes cut across the inputs needed for health systems strengthening. These findings 
suggested the shift from solely disease-focused interventions towards more system-wide approaches 
to achieve health outcomes and acknowledged that health is complex and comprehensive; hence, 
requiring an even more holistic approach for health service delivery.  
 
Chapter Seven 
 162
Developing an HSS framework based on identified HSS domains and measures 
 
As stated above, HSS assessments require having a better understanding of key HSS concepts and 
measures. To achieve this objective, Chapter Two provided baseline information on how HSS 
monitoring and evaluation was done across the European Region and where data permit, a template 
for HSS monitoring and evaluation framework and processes that other countries and HSS program 
providers can use as a guide for their own. Specifically, chapter two provides a comprehensive 
description of the different concepts, domains, and indicators used for HSS assessments across the 
Region. Europe was selected to address this research objective because compared to all other 
regions, Europe had its own Task Force for Health Systems Strengthening Performance 
Assessments and have made Member States commit to assessments of the health systems when 
these countries signed the Tallinn Charter (WHO, 2008b). Using the WHO Health Systems 
Building Block framework as a guide, additional data sources were sought from the Member States 
and examined to identify the key HSS domains that already existed and were identified as relevant 
by the countries themselves. These domains were then used to develop a new HSS monitoring and 
evaluation framework that combines all the potential domains that other countries can examine and 
use for their own HSS assessments. This framework can be used for the initial design phases of 
HSS, particularly for countries who are yet to structure their monitoring and evaluation systems. 
These findings provided countries with resources to choose from to map, measure, and assess their 
own HSS and/or improve their current HSS assessment practices.  
 
Existing and potential HSS program-level indicators tailored to specific country capacities and 
purposes 
 
After identifying the framework and key dimensions that are available within countries, the next 
step to guide HSS assessments was to identify existing and other potential programme-level HSS 
indicators that were tailored to specific country capacities and purposes. To achieve this objective, 
Chapter Three identified indicators from existing HSS monitoring and evaluation frameworks of 
HSS grant recipients. Prior to receiving HSS grants, countries commit to the indicators that will be 
used to determine their health systems progress and to guide allocation of HSS grants specifically 
intended to improve immunisation outcomes. From the monitoring and evaluation frameworks that 
countries submitted, I identified additional tailored HSS indicators to complement the existing core 
indicators for HSS grants. Based on a systematic analysis, interviews, and internal review 
processes, I identified existing and potential indicators that can be used to streamline the monitoring 
and evaluation of HSS grants, while considering country’s capacities to track and perform against 
these indicators. Findings showed the wide variability for HSS indicators across HSS-recipient 
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countries. Internal scoring was done to assess the validity of each indicator for HSS and examined 
how such measures can be used to track performance and progress against HSS grant objectives. 
Findings provide baseline information on how HSS can be assessed to inform existing and future 
HSS grant allocations. This process can also then facilitate creation of more standard measures to 
assist other ongoing and future HSS programs. 
 
How significant are HSS initiatives to improve health outcomes? 
 
 
Socioeconomic and institutional factors that may significantly influence child health outcomes 
and life expectancies 
 
Central to the work towards health systems strengthening was the analysis of how each health 
system building block affected health outcomes. Despite the vast research done on HSS, little 
research has still been conducted to determine how each health system building block is related to 
health outcomes especially in the context of LMICs (Mounier-Jack et al., 2014). Chapter Four 
examined the relationship between key health systems indicators and different measures of health 
outcomes, including infant mortality rates, child mortality rates, and life expectancy rates, using 
cross-sectional data from 137 low and middle income countries from 1990 to 2010. Health systems 
performance and health outcomes have been continuously improving in LMICs over the years, but 
it remains unclear how much of this can be attributed to HSS (Berger & Messer, 2002; Gani, 2009). 
My discussion focused on how improving controls for corruption, ensuring government 
effectiveness, and implementing the rule of law, as well as increasing external and private resources 
for health would potentially reduce child mortality rates and improve life expectancies. Findings 
also reiterated the importance of antenatal care coverage particularly in LMICs and how 
pharmaceutical public spending may also aid in ensuring access for medical products and 
technologies; hence, further increasing health outcomes. Overall, results showed how every unit of 
increase in the scores for governance, service delivery and workforce also leads to 2 to 3 more 
months of life for every child and how each unit of increase in health workforce saves 7 more 
infants and 536 children per 1000 live births. Findings highlighted the importance of continuing 
efforts to strengthen these different functions of the health systems and also better understand how 
they relate to health outcome indicators that are being used to assess HSS initiatives. 
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Opportunities and barriers for developing a composite indicator for health systems performance 
and identify taxonomies of health systems performance in low- and middle-income countries 
 
Chapter Five developed a taxonomy of HSS initiatives to clearly point out the similarities and 
differences in health systems performance of different countries; to discuss how differences in 
health systems characteristics influences health outcomes; and to understand how overall HSS 
progressed over the years. Despite the limitations, assessing health systems performance using 
observable characteristics is necessary and can be informative. The taxonomy developed builds on 
indicators identified in previous health systems performance assessments that were constantly 
monitored and made comparable across countries. While context specificity is important and many 
other factors related to health systems may not be accounted for in national databases, I argue that 
such empirically derived taxonomies can still be used to identify country-level and global progress 
on key health systems performance indicators. This information may also be used to determine 
which measures matter for global monitoring of trends on HSS. In a similar way that quality 
scorecards are used in healthcare delivery, the resulting taxonomy can also be used to improve 
systems-level approaches. The OECD has provided a springboard for many comparative analyses of 
health policies that examined how sector-specific institutional contexts shape health policies (Burau 
& Blank, 2006; Mossialos, 2010). Findings provided an overview for the progress on each health 
system building block that were dominant and comparable in many countries (Mossialos, 2010). 
Evidence showed the characteristics and the geographical locations of least performing health 
systems, which were not yet examined in the current literature. Findings may also be used to assist 
in determining such characteristics of poor performing health systems and can also be used as a 
starting point or guide for health systems performance monitoring. It can then provide insights to 
improve strategies for HSS and to identify health systems barriers. Taxonomies can also help 
capture targets central to achieve health goals, contributing towards evidence-informed health 
policies and interventions across countries. Taxonomies can also be used to set national 
improvement priorities (WHO, 2013f).  
 
Factors to be considered when assessing HSS in Cambodia and the Philippines  
 
In Chapter Six, I focused on the governance dimension of HSS, particularly the transitions from 
centralized health systems to a more decentralized one. This chapter moved the discussions forward 
from the global contexts of HSS discussed in previous chapters to a national-level context for health 
systems analysis. Specifically, this chapter addresses whether decentralized health systems translate 
to positive child health outcomes. In particular, I examined how decentralized health systems in 
Cambodia and the Philippines relate to infant mortality rates and fertility rates and determined how 
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the different HSS initiatives in Cambodia and the Philippines operate in a decentralized system. I 
found that decentralization significantly affects regional-level infant mortality rates in Cambodia, 
but did not show significant difference for the Philippines. Despite widening fiscal decentralization 
in the Philippines and better vertical balances for its regions, previous studies showed that local 
government units in the Philippines did not spend more on health systems. I also found significant 
inequalities across regions, particularly in terms of local resources allocated for improve health 
outcomes. In both countries, results showed that areas with more fiscal gaps were mostly in rural 
areas or conflict-affected areas like ARMM for the Philippines and Mondul Kiri and Ratanak Kiri 
for Cambodia. These countries also had poorer health outcomes, implying that the potential of 
decentralized health systems may not necessarily be realised in areas with larger vertical 
imbalances. These findings also suggest that as long as an LGU spends more than its revenues, 
healthcare is most likely least prioritised despite increasing intergovernmental transfers and fiscal 
capacity.  
 
Main conclusions and recommendations 
 
In this thesis, I gathered evidence that can be put into practical use in health systems monitoring and 
evaluation. This thesis provided a new framework for assessing HSS initiatives, developed a 
reference list of indicators for health systems performance, and examined different cases of HSS 
initiatives at the global and national levels.  The main conclusions and recommendations are: 
• Health Systems Strengthening (HSS) concepts, frameworks, and measures should be 
defined to facilitate comparison, judge validity and improve quality of HSS monitoring and 
evaluation. This thesis, particularly chapters one to three, contributed to achieve this 
objective. 
• Methods for quantifying the effects of HSS on child health outcomes, particularly infant 
mortality rates and life expectancy at birth should be determined and examined to assist in 
tracking performance and progress towards achieving the health systems goals. Different 
regression models, principal components analyses, and clustering were applied in Chapters 
four and five, which were developed for use in HSS assessments. These models can be 
based on a combination of factors from the six health systems building blocks and other 
variables identified as relevant for HSS in the previous frameworks. Meanwhile, Chapter six 
provided two cases of HSS assessments. In particular, Chapter six focused on  the 
governance aspect of health systems using the cases of decentralised health systems in 
Cambodia and the Philippines, examining how HSS assessments can be used to further 
inform and guide health policymaking and practices.  
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Appendices 
 
Appendix 1. Supplementary information for Chapter One 
 
Table A1. Dimensions of health systems performance compared across different existing 
health systems frameworks 
Dimensions Chapter 2  WHO OECD CF UK Canada USA 
Leadership/governance √ √ √  √ √  
Health financing, expenditure 
or costs 
√ √ √ √ √ √ √ 
Service delivery or health care 
activities 
√ √ √ √ √  √ 
Health workforce √ √ √ √  √ √ 
Medical products and 
technologies 
√ √    √  
Health information systems √ √      
Socioeconomic contexts √  √     
Cultural and environmental 
contexts 
√    √   
Other health or non-healthcare 
determinants 
√  √     
Access √ √ √ √ √ √ √ 
Appropriateness √   √  √  
Availability √       
Competence √     √  
Continuity and sustainability √   √  √  
Effectiveness √  √ √ √ √ √ 
Efficiency √ √    √ √ 
Equality √       
Equity √ √ √  √ √ √ 
People-centeredness and 
empowerment 
√ √ √ √ √ √ √ 
Responsiveness √ √ √ √ √ √ √ 
Safety √ √ √  √ √ √ 
Social and financial risk 
protection 
√ √      
Health status √ √ √     
Health impact √       
Inter-sectoral linkages √       
Quality  √ √     
Notes: WHO, World Health Organisation (WHO, 2000); OECD, Organisation for Economic 
Cooperation and Development (Arah et al., 2006); CF, Commonwealth Fund (Arah et al., 2006; 
CommonwealthFund, 2015); UK, United Kingdom (Arah et al., 2006; EuropeanObservatory, 
2015b); USA United States of America (Arah et al., 2006) Source: Author’s findings discussed in 
Chapter 2 and findings of Arah, 2006 (Arah et al., 2006). 
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Appendix 2. Supplementary information for Chapter Four 
 
a) Governance b) Financing 
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Figure A2. Scree plots of eigenvalues per HS building block calculated using principal components 
analysis. Panel A plots the eigenvalues after factor for governance indicators, Panel B for health 
financing indicators. Panel C for service delivery indicators, Panel D for health workforce 
indicators, Panel E for medical products and technologies, and Panel F for health information 
systems.  
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Appendix 3. Supplementary information for Chapter Four and Five 
 
Table A3. Summary statistics for the data used for each building block 
Variable  Mean Std Dev Min Max Observations 
Dependent 
variables 
      
IMR overall 67.45 29.41 11.1 152.5 N = 227 
between  28.22 13.85 135.5 n = 83 
within  12.47 34.47 104.72 T = 2.73 
CMR overall 105.61 59.98 11.6 326.2 N = 227 
between  56.21 15.3 282.17 n = 83 
within  22.38 41.14 178.11 T = 2.73 
LE overall 59.01 10.81 19.5 79.56 N = 7113 
between  9.24 37.8 73.98 n = 142 
within  5.86 29.23 80.78 T = 50.09 
DTP3 overall 60.45 22.66 2.6 97.9 N = 192 
between  19.45 15.95 96.2 n = 72 
within  13.24 14.55 94.28 T = 2.67 
Governance       
control of corruption overall -0.5 0.62 -2.06 1.56 N = 1953 
between  0.58 -1.72 1.43 n = 137 
within  0.21 -1.43 0.6 T-bar = 13.66 
government 
effectiveness 
overall -0.51 0.64 -2.45 1.28 N = 1946 
between  0.61 -2.18 1.21 n = 137 
within  0.2 -1.62 0.42 T-bar = 13.61 
political stability and 
absence of violence 
overall -0.41 0.94 -3.32 1.54 N = 1939 
between  0.88 -2.83 1.37 n =  137 
within  0.34 -2.51 1.1 T-bar = 13.56 
regulatory quality overall -0.49 0.73 -2.68 1.64 N = 1948 
between  0.69 -2.43 1.48 n = 137 
within  0.23 -1.83 0.67 T-bar = 13.62 
rule of law overall -0.52 0.7 -2.67 1.38 N = 1969 
between  0.68 -2.36 1.25 n = 137 
within  0.19 -1.44 0.94 T-bar = 13.77 
voice and 
accountability 
overall -0.39 0.84 -2.28 1.31 N = 1978 
between  0.81 -2.17 1.19 n = 137 
within  0.21 -1.65 0.41 T-bar = 13.8322 
Financing       
external resources 
for health as % of 
total expenditure on 
health 
overall 11.72 15.41 0.01 105.05 N = 2150 
between  13.43 0.06 70.97 n = 137 
within  7.6 -27.05 67.88 T = 15.47 
OOP as % of private 
expenditure on 
health 
overall 80.29 20.82 0.55 100 N = 2330 
between  20.37 2.04 100 n = 137 
within  5.42 51.54 105.79 T = 16.64 
  191 
per capita 
government 
expenditure on 
health, PPPint 
overall 159.14 187.05 0.12 1222.41 N = 2340 
between  169.43 2.38 1064.97 n = 137 
within  79.2 -172.12 610.35 T = 16.71 
per capita total 
expenditure on 
health, PPPint 
overall 275.02 281.54 9.23 1605.32 N = 2326 
between  254.48 16 1411.37 n = 137 
within  121.24 -193.73 937.98 T = 16.73 
private expenditure 
on health as % of 
THE 
overall 47.87 20.08 0.02 99.61 N = 2330 
between  19.04 0.14 87.13 n = 137 
within  6.7 7.05 87.84 T = 16.64 
private prepaid plans 
as % of private 
expenditure on 
health 
overall 9.89 14.2 0.01 86.5 N = 1642 
between  13.09 0.09 73.96 n = 107 
within  4.78 -20.9 55.93 T = 15.35 
Service delivery 
pregnant women 
who attended at least 
one antenatal care 
visit 
overall 79.74 18.23 24.5 98.7 N = 176 
between  16.36 29.1 98.7 n = 71 
within  7.32 54.97 103.84 T = 2.48 
HIV test results 
received in the last 
12 months of female 
population aged 15 
to 49 
overall 4 3.78 0.1 40.32 N = 1750 
between  3 0.3 13.51 n = 137 
within  1.58 -6.61 30.81 T = 12.41 
improved sanitation 
facilities 
overall 58.02 29.73 2.3 100 N = 2939 
between  29.55 7.15 99.78 n = 137 
within  5.13 24.39 82.48 T = 20.69 
Medical products and technologies 
pharmaceutical 
public spending per 
capita 
overall 10.37 14.71 0.04 117.37 N = 976 
between  12.78 0.06 102.37 n = 105 
within  5.36 -12.05 41.8 T = 9.30 
pharmaceutical 
private spending per 
capita 
overall 19.35 22.24 0.32 157.97 N= 959 
between  24.54 0.84 135.57 n = 102 
within  10.4 -51.98 84.81 T = 9.40 
total pharmaceutical 
expenditure as % of 
THE 
overall 26.49 12.03 5.77 68.01 N = 1142 
between  11.45 8.7 64.92 n = 124 
within  5.3 -5.35 61.9 T = 9.21 
total pharmaceutical 
expenditure at US 
exchange rate 
overall 28.68 31.92 0.84 199.53 N = 1142 
between  29.7 1.33 144.92 n = 124 
within  13.64 -65.07 125.57 T = 9.21 
Workforce       
births attended by 
doctors, % of total 
births 
overall 23.55 26.69 0.3 97 N = 177 
between  26.76 0.4 91.2 n = 75 
within  7.19 -7.13 59.57 T = 2.36 
births attended by 
other health 
professionals, % of 
total births 
overall 32.85 21.33 2 97.9 N = 179 
between  22.28 3 97.9 n = 75 
within  8.51 -0.43 63.77 T = 2.39 
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births attended by 
skilled health staff, 
% of total births 
overall 80.31 25.62 5.6 100 N = 1017 
between  26.73 7.1 100 n = 137 
within  6.45 49.11 111.11 T = 7.21 
Control variables       
fertility rate overall 4.37 1.58 1.2 11.3 N = 228 
between  1.51 1.3 7.1 n = 84 
within  0.57 1.92 8.62 T = 2.71 
GDP per capita overall 1950.1
7 
2011.28 50.04 14678.61 N = 5589 
between  1915.1 156.75 9467.01 n = 139 
within  818.55 -3472.37 8626.41 T-bar = 40.21 
GINI Index overall 43.29 9.98 21.6 74.33 N = 791 
between  9.04 27.66 69.12 n = 121 
within  3.68 26.11 66.37 T = 6.54 
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Figure A3.1 Scatterplot matrices for each health system building block and life expectancy at birth for wave one; 3 - low income countries; 2 -
lower middle income countries; and 1 - upper middle income countries 
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Figure A3.2 Scatterplot matrix for each health system building block and life expectancy at birth for wave two of the data; 3 - low income 
countries; 2 - lower middle income countries; and 1 - upper middle income countries 
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Figure A3.3 Scatterplot matrix for each health system building block and life expectancy at birth for wave three of the data; 3 - low income countries; 
2 - lower middle income countries; and 1 - upper middle income countries 
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Appendix 4. Supplementary information for Chapter Six 
 
Table A4.1 Summary statistics for the regional dataset in the Philippines 
Variable Mean Std. Dev. Min Max Obs 
IMR overall 32.65 11.07 14.00 61.40 N = 82 
 between  6.69 22.56 46.03 n = 17 
 within  9.02 7.21 51.57 T-bar = 4.82 
Fertility overall 3.83 0.74 2.30 5.91 N = 82 
 between  0.55 2.53 4.76 n = 17 
 within  0.51 2.70 5.11 T-bar = 4.82 
VB overall 0.90 0.07 0.78 1.05 N = 75 
 between  0.03 0.85 0.95 n = 15 
 within  0.06 0.80 1.04 T-bar = 5 
ANC overall 32.85 15.75 11.60 81.30 N = 82 
 between  15.20 15.28 73.48 n = 17 
 within  5.08 17.57 45.37 T-bar = 4.82 
Asst overall 28.87 14.20 3.40 67.50 N = 82 
 between  12.84 8.10 61.68 n = 17 
 within  6.79 14.21 53.21 T-bar = 4.82 
Place overall 28.20 14.48 4.00 72.40 N = 82 
 between  10.59 6.40 51.90 n = 17 
 within  10.29 8.80 56.00 T-bar = 4.82 
Cont overall 98.21 4.28 77.90 100.00 N = 82 
 between  3.60 85.55 99.88 n = 17 
 within  2.74 84.77 104.86 T-bar = 4.82 
Educ overall 6.22 5.13 0.00 30.40 N = 82 
 between  4.34 2.26 21.33 n = 17 
 within  3.26 2.51 16.84 T-bar = 4.82 
Source: Author’s computations using the Philippine NDHS and government financial reports 
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Table A4.2 Summary statistics for the regional dataset in Cambodia 
Variable 
 
Mean 
Std. 
Dev Min Max Observations 
infant mortality rates overall 72.798 31.00 13.00 169.80 N = 96 
between 
 
17.41 27.40 111.45 n = 24 
within 
 
25.84 26.45 134.85 T = 4 
total fertility rate overall 3.581 0.87 2.00 6.30 N = 96 
between 
 
0.58 2.15 4.83 n = 24 
within 
 
0.66 2.06 5.06 T = 4 
vertical balance overall 0.761 0.15 0.36 1.00 N = 144 
between 
 
0.10 0.59 0.97 n = 24 
within 
 
0.12 0.41 1.02 T = 6 
antenatal coverage overall 3.794 8.34 0.00 67.20 N = 96 
between 
 
5.43 0.73 23.88 n = 24 
within 
 
6.41 -13.98 47.12 T = 4 
assisted births overall 6.461 9.74 0.10 73.20 N = 96 
between 
 
7.20 1.95 36.63 n = 24 
within 
 
6.69 -19.66 43.04 T = 4 
place of delivery overall 32.446 26.94 1.90 96.00 N = 96 
between 
 
10.17 18.95 64.70 n = 24 
within 
 
25.01 -9.48 85.67 T = 4 
contraceptive 
knowledge 
overall 69.432 27.91 21.50 100.00 N = 96 
between 
 
5.96 54.53 78.48 n = 24 
within 
 
27.29 31.86 112.21 T = 4 
educational attainment overall 28.091 12.07 8.80 75.10 N = 96 
between 
 
9.23 11.60 53.78 n = 24 
within 
 
7.95 8.22 49.69 T = 4 
Source: Author’s computations using the Cambodian NDHS and government financial reports 
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Figure A4.1 Regional infant mortality rates for the Philippines from 2001 to 2008 
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Figure A4.2 Regional infant mortality rates in Cambodia from 2000 to 2014 
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Figure A4.3 Regional total fertility rates in the Philippines from 2001 to 2008 
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Figure A4.4 Regional total fertility rates in Cambodia from 2000 to 2014 
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Figure A4.5 Regional vertical balance values in the Philippines from 2001 to 2008 
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Figure A4.6 Regional vertical balance in Cambodia from 2000 to 2014 
